
<html lang="en"     class="pb-page"  data-request-id="a49bb465-c8a1-4e4f-9493-0da388e315f2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2011.54.issue-12;website:website:acspubs;article:article:10.1021/jm1016279;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds" /></meta><meta name="dc.Creator" content="Daniel I.  Perez" /></meta><meta name="dc.Creator" content="Valle  Palomo" /></meta><meta name="dc.Creator" content="Concepción  Pérez" /></meta><meta name="dc.Creator" content="Carmen  Gil" /></meta><meta name="dc.Creator" content="Pablo D.  Dans" /></meta><meta name="dc.Creator" content="F. Javier  Luque" /></meta><meta name="dc.Creator" content="Santiago  Conde" /></meta><meta name="dc.Creator" content="Ana  Martínez" /></meta><meta name="dc.Description" content="Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, b..." /></meta><meta name="Description" content="Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, b..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 17, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1016279" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1016279" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1016279" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1016279" /></link>
        
    
    

<title>Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1016279" /></meta><meta property="og:title" content="Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0015.jpeg" /></meta><meta property="og:description" content="Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following our hypothesis based on the enhanced reactivity of residue Cys199 in the binding site of GSK-3, we examine here the suitability of phenylhalomethylketones as irreversible inhibitors. Our data confirm that the halomethylketone unit is essential for the inhibitory activity. Moreover, addition of the halomethylketone moiety to reversible inhibitors turned them into irreversible inhibitors with IC50 values in the nanomolar range. Overall, the results point out that these compounds might be useful pharmacological tools to explore physiological and pathological processes related to signaling pathways regulated by GSK-3 opening new avenues for the discovery of novel GSK-3 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1016279"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1016279">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1016279&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1016279&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1016279&amp;href=/doi/10.1021/jm1016279" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4042-4056</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101625x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200028h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+I.++Perez">Daniel I. Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valle++Palomo">Valle Palomo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Concepci%C3%B3n++P%C3%A9rez">Concepción Pérez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Gil">Carmen Gil</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pablo+D.++Dans">Pablo D. Dans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Javier++Luque">F. Javier Luque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Conde">Santiago Conde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Mart%C3%ADnez">Ana Martínez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div><div class="aff-info" id="aff2"><span class="aff-text">Biomolecular Simulations Group, Institut Pasteur de Montevideo, Mataojo 2020, 11400 Montevideo (Uruguay)</span></div><div class="aff-info" id="aff3"><span class="aff-text">Departamento de Fisicoquímica e Instituto de Biomedicina (IBUB), Facultad de Farmacia, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona (Spain)</span></div><div class="corresp-info">Phone: +34 91 5680010. Fax: +34 91 5644853. E-mail: <a href="/cdn-cgi/l/email-protection#2a4b474b585e43444f506a435b470449594349044f59"><span class="__cf_email__" data-cfemail="85e4e8e4f7f1ecebe0ffc5ecf4e8abe6f6ece6abe0f6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1016279&amp;href=/doi/10.1021%2Fjm1016279" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4042–4056</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 18, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 December 2010</li><li><span class="item_label"><b>Published</b> online</span>17 May 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 June 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1016279" title="DOI URL">https://doi.org/10.1021/jm1016279</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4042%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniel%2BI.%2BPerez%252C%2BValle%2BPalomo%252C%2BConcepci%25C3%25B3n%2BP%25C3%25A9rez%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D12%26contentID%3Djm1016279%26title%3DSwitching%2BReversibility%2Bto%2BIrreversibility%2Bin%2BGlycogen%2BSynthase%2BKinase%2B3%2BInhibitors%253A%2BClues%2Bfor%2BSpecific%2BDesign%2Bof%2BNew%2BCompounds%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4056%26publicationDate%3DJune%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1016279"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3832</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1016279" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;I. Perez&quot;},{&quot;first_name&quot;:&quot;Valle&quot;,&quot;last_name&quot;:&quot;Palomo&quot;},{&quot;first_name&quot;:&quot;Concepción&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Gil&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;D. Dans&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Javier Luque&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Conde&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Martínez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;4042-4056&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1016279&quot;},&quot;abstract&quot;:&quot;Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following our hypothesis based on the enhanced reactivity of residue Cys199 in the binding site of GSK-3, we examine here the suitability of phenylhalomethylketones as irreversible inhibitors. Our data confirm that the halomethylketone unit is essential for the inhibitory activity. Moreover, addition of the halomethylketone moiety to reversible inhibitors turned them into irreversible inhibitors with IC50 values in the nanomolar range. Overall, the results point out that these compounds might be useful pharmacological tools to explore physiological and pathological processes related to signaling pathways regulated by GSK-3 opening new avenues for the discovery of novel GSK-3 inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016279" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016279&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016279" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016279&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016279" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1016279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016279&amp;href=/doi/10.1021/jm1016279" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1016279" /></input><a href="/doi/pdf/10.1021/jm1016279" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1016279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1016279%26sid%3Dliteratum%253Aachs%26pmid%3D21500862%26genre%3Darticle%26aulast%3DPerez%26date%3D2011%26atitle%3DSwitching%2BReversibility%2Bto%2BIrreversibility%2Bin%2BGlycogen%2BSynthase%2BKinase%2B3%2BInhibitors%253A%2BClues%2Bfor%2BSpecific%2BDesign%2Bof%2BNew%2BCompounds%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D12%26spage%3D4042%26epage%3D4056%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jmcmar.2011.54.issue-12/production/jmcmar.2011.54.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following our hypothesis based on the enhanced reactivity of residue Cys199 in the binding site of GSK-3, we examine here the suitability of phenylhalomethylketones as irreversible inhibitors. Our data confirm that the halomethylketone unit is essential for the inhibitory activity. Moreover, addition of the halomethylketone moiety to reversible inhibitors turned them into irreversible inhibitors with IC<sub>50</sub> values in the nanomolar range. Overall, the results point out that these compounds might be useful pharmacological tools to explore physiological and pathological processes related to signaling pathways regulated by GSK-3 opening new avenues for the discovery of novel GSK-3 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases are important targets for cancer, inflammatory diseases, diabetes, and neurodegenerative disorders, because aberrant protein kinase signaling is implicated in many of these human diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To date, ten protein kinase (PK) inhibitors are in clinical use for different cancer treatments.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While some of these agents are active in a subset of patients, most of them develop resistance within the course of one year. To overcome such a problem, irreversible PK inhibitors are gaining importance<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> as a new class of therapeutic agents. This knowledge is now being applied to other therapeutic areas such as inflammatory and neurodegenerative pathologies, where PK inhibitors have not reached clinical use yet.</div><div class="NLM_p">Although several candidate therapeutics for PKs in the central nervous system (CNS) are now in different preclinical and clinical stages,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> the development of kinase-targeted therapies for CNS diseases remains a challenge. Specifically inhibition of kinases that phosporylate tau protein could be beneficial for neurodegenerative diseases.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Among them, glycogen synthase kinase 3 (GSK-3) and cyclin-dependent kinase 5 (CDK-5) play a major hyperphosphorylating role <i>in vivo</i>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> GSK-3 inhibitors offer a valuable approach for a future therapy against Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Thus, abnormally high GSK-3 activity found in AD patient brains accounts not only for tau hyperphosphorylation, but also for memory impairment, increased β-amyloid production and local plaque-associated microglial-mediated inflammatory responses, which are characteristic hallmarks of the disease.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Recently, the reversion of these pathological features <i>in vivo</i> has been shown after oral treatment with a GSK-3 inhibitor in a double transgenic animal model of AD.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Many drug discovery programs are focused on the development of selective GSK-3 inhibitors. The discovery of non ATP-competitive inhibitors with high GSK-3 specificity is particularly challenging in order to minimize unfavorable off-target effects. In this context, allosteric GSK-3 modulation, as suggested for the basic alkaloid manzamine,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> or GSK-3 substrate competition,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> as noted for a small peptide in a study for diabetes, have been valuable strategies to modulate the activity of GSK-3. Other approaches to target GSK-3 avoiding ATP competition have also been envisaged. Specifically, on the basis of previous studies on GSK-3 inhibitors,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> we have recently hypothesized a new way to selectively target this important kinase based on the existence of a cysteine (Cys199) located in the ATP binding site.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Since Cys199 in GSK-3 is replaced by different amino acids in other structurally related kinases, such as CDK-1, CDK-2, or CDK-5, this approach would offer the possibility to design specific drugs via covalent modification of this key residue. Indirect support for this strategy comes from the inhibitory activity determined for thienylhalomethylketones and thiadiazolidindiones (TDZDs),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which are the first reported non ATP-competitive GSK-3 inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Among TDZDs, tideglusib (formerly known as NP-12) is now in phase II clinical trials both for AD and for an orphan tauopathy called progressive supranuclear palsy (PSP).</div><div class="NLM_p">Simultaneously with the writing of this manuscript, some data underlying the importance of cysteine identification on the kinase nucleotide binding site for the design of covalent specific protein kinase inhibitors have been reported.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">Our aim here is to examine the suitability of targeting Cys199, at the entrance of the ATP binding site of GSK-3, as a new drug discovery strategy to develop compounds useful as selective pharmacological tools against this important protein kinase. To this end, we first report the synthesis and biological characterization of phenylhalomethylketones chosen as bioisosters of the irreversible inhibitors previously described in our studies.<a onclick="showRef(event, 'ref17 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref21">(17, 21)</a> Moreover, based on X-ray crystallographic and molecular modeling data of GSK-3 complexes, the suitability of our strategy is reinforced by switching compounds with reversible inhibitory properties into irreversible inhibitors. This strategy led us to design, synthesize, and evaluate chemically diverse GSK-3 inhibitors with different kinetics regarding this enzyme. Overall, the results support the implications of Cys199 in the irreversible inhibition of GSK-3 and discover new clues for the synthesis of novel inhibitors for the treatment of human neurodegenerative diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Lead Modification and Structure–Activity Relationship</h3><div class="NLM_p">Screening of our compound library led to the discovery of thienylhalomethylketones as GSK-3 inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This behavior was reinforced by the inhibitory activity found for a small set of commercially available 4-substituted chloro and bromoacetylphenyl derivatives (<b>1</b>–<b>9</b>), as expected from the known bioisosterism between thiophene and benzene rings. Although these compounds showed an interesting range of activities, no clear relationship could be identified between the chemical features of the <i>para</i>-substitution and the biological activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GSK-3 Inhibitory Activity of HMKs and Related Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0001.gif" alt="" id="_i5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center" valign="top">no</th><th align="center" valign="top">X</th><th align="center" valign="top">R</th><th align="center" valign="top">Y</th><th align="center" valign="top" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="center"><b>1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Cl</td><td align="left">H</td><td align="left">O</td><td align="char" char=".">50</td></tr><tr valign="top"><td align="center"><b>2<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">H</td><td align="left">O</td><td align="char" char=".">5.0</td></tr><tr valign="top"><td align="center"><b>3<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Cl</td><td align="left">Cl</td><td align="left">O</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="center"><b>4<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">Cl</td><td align="left">O</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="center"><b>5<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">0.5</td></tr><tr valign="top"><td align="center"><b>6<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">Me</td><td align="left">O</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="center"><b>7<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">Ph</td><td align="left">O</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="center"><b>8<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">OMe</td><td align="left">O</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="center"><b>9<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></b></td><td align="left">Br</td><td align="left">NO<sub>2</sub></td><td align="left">O</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="center"><b>10</b></td><td align="left">I</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="center"><b>11</b></td><td align="left">phthalimide</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="center"><b>12</b></td><td align="left">NH<sub>2</sub></td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="center"><b>13</b></td><td align="left">SEt</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">>10</td></tr><tr valign="top"><td align="center"><b>14</b></td><td align="left">SPh</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="center"><b>15</b></td><td align="left">SBn</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">>10</td></tr><tr valign="top"><td align="center"><b>16</b></td><td align="left">OCOMe</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="center"><b>17</b></td><td align="left">OH</td><td align="left">Br</td><td align="left">O</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="center"><b>18</b></td><td align="left">Br</td><td align="left">Br</td><td align="left">NOH</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="center"><b>19</b></td><td align="left">Br</td><td align="left">Br</td><td align="left">NOMe</td><td align="char" char=".">50</td></tr><tr valign="top"><td align="center"><b>20</b></td><td align="left">Cl</td><td align="left">Br</td><td align="left">SO</td><td align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></div></div><div class="NLM_p">To gain insight into the structure–activity relationships of phenylhalomethylketones as GSK-3 inhibitors, a chemically more diverse set of molecules was evaluated using the 4-bromo-substituted derivative <b>5</b> as lead compound due to its high inhibitory activity (IC<sub>50</sub> = 0.5 μM). The novel derivatives were designed to explore the influence played by the nature of the halide atom and/or the carbonyl group, which were replaced by different heteroatoms or moieties such as iodine (<b>10</b>), oxygen (<b>16</b>, <b>17</b>), nitrogen (<b>11</b>, <b>12</b>), sulfur (<b>13</b>–<b>15</b>), sulfur monoxide (<b>20</b>), oxime (<b>18</b>), and alkyloxime (<b>19</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) KI, acetone, Δ; (ii) potassium phthalimide, AcN, Δ; (iii) RSH, K<sub>2</sub>CO<sub>3</sub>, EtOH; (iv) (AcO)<sub>2</sub>O, NaAcO, AcOH, Δ; (v) CAL-B, <sup>t</sup>BuOH:citrate-phosphate buffer (9:1); (vi) NH<sub>2</sub>OH·HCl or NH<sub>2</sub>OMe·HCl, EtOH, pyr; (vii) SO<sub>2</sub>Cl<sub>2</sub>, AgNO<sub>3</sub>, AcN.</p></p></figure><div class="NLM_p">The GSK-3 inhibitory activity was measured following a previously described method that uses [γ-<sup>32</sup>P]ATP and the small peptide GS-1 (based on residues of glycogen synthase phosphorylated by GSK-3) as substrate.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Among the different chemical modifications examined here, only replacement of the bromo acetyl moiety in compound <b>5</b> by the iodoacetyl one in <b>10</b> retained the inhibitory activity (IC<sub>50</sub> = 3.0 μM). All the other compounds did not show significant inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Therefore, these findings point out that the halomethylketone (HMK) moiety is a chemical feature necessary for the inhibition of GSK-3.</div><div class="NLM_p">To further examine the influence of the substituent in the benzene ring, different commercial acetophenones were converted to their bromomethylketo derivatives (<b>21</b>,<b> 23</b>, <b>25</b>, and <b>27</b>) by bromine treatment in chloroform at low temperature (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). In some cases, the dibromo methyl keto compound (<b>22</b>, <b>24</b>, <b>26</b>, and <b>28</b>) was also isolated. When <i>p</i>-aminoacetophenone was used as starting material, bromination not only in the methylketone group but also in the benzene ring was obtained (<b>29</b>). Furthermore, the benzene ring was replaced by the π-deficient 2-pyridine heterocycle, and bromination of 2-acetylpyridine yielded the dibromo derivative <b>30</b>. In all cases, an IC<sub>50</sub> value in the micromolar range was found (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), thus reinforcing the assumption that the bromoacetyl moiety is the key structural feature responsible for the inhibitory activity.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. </div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GSK-3 Inhibitory Activity of Bromoacetyl Aryl Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0002.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0017.gif" alt="" id="_i8" /></img><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemical Reactivity of Phenylhalomethylketones versus Thiol Group</h3><div class="NLM_p">It can be hypothesized that the GSK-3 inhibitory activity of haloacetylphenyl derivatives stems from the reactivity of the HMK moiety with the thiol unit of Cys199, which is located in the ATP binding site. It is therefore necessary to characterize the potential reactivity of haloacetylphenyl compounds in front of thiol groups. To this end, we have analyzed by HPLC–MS the reaction of compound <b>3</b> or <b>4</b> with 2-mercaptoethanol at room temperature (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The reaction afforded 11% and 20% of the S-alkylated product for <b>3</b> and <b>4</b>, respectively, in a 1:1 mix ratio after 1 h. When the mixture was stirred for 18 h, the yield of the S-alkylation was 74% and 50%, respectively. When the concentration of mercaptoethanol was increased 10-fold, 78% and 100% of the S-alkylated product was formed after 18 h. On the other hand, upon addition of a tertiary amine, such as triethylamine, at equimolar concentrations of compound <b>3</b> or <b>4</b> and mercaptoethanol, the S-alkylated product was formed in 65% (<b>3</b>) and 66% (<b>4</b>) after 1 h. The mixture was stirred for 18 h, but a significant increase of the S-alkylated product was not observed. Overall, the results confirm the susceptibility of phenylhalomethylketones to react with thiol groups and the enhanced reactivity upon addition of a suitable base, which might presumably enhance the nucleophilicity of the sulfur atom.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Formation of S-Alkylated Products in the Reaction of Compounds <b>3</b> and <b>4</b> with Mercaptoethanol</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0003.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">1 h</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">18 h</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">reaction conditions</th><th class="colsep0 rowsep0" align="center" char=".">SM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">FP<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">SM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">FP<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b>:SHEtOH 1:1</td><td class="colsep0 rowsep0" align="char" char=".">88%</td><td class="colsep0 rowsep0" align="char" char=".">11%</td><td class="colsep0 rowsep0" align="char" char=".">24%</td><td class="colsep0 rowsep0" align="char" char=".">74%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b>:SHEtOH 1:10</td><td class="colsep0 rowsep0" align="char" char=".">81%</td><td class="colsep0 rowsep0" align="char" char=".">19%</td><td class="colsep0 rowsep0" align="char" char=".">20%</td><td class="colsep0 rowsep0" align="char" char=".">78%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b>:SHEtOH:Et<sub>3</sub>N 1:1:1</td><td class="colsep0 rowsep0" align="char" char=".">33%</td><td class="colsep0 rowsep0" align="char" char=".">65%</td><td class="colsep0 rowsep0" align="char" char=".">34%</td><td class="colsep0 rowsep0" align="char" char=".">65%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b>:SHEtOH 1:1</td><td class="colsep0 rowsep0" align="char" char=".">80%</td><td class="colsep0 rowsep0" align="char" char=".">20%</td><td class="colsep0 rowsep0" align="char" char=".">50%</td><td class="colsep0 rowsep0" align="char" char=".">50%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b>:SHEtOH 1:10</td><td class="colsep0 rowsep0" align="char" char=".">47%</td><td class="colsep0 rowsep0" align="char" char=".">53%</td><td class="colsep0 rowsep0" align="char" char=".">----</td><td class="colsep0 rowsep0" align="char" char=".">100%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b>:SHEtOH:Et<sub>3</sub>N 1:1:1</td><td class="colsep0 rowsep0" align="char" char=".">33%</td><td class="colsep0 rowsep0" align="char" char=".">66%</td><td class="colsep0 rowsep0" align="char" char=".">25%</td><td class="colsep0 rowsep0" align="char" char=".">75%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">SM: starting material (compound <b>3</b> or <b>4</b>).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">FP: Final product (S-adduct).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Turning Reversible Inhibitors into Irreversible Inhibition</h3><div class="NLM_p">To confirm the implication of Cys199 in the inactivation of GSK3 by incubation with phenylhalomethylketones, we checked the possibility of turning reversible inhibitors into irreversible ones upon addition of the HMK unit in a proper position that facilitates the reaction with the thiol group of Cys199. To this end, three structurally distinct compounds were selected taking advantage of the known binding mode to GSK-3 from the X-ray crystallographic structures deposited in the Protein Data Bank: an analogue of ATP (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>), and two reversible inhibitors (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>). Accordingly, three classes of HMK-containing compounds—derivatives of adenine (<b>31</b>, <b>32</b>), benzimidazole (<b>35</b>, <b>36</b>), and maleimide (<b>37</b>–<b>40</b>)—were considered for chemical modification with Cys199 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (Top) Representation of the binding mode of an ATP analogue (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>), and two reversible inhibitors (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>; shown in sticks) in the ATP-binding site of GSK-3. Cys199 is shown in spheres. (Bottom) Structure-based design of novel compounds with potential GSK-3 inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The feasibility of this strategy was first explored by means of docking calculations, which were performed using <i>rDock</i> (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Molecular Modeling). The reliability of <i>rDock </i>was assessed by docking a set of known GSK-3 inhibitors taking advantage of the X-ray crystallographic structures of their complexes with the enzyme (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q5K">1Q5K</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UV5">1UV5</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O5K">2O5K</a>). It is noteworthy that the unrestrained docking protocol was able to predict satisfactorily the X-ray orientation of the compounds in five out of the six cases, as the experimental binding mode was identified as the first or second ranked pose with root-mean-square deviations less than 1.8 Å (see Table S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The X-ray binding mode of the ATP analogue had a higher rank (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>), as expected from the larger flexibility of the phosphodiester chain (see <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>). Inspection of the predicted poses derived for docking calculations for compounds <b>32</b>, <b>36</b>, and <b>40</b> revealed the existence of ligand orientations in the binding site that yielded the HMK moiety suitably positioned for chemical modification by Cys199. This is illustrated for <b>36</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> (see also <a class="ref internalNav" href="#notes-1" aria-label="Figure S1">Figure S1</a> for compounds <b>32</b> and <b>40</b>), which shows the second best pose of the compound, which places the C<sub>α</sub> atom of the HMK moiety at around 3.6 Å from the sulfur atom in Cys199).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked pose for compound <b>36</b> with the halomethyketone moitey suitably positioned for chemical modification by Cys199 (shown in spheres; distance from S atom in Cys199 to the C<sub>α</sub> atom around or less than 4 Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>N</i>-Acylation of adenine was achieved by treatment of acetic anhydride and pyridine in DMSO<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> at room temperature overnight (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The precipitate formed was filtered and washed with cold pyridine and ether to achieve the desired product <b>31</b> (51% yield). No bromoacetyl derivative of compound <b>31</b> was obtained after treatment of this compound with bromine either at low temperature or reflux. In order to synthesize the haloacetyl derivative <b>32</b> of compound <b>31</b>, reaction was carried out employing adenine, pyridine, and chloroacetic anhydride in THF.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Acetic anhydride, DMSO, rt; (ii) Chloroacetic anhydride, THF, rt.</p></p></figure><div class="NLM_p">The synthesis of benzimidazole compounds is described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 1-Bromo-2-nitro-4-acetyl-benzene was treated with 4-methoxyaniline and sodium acetate in DMF to obtain compound <b>33</b> in good yield (73%) after recrystallization. The nitro moiety was reduced under catalytic hydrogenation conditions to yield quantitatively derivative <b>34</b>. Final cyclization to synthesize benzimidazole <b>35</b> was achieved employing formic acid and HCl 4 N solution. The desired halomethylketone <b>36</b> was obtained by reaction of the benzimidazole <b>35</b> with bromine in acetic acid under reflux.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Sodium acetate, DMF, 100 °C; (ii) H<sub>2</sub>, Pd(C), 20 psi THF, rt; (iii) Formic acid, HCl; (iv) Br<sub>2</sub>, acetic acid, Δ.</p></p></figure><div class="NLM_p">Finally, the direct formation of the maleimide moiety was chosen for synthesis of maleimide derivatives (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Because commercial indole products required to synthesize those compounds do not contain a fluorine atom in their structure, we eliminated the fluorine atom from the structure originally proposed. The reaction conditions were carefully optimized to avoid the formation of the major byproduct indoleglyoxylic acid. Thus, methyl 2-indoleglyoxylate or 2-(1-methyl-indol)-glyoxylate was added to a solution of potassium <i>tert</i>-butoxide and acetamide in tetrahydrofuran at −60 °C. Under these conditions, compound <b>37</b> was obtained with good yield (74%), whereas the methyl indole compound <b>38</b> reached 56% yield. These compounds were treated with bromine in acetic acid under reflux to yield HMK compounds <b>39</b> and <b>40</b>, respectively.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) <sup>t</sup>BuOK, THF, −60 °C to 20 °C; (ii) Br<sub>2</sub>, acetic acid, Δ.</p></p></figure><div class="NLM_p">All the newly prepared acetyl and halomethylketo heterocycles <b>31</b>, <b>32</b>, and <b>35</b>–<b>40</b> were evaluated as GSK-3 inhibitors using a recently well described luminescent technique<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as a safer nonradioactive assay (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The four HMK-containing compounds (<b>32</b>, <b>36</b>, <b>39</b>, and <b>40</b>) are more potent that their corresponding acetyl derivatives (<b>31</b>, <b>35</b>, <b>37</b>, and <b>38</b>, respectively), showing in one case an IC<sub>50</sub> value in the nanomolar range.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> More importantly, the inhibitory activity determined at different preincubation times confirmed the switch from reversible to irreversible inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Thus, the inhibition of the acetyl-containing compounds <b>37</b> and <b>38</b> remained unaltered at different preincubation times, mimicking the behavior of alsterpaullone, a known reversible inhibitor. In contrast, the enzyme inhibition increased with preincubation time for the thiophene irreversible inhibitor <b>HMK-32</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and for the HMK-containing compounds <b>36</b>, <b>39</b>, and <b>40</b>. Overall, these findings are in agreement with our working hypothesis, which provides new clues for the specific design of irreversible GSK-3 inhibitors.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time-dependent GSK-3 inhibition of controls (alsterpaullone and HMK-32) and the newly synthetized protein kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. GSK-3 Inhibition Values and Binding Mode of Computer Aided-Designed New Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">binding mode</th><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">binding mode</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="left">----</td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="left">----</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">13.4</td><td class="colsep0 rowsep0" align="left">irreversible</td><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">0.58 ± 0.07</td><td class="colsep0 rowsep0" align="left">irreversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">4.47 ± 0.35</td><td class="colsep0 rowsep0" align="left">reversible</td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">0.89 ± 0.19</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">0.047 ± 0.007</td><td class="colsep0 rowsep0" align="left">irreversible</td><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">0.005 ± 0.001</td><td class="colsep0 rowsep0" align="left">irreversible</td></tr></tbody></table></div></div><div class="NLM_p">The covalent binding of compound <b>40</b> to GSK-3 was confirmed biophysically by MALDI-TOF analyses.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compounds <b>38</b> and <b>40</b> were added in two different experiments to the GSK-3 enzyme under the same conditions as that used for IC<sub>50</sub> measurements. Mass analysis revealed that, when the reversible inhibitor <b>38</b> was used, only the mass corresponding to GSK-3 (48 794 Da) was detected, whereas the use of an irreversible inhibitor (compound <b>40</b>) showed a mass peak of 49 036 Da confirming its covalent irreversible binding to the enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Maldi-TOF spectra. (A) Reversible inhibitor <b>38</b> (MW = 268) with GSK-3 (MW = 48 794) showed a 48 794 mass peak. (B) Irreversible inhibitor <b>40</b> (MW = 346) with GSK-3 showed a 49 036 mass peak corresponding to the covalent bond S–C formed between the GSK-3 enzyme and the inhibitor <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cellular Effects of Phenylhalomethylketones on GSK-3 Inhibition</h3><div class="NLM_p">All the preceding results suggest that phenylhalomethylketones may be versatile pharmacological tools to explore GSK-3-mediated cellular processes in physiological or pathological conditions. As GSK-3 is involved in tau phosphorylation in transfected cells and <i>in vivo</i>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> we further explored their ability to interfere with the GSK-3 mediated tau phosphorylation in cells using primary granule cerebellar neurons (GCNs), which also allow us to evaluate the cell permeability of the new inhibitors.</div><div class="NLM_p">The effect on tau phosphorylation was determined by Western blotting, and detection was carried out using specific antibodies: Tau-1 for tau inmunoreactivity, and PHF-1 as tau phosphospecific Ser396 reagent. This last epitope is specifically phosphorylated by GSK-3 on tau protein.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Lithium chloride, the first reported GSK-3 inhibitor, was used as standard reference and was added as positive control to the medium at 20 mM. The bands were quantified by densitometric analysis. Following this procedure, data showed that the addition of phenylhalomethylketone <b>6</b> or <b>8</b> reduced (PHF-1) or increased (Tau-1) the tau-immunoreactivity, thus mimicking the effect observed when lithium chloride was used as a GSK-3 inhibitor (IC<sub>50</sub> = 1.5 mM) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative Western blot of soluble extracts from Granule cerebellar neurons (GCNs), obtained after 16 h in the presence of lithium chloride (Li) or different phenylhalomethylketones (<b>6</b> and <b>8</b>). C represents cell extracts from control GCNs. Identical samples were incubated with antitau-1, anti PHF-1, or anti-β-actin, which was used as a loading control. In each experiment, PHF-1 was normalized with respect to the amount of actin present in each cell extract.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Kinase and Neurotransmitter Binding Profiles of Phenylhalomethyl Ketones</h3><div class="NLM_p">To examine the PK selectivity of phenylhalomethylketones for GSK-3, compounds <b>3</b>, <b>5</b>, and <b>6</b> were tested as inhibitors of serine/threonine cAMP-dependent protein kinase (PKA). All of them remained inactive at the highest concentration (100 μM) used. Furthermore, the same set of compounds was evaluated against a panel of eight different serine/threonine and tyrosine kinases (CaM-K II, MAP-K, EGFR-K, IR-K MeK1-K, Abl-K, PKp56, and Src), which are involved in very different signaling pathways not only in neurodegeneration (Cam-KII and MAP-K), but also in other physiological processes and diseases, such as insulin signal pathway (IR-K) or cancer (Abl-K, EGFR-K, MeK1-K, and Src). The inhibitory assays (performed using a 10 μM concentration for the different compounds) showed that, in general, HMKs did not exhibit a significant inhibitory effect on the whole set of kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Only the proto-oncogenic Src, which is elevated in some human tumors, is smoothly inhibited by the three selected compounds.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activity (% Inhibition)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> Showed by Selected Phenylhalomethylketones for Several Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound (10 μM)</th><th class="colsep0 rowsep0" align="center" char=".">Abl-K</th><th class="colsep0 rowsep0" align="center" char=".">Cam-KII</th><th class="colsep0 rowsep0" align="center" char=".">EGFR-K</th><th class="colsep0 rowsep0" align="center" char=".">IR-K</th><th class="colsep0 rowsep0" align="center" char=".">MAP-K</th><th class="colsep0 rowsep0" align="center" char=".">MEK-1 K</th><th class="colsep0 rowsep0" align="center" char=".">PK p56</th><th class="colsep0 rowsep0" align="center" char=".">Src-K</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The symbol – indicates an inhibitory activity of less than 10%.</p></div></div></div><div class="NLM_p">Furthermore, it is also important for pathway analysis <i>in vivo</i> and in cellular systems to evaluate the potential off-target effects of these new pharmacological tools. This is of particular relevance in phenylhalomethylketones due to the presence of a potential reactive group in their chemical structure, which might react with different neurotransmitter receptors, thus masking a neat GSK-3 response. In order to determine the potential off-target effects of these compounds, we evaluated the <i>in vitro</i> binding to different neurotransmitter receptors: α-adrenergic (α<sub>2</sub>), dopaminergic (hD2 and hD3), glutamatergic (AMPA and NMDA), muscarinic (hM), nicotinic (bungarotoxin sensitive and insensitive), and serotoninergic (5-HT) receptors. Results showed that compounds <b>3</b>, <b>5</b>, and <b>6</b> (at 10 μM concentration) did not bind to any of these neurotransmitter receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibitory Activity (% Inhibition)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> Exhibited by Selected Phenylhalomethylketones for Neurotransmitter Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound (10 μM)</th><th class="colsep0 rowsep0" align="center" char=".">α2</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>D2</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>D3</th><th class="colsep0 rowsep0" align="center" char=".">AMPA</th><th class="colsep0 rowsep0" align="center" char=".">NMDA</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>M</th><th class="colsep0 rowsep0" align="center" char=".">N (αBGT insensitive)</th><th class="colsep0 rowsep0" align="center" char=".">N (αBGT sensitive)</th><th class="colsep0 rowsep0" align="center" char=".">5-HT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">The symbol – indicates inhibitory activity of less than 10%.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">GSK-3 is a therapeutically valuable kinase that is very promising for severe unmet diseases such as AD. To the best of our knowledge, only a small molecule acting as GSK-3 inhibitor, the TDZD compound called Tideglusib, has reached phase IIb clinical trials for the treatment of AD. Additionally, lithium is used in the clinic as the first option for treatment of bipolar disorders, and it is known to inhibit GSK-3 among other mechanisms of action.</div><div class="NLM_p">The irreversible inhibition of GSK-3 reported for thienylhalomethylketones was suggested to involve covalent modification of Cys199,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which is located in the ATP-binding site. Modification of Cys199 might then be a new strategy for the design of specific GSK-3 inhibitors. At this point, the series of phenylhalomethylketone derivatives examined confirms unequivocally the key role of the HMK moiety on GSK-3 inhibition. Furthermore, the implication of Cys199 is supported by the structure-based design of novel compounds characterized by reversible inhibition, which turn out to be irreversible inhibitors upon addition of an HMK unit to their chemical structure.</div><div class="NLM_p">Overall, chemical modification of Cys199 represents a new mechanism of action that opens new avenues for the development of potent, selective GSK-3 inhibitors. In this context, it is worth highlighting that phenylhalomethylketones (i) act as cell-permeable inhibitors, (ii) decrease tau phosphorylation in cell cultures, (iii) are rather selective against a panel of protein kinases, and (iv) do not bind to different neurotransmitter receptors. Thus, they may be considered useful pharmacological tools to explore physiological and pathological cellular signaling pathways in which GSK-3 is involved.</div><div class="NLM_p last">These findings are especially relevant, as an emerging aspect in the effectiveness of protein kinases inhibitors <i>in vivo</i> is the ability to compete with cellular concentrations of ATP (typically about 1–10 mM). For epidermal growth factor receptor kinase (EGFR-K), such problems have been overcome with compound HKI-272, which binds covalently to a cysteine residue.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A similar strategy has been recently reported for the irreversible inhibition of HCV NS3/4A viral protease by targeting a noncatalytic cysteine residue.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In this context, the strategy explored here, which relies on the key role of Cys 199 in GSK-3 inhibition, might then represent a promising strategy for the development of novel GSK-3 inhibitors for the treatment of severe human diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p">Substrates were either purchased from commercial sources or used without further purification. Melting points were determined with a Reichert-Jung Thermovar apparatus and a Mettler Toledo MP70 apparatus and are uncorrected. Flash column chromatography was carried out at medium pressure using silica gel (E. Merck, grade 60, particle size 0.040–0.063 mm, 230–240 mesh ASTM) with the indicated solvent as eluent. Compounds were detected with UV light (254 nm). <sup>1</sup>H NMR spectra were obtained on a Gemini-200 spectrometer working at 200 MHz and on a Bruker AVANCE-300 spectrometer working at 300 MHz. Typical spectral parameters: spectral width 10 ppm, pulse width 9 μs (57°), data size 32 K. <sup>13</sup>C NMR experiments were carried out on the Varian Gemini-200 spectrometer operating at 50 MHz and on the Bruker AVANCE-300 spectrometer operating at 75 MHz. The acquisiton parameters: spectral width 16 kHz, acquisition time 0.99 s, pulse width 9 μs (57°), data size 32 K. Chemical shifts are reported in values (ppm) relative to internal Me<sub>4</sub>Si and <i>J</i> values are reported in Hertz. Elemental analyses were performed by the analytical department at CENQUIOR (CSIC), and the results obtained were within ±0.4% of the theoretical values. The combustion analyses are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Mass spectra were obtained by electronic impact in a Hewlett-Packard 5973 spectrophotometer. All compounds are >95% pure by HPLC analyses. HPLC analyses for compounds 10–30 were performed on a Waters 6000 instrument, with UV detector (214–254 nm), using different columns; μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm) and Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm). Acetonitrile/H<sub>2</sub>O [(0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N)] 50/50 was used as mobile phase. For the chemical reactivity of HMKs versus thiol groups and HPLC analyses for compounds <b>31</b>–<b>40</b>, experiments were performed on Alliance Waters 2690 equipment with a UV detector photodiode array Waters 2996 with MS detector MicromassZQ (Waters) positive electrospray, using the Sunfire column C18, 3.5 μm (50 × 4.6 mm) and acetonitrile (0.08% formic acid) and MilliQ water (0.1% formic acid) as mobile phase in a 10 min run from 10% to 100% acetonitrile gradient at a flow rate of 0.25 mL/min.</div><div class="NLM_p">MALDI-MS measurements were performed on a Voyager DE-PRO mass spectrometer (Applied Biosystems, Foster City, CA) equipped with a pulsed nitrogen laser (λ = 337 nm, 3 ns pulse width, and 3 Hz frequency) and a delayed extraction ion source. Ions generated by the laser desorption were introduced into a time-of-flight analyzer (1.3 m flight path) with an acceleration voltage of 25 kV, a 88% grid voltage, a 0.3% ion guide wire voltage, and a delay time of 500 ns in the linear positive ion mode.</div><div class="NLM_p last">Mass spectra were obtained over the <i>m</i>/<i>z</i> range 30 000–125 000 μ. External mass calibration was applied using the monoisotopic [M+H]+ value of Enolase. Sinapinic acid (>99%; Fluka, Buchs, Switzerland) at 10 mg mL<sup>–1</sup> in 0.3% trifluoroacetic acid/acetonitrile, 70:30 (v/v) was used as matrix. Samples were mixed with the matrix at a ratio of approximately 1:1, and 1 μL of this solution was spotted onto a flat stainless steel sample plate and dried in air.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-(4-Bromophenyl)-2-iodoethanone (<b>10</b>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h4><div class="NLM_p last">A mixture of 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>) (2.0 g, 7.20 mmol) and potassium iodide (8.40 g, 50 mmol) in acetone (50 mL) was stirred and refluxed for 3 h. The solvent was evaporated, and CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and H<sub>2</sub>O (100 mL) were added to the reaction mixture. The organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. Compound <b>10</b> was purified by silica gel chromatography (hexane/ethyl acetate 6:1), 1.91 g (82%), colorless solid, mp 95–96 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J=</i> 8.3 Hz, 2H), 7.60 (d, <i>J=</i> 8.3 Hz, 2H), 4.30 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 190.7, 131.6, 129.5, 127.8, 123.7, 24.3. <i>m</i>/<i>z</i> (EI): 326, 324, (M <sup>+</sup>, 12, 13%), 185, 183 (M-CH<sub>2</sub>I, 97, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 14.15 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(2-(4-Bromophenyl)-2-oxoethyl)isoindoline-1,3-dione (<b>11</b>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></h4><div class="NLM_p last">A mixture of 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>) (0.3 g, 1.08 mmol) and potassium phthalimide (0.21 g, 1.13 mmol) in acetonitrile (50 mL) was stirred and refluxed for 2 h. The solvent was evaporated, and CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and H<sub>2</sub>O (100 mL) were added to the mixture. The organic layer was washed with a 0.2 N sodium hydroxide solution (50 mL) and water (50 mL). Then the organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. Compound <b>11</b> was purified by silica gel chromatography (hexane:ethyl acetate 3:1), 0.28 g (76%), colorless solid, mp 223–225 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.91 (m, 2H), 7.87 (d, <i>J=</i> 8.4 Hz, 2H), 7.76 (m, 2H), 7.67 (d, <i>J=</i> 8.4 Hz, 2H), 5.01 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 190.1, 167.8, 134.2, 132.2, 129.6, 123.5, 133.1, 132.7, 132.1, 129.4, 44.0. <i>m</i>/<i>z</i> (EI): 345, 343 (M <sup>+</sup>, 21, 21%), 185, 183 (M-CH<sub>2</sub> phthalimide, 98, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 3.66 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Amino-4′-bromoacetophenone hydrochloride (<b>12</b>)</h4><div class="NLM_p last">Commercially available from Sigma Aldrich.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for the Synthesis of Sulfur Derivatives (Compounds <b>13</b>–<b>15</b>)</h4><div class="NLM_p last">A mixture of 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>), potassium carbonate, and the corresponding thiol (ethanethiol, thiophenol, and benzylthiol) in ethanol (50 mL) was stirred and refluxed for 2 h. The mixture was filtered, and CH<sub>2</sub>Cl<sub>2</sub> (75 mL) and water (75 mL) were added to the solution. The organic layer was washed with water (2 × 75 mL). Then the organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. The compounds were purified by silica gel chromatography.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(4-Bromophenyl)-2-(ethylthio)ethanone (<b>13</b>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">2-Bromo-1-(4-bromophenyl) ethanone (<b>5</b>) (0.5 g, 1.80 mmol), potassium carbonate (0.25 g, 1.80 mmol), ethanethiol (0.11 g, 1.80 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 4:1), 0.20 g (45%), colorless solid, mp 64–65 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.74 (d, <i>J =</i> 8.7 Hz, 2H), 7.50 (d, <i>J =</i> 8.7 Hz, 2H), 3.65 (s, 2H), 2.46 (q, <i>J=</i> 14.6, 7.3 Hz, 3H), 1.16 (t, <i>J=</i> 7.3 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 194.3, 134.7, 132.8, 131.2, 129.4, 37.5, 27.2, 14.9. <i>m</i>/<i>z</i> (EI): 260, 258 (M <sup>+</sup>, 10, 9%), 185, 183 (M-SCH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>, 100, 99%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 5.85 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(4-Bromophenyl)-2-(phenylthio)ethanone (<b>14</b>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></h4><div class="NLM_p last">2-Bromo-1-(4-bromophenyl) ethanone (<b>5</b>) (0.5 g, 1.80 mmol), potassium carbonate (0.25 g, 1.80 mmol), benzenethiol (0.20 g, 1.80 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 4:1), 0.29 g (53%), colorless solid, mp 60–61 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.68 (d, <i>J=</i> 8.7 Hz, 2H), 7.49 (d, <i>J=</i> 8.7 Hz, 2H), 7.24–7.20 (m, 5H), 4.10 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 192.8, 134.0, 133.7, 130.4, 130.1, 129.9, 128.8, 128.4, 127.0, 40.7. <i>m</i>/<i>z</i> (EI): 308, 306 (M<sup>+</sup>, 55, 52%), 185, 183 (M-SCH<sub>2</sub>Ph, 100, 98%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 8.15 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(Benzylthio)-1-(4-bromophenyl)ethanone (<b>15</b>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h4><div class="NLM_p last">2-Bromo-1-(4-bromophenyl) ethanone (<b>5</b>) (0.5 g, 1.80 mmol), potassium carbonate (0.25 g, 1.80 mmol), benzylthiol (0.22 g, 1.80 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 4:1), 0.32 g (55%), colorless solid, mp 158–159 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.68 (d, <i>J=</i> 8.7 Hz, 2H), 7.49 (d, <i>J=</i> 8.7 Hz, 2H), 7.24–7.20 (m, 5H), 3.63 (s, 2H), 3.52 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 192.3, 136.1, 133.0, 130.9, 129.2, 128.3, 127.6, 126.4, 126.3, 35.1, 34.7. <i>m</i>/<i>z</i> (EI): 322, 320 (M <sup>+</sup>, 17, 17%), 200, 198 (M-SCH<sub>2</sub>Ph, 85, 83%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 9.76 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(4-Bromophenyl)-2-oxoethyl acetate (<b>16</b>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></h4><div class="NLM_p last">To a solution of 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>) (0.5 g, 1.80 mmol) in acetic acid (50 mL) was added sodium acetate (0.44 g, 5.40 mmol) and acetic anhydride (0.55 g, 5.40 mmol). The mixture was stirred and refluxed for 5 h. CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and H<sub>2</sub>O (100 mL) were added to the reaction mixture. The organic layer was washed with H<sub>2</sub>O (2 × 100 mL), a saturated solution of NaHCO<sub>3</sub> (100 mL), and a saturated solution of NaCl (100 mL). The organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. Compound <b>16</b> was purified by silica gel chromatography (hexane:ethyl acetate 7:1), 0.41 g (87%), colorless solid, mp 84–85 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.67 (d, <i>J =</i> 8.6 Hz, 2H), 7.35 (d, <i>J =</i> 8.6 Hz, 2H), 5.18 (s, 2H), 2.12 (s, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>): δ 190.3, 169.3, 131.8, 131.2, 128.2, 128.1, 64.8, 19.5. <i>m</i>/<i>z</i> (EI): 260, 258 (M <sup>+</sup>, 15, 15%), 183, 181, 179 (M-C<sub>3</sub>H<sub>5</sub>O<sub>2</sub>, 25, 89, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 100%, r.t = 6.41 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(4-Bromophenyl)-2-hydroxyethanone (<b>17</b>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></h4><div class="NLM_p last">Enzymatic deacylation of <b>16</b>, was done employing different lipases (PPL (<i>Pancreatic Porcine Lipase</i>), PSL (<i>Pseudomonas cepacia Lipase</i>), MML (<i>Mucor miehi Lipase</i>), and CAL-B (<i>Candida Antartica Lipase-B</i>) under the same reaction conditions (citrate-phosphate 9:1 buffer pH 7, <i>tert</i>-butanol, 45 °C, 24 h). No product was obtained using MML, while partial hydrolysis was done when lipases PPL and PSL were employed. However, the use of CAL-B gave exclusively compound <b>17</b> with an 85% yield. Accordingly, a mixture of 2-(4-bromophenyl)-2-oxoethyl acetate (<b>16</b>) (20 mM) and CAL-B (20 mM) in <i>tert</i>-butanol:citrate phosphate buffer (pH = 7) 9:1 (85 mL) was orbitally stirred and refluxed for 24 h. The reaction was filtered and ethyl acetate (75 mL) and H<sub>2</sub>O (50 mL) were added to the solution. The organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. Compound <b>17</b> was purified by silica gel chromatography (hexane:ethyl acetate 1:1), 0.36 g (85%), colorless solid, mp 103–104 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.80 (d, <i>J =</i> 8.6 Hz, 2H), 7.65 (d, <i>J =</i> 8.6 Hz, 2H), 4.85 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 197.8, 132.9, 132.4, 130.1, 129.5, 65.7. <i>m</i>/<i>z</i> (EI): 216, 214 (M <sup>+</sup>, 11, 11%), 185, 183, (M-CH<sub>3</sub>O, 100, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 3.81 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for Oxime (<b>18</b>) and Methyl Oxime Synthesis (<b>19</b>)</h4><div class="NLM_p last">To a mixture of hydroxylamine hydrochloride or methylhydroxylamine hydrochloride and pyridine in ethanol (50 mL) was added 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>). The mixture was stirred and refluxed for 4 h. The solvent was evaporated and cold water (25 mL) was added to the mixture. The mixture is left at 0 °C for 12 h and the precipitate formed was filtered. The compounds were purified by silica gel chromatography.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E,Z</i>)-2-Bromo-1-(4-bromophenyl)ethanone Oxime (<b>18</b>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></h4><div class="NLM_p last">Hydroxylamine hydrochloride (0.26 g, 3.81 mmol), pyridine (0.31 g, 3.81 mmol), and 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>) (1.0 g, 3.59 mmol). Purified silica gel column chromatography (hexane:ethyl acetate 6:1), 0.82 g (78%), colorless solid, mp 115–116 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 11.8, 11.7 (s, 1H), 7.52–7.41 (m, 4H), 4.48, 4.35 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.0, 153.9, 132.7, 132.3, 128.2, 124.7, 32.1, 27.2. <i>m</i>/<i>z</i> (EI): 295, 293, 291 (M <sup>+</sup>, 36, 72, 38%), 102 (M-CH<sub>3</sub>Br<sub>2</sub>O, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 8.15 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>,<i>Z</i>)-2-Bromo-1-(4-bromophenyl)ethanone <i>O</i>-Methyl Oxime (<b>19</b>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></h4><div class="NLM_p last">Methyl hydroxylamine hydrochloride (0.30 g, 3.59 mmol), pyridine (0.28 g, 3.59 mmol), and 2-bromo-1-(4-bromophenyl)ethanone (<b>5</b>) (1.0 g, 3.59 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 6:1), 0.56 g (82%), colorless solid, mp 48–49 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.65–7.51 (m, 4H), 4.52, 4.35 (s, 2H), 4.15, 4.05 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 151.2, 132. 4, 131.9, 127.7, 124.1, 63.0, 62.9, 32.2, 32.1. <i>m</i>/<i>z</i> (EI): 309, 307, 305 (M <sup>+</sup>, 13, 26, 13%), 102 (M-C<sub>2</sub>H<sub>5</sub>Br<sub>2</sub>O, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 8.10 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-Bromo-4-(chloromethylsulfinyl)benzene (<b>20</b>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></h4><div class="NLM_p last">A solution of sulfuryl chloride (0.33 g, 2.46 mmol) in acetonitrile (5 mL) was added dropwise to a mixture of bromothioanisol (0.50 g, 2.46 mmol) and silver nitrate (0.42 g, 2.46 mmol) in acetonitrile (10 mL) at 0 °C. The mixture was then stirred 1 h at room temperature. CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and H<sub>2</sub>O (10 mL) were added to the reaction mixture. The organic layer was washed with H<sub>2</sub>O (2 × 100 mL), dried over MgSO<sub>4</sub>, and the solvent was evaporated. Compound <b>20</b> was purified by silica gel chromatography (hexane:ethyl acetate 1:1), 0.44 g (71%), colorless solid, mp 91–92 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.71 (d, <i>J =</i> 8.7 Hz, 2H), 7.58 (d, <i>J =</i> 8.7 Hz, 2H), 4.38 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 142.1, 132.6, 126.4, 93.1, 6.8. <i>m</i>/<i>z</i> (EI): 256, 254, 252 (M <sup>+</sup>, 4, 16, 12%), 205, 203 (M-CH<sub>2</sub>Cl, 100, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 99%, r.t = 4.73 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure for Bromoacetyl Benzene (<b>21</b>, <b>23</b>, <b>25</b>, <b>27</b>, and <b>29</b>), Dibromoacetyl Benzene (<b>22</b>, <b>24</b>, <b>26</b>, <b>28</b>), and Pyridine (<b>30</b>) Synthesis</h4><div class="NLM_p last">To a solution of acetophenone derivative or 2-acetyl pyridine dissolved in CHCl<sub>3</sub> (35 mL) was added dropwise a solution of bromine in CHCl<sub>3</sub> (10 mL) at 0 °C. The mixture was stirred 2 h. The solvent was evaporated and to the mixture was added CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and a saturated solution of NaHCO<sub>3</sub> (50 mL). The organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. Compounds were purified/separated by silica gel chromatography.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(2-Bromoacetyl)benzonitrile (<b>21</b>)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and 4-(2,2-Dibromoacetyl)benzonitrile (<b>22</b>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></h4><div class="NLM_p last">4-Acetylbenzonitrile (1.0 g, 6.89 mmol), bromine (1.12 g, 7.02 mmol). Mixture of compounds separated by silica gel chromatography (hexane:ethyl acetate 3:1), 0.69 g (45%) (<b>21</b>), colorless solid, mp 90–91 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.10 (d, <i>J</i> = 8.79 Hz, 2H), 7.82 (d, <i>J</i> = 8.79 Hz, 2H), 4.44 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 190.4, 137.3, 133.0, 129.8, 118.0, 117.6, 30.4. <i>m</i>/<i>z</i> (EI): 225, 223 (M <sup>+</sup>, 4, 4%), 130 (M-COCH<sub>2</sub>Br, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 97%, r.t = 4.41 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50. Compound (<b>22</b>). 0.31 g (15%), colorless solid, mp 95–96 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.23 (d, <i>J</i> = 8.79 Hz, 2H), 7.83 (d, <i>J</i> = 8.79 Hz, 2H), 6.58 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 185.0, 134.4, 132.9, 130.7, 117.9, 117.8, 39.0. <i>m</i>/<i>z</i> (EI): 305, 303, 301 (M <sup>+</sup>, 4, 12, 4%), 130 (M-COCHBr<sub>2</sub>, 100%). HPLC: μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 98%, r.t = 4.11 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Bromo-1-(4-(trifluoromethyl)phenyl)ethanone (<b>23</b>)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and 2,2-Dibromo-1-(4-(trifluoromethyl)phenyl)ethanone (<b>24</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h4><div class="NLM_p last">1-(4-(Trifluoromethyl)phenyl) ethanone (1.0 g, 5.31 mmol), bromine (1.10 g, 6.90 mmol). Mixture of compounds separated by silica gel chromatography (hexane:ethyl acetate 8:1), 0.18 g (6%) (<b>23</b>), colorless solid, mp 55–56 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.12 (d, <i>J</i> = 8.06 Hz, 2H), 7.79 (d, <i>J</i> = 8.06 Hz, 2H), 4.47 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 190.4, 136.5, 135.0 (q, <i>J</i><sub>CF</sub> = 33.09 Hz), 129.3, 125.9, 123.3. (q, <i>J</i><sub>CF</sub> = 272.9 Hz), 30.4. <i>m</i>/<i>z</i> (EI): 268, 266 (M <sup>+</sup>, 6, 6%), 172 (M-COCH<sub>2</sub>Br, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 97%, r.t = 6.53 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50. Compound (<b>24</b>). 0.64 g (45%), colorless solid, mp 41–42 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.22 (d, <i>J</i> = 8.3 Hz, 2H), 7.81 (d, <i>J</i> = 8.3 Hz, 2H), 6.6 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 184.1, 134.7 (q, <i>J</i> = 272.9 Hz), 132.7, 129.2, 124.8, 119.5 (q, <i>J</i> = 33.09), 38.2. <i>m</i>/<i>z</i> (EI): 348, 346, 344 (M <sup>+</sup>, 1, 6, 1%), 173 (M-CHBr<sub>2</sub>, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 97%, r.t = 9.96 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Bromo-1-(4-morpholinophenyl)ethanone (<b>25</b>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></h4><div class="NLM_p last">1-(4-Morpholinophenyl) ethanone (1.0 g, 4.87 mmol), bromine (1.01 g, 6.33 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 1:1), 0.56 g (42%) (<b>25</b>), colorless solid, mp 108–109 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.95 (d, <i>J</i> = 4 Hz, 2H), 7.04 (d, <i>J</i> = 4 Hz, 2H), 4.60 (s, 2H), 3.83 (m, 4H), 3.65 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 189.9, 154.9, 130.5, 120.3, 113.5, 67.8, 47.6, 26.7. <i>m</i>/<i>z</i> (EI): 285, 283 (M <sup>+</sup>, 14, 13%), 190 (M-CH<sub>2</sub>Br, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 99%, r.t = 4.56 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2,2-Dibromo-1-(4-iodophenyl)ethanone (<b>26</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h4><div class="NLM_p last">1-(4-Iodophenyl)ethanone (0.40 g, 1.60 mmol), bromine (0.1 mL, 1.70 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 6:1), 0.31 g (48%) (<b>26</b>), colorless solid, mp 77–78 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.82 (d, <i>J</i> = 4.2 Hz, 2H), 7.73 (d, <i>J</i> = 4.2 Hz, 2H), 6.3 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 185.3, 138.6, 131.3, 130.4, 103.4, 39.6. <i>m</i>/<i>z</i> (EI): 406, 404, 402 (M <sup>+</sup>, 9, 17, 9%), 231, (M-CHBr<sub>2</sub>, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 98%, r.t = 4.51 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(2-Bromoacetyl)benzonitrile (<b>27</b>)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and 3-(2,2-Dibromoacetyl)benzonitrile (<b>28</b>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></h4><div class="NLM_p last">3-Acetylbenzonitrile (0.5 g, 3.44 mmol), bromine (0.72 g, 4.48 mmol). Mixture of compounds separated by silica gel chromatography (hexane:ethyl acetate 5:2), 0.10 g (13%) (<b>27</b>), colorless solid, mp 70–71 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.21 (t, <i>J</i> = 1.5 Hz, 1H), 8.15 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 7.95 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 7.80 (t, <i>J =</i> 7.9 Hz, 1H), 4.32 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 189.8, 137.0, 135.1, 133.2, 133.0, 130.2, 117.9, 113.9, 30.1. <i>m</i>/<i>z</i> (EI): 225, 223 (M <sup>+</sup>, 2, 2%), 130 (M-CH<sub>2</sub>Br, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 97%, r.t = 3.60 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50. Compound (<b>28</b>). 0.38 g (37%), colorless solid, mp 85–86 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.25 (t, <i>J</i> = 1.5 Hz, 1H), 8.15 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 7.85 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 7.70 (t, <i>J =</i> 7.9 Hz, 1H), 6.40 (s, 1H, CH). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 184.5, 137.4, 134.1, 133.8, 132.1, 130.2, 117.8, 114.0, 38.9. <i>m</i>/<i>z</i> (EI): 305, 303, 301 (M <sup>+</sup>, 3, 9, 3%), 130 (M-COCHBr<sub>2</sub>, 100%). HPLC: Column μ Bondapack C18, 10 μm, 125 Å, (300 × 3.9 mm), Purity 98%, r.t = 4.10 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(4-Amino-3,5-dibromophenyl)-2-bromoethanone (<b>29</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h4><div class="NLM_p last">1-(4-Aminophenyl) ethanone (0.5 g, 3.70 mmol), bromine (0.20 mL, 4.06 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 2:1), 0.80 g (58%) (<b>29</b>), colorless solid, mp 146–147 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.0 (s, 2H), 5.1 (s, 2H), 4.2 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 187.5, 147.3, 132.7, 123.3, 106.2, 38.3. <i>m</i>/<i>z</i> (EI): 375, 373, 371, 369 (M <sup>+</sup>, 10, 31, 31, 10%), 281, 279, 277 (M-CHBr<sub>2</sub>, 64, 100, 67%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 96%, r.t = 9.98 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2,2-Dibromo-1-(pyridin-2-yl)ethanone (<b>30</b>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></h4><div class="NLM_p last">1-(Pyridin-2-yl)ethanone (1.0 g, 8.25 mmol), bromine (1.45 g, 9.08 mmol). Purified by silica gel chromatography (hexane:ethyl acetate 6:1), 1.69 g (74%) (<b>30</b>), colorless solid, mp 196–197 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 8.71 (m, 1H), 8.10 (m, 2H), 7.82 (m, 1H), 6.13 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 187.0, 149.5, 148.1, 138.4, 129.0, 124.0, 45.0. <i>m</i>/<i>z</i> (EI): 281, 279, 277 (M <sup>+</sup>, 9, 19, 9%), 106 (M-CHBr<sub>2</sub>, 100%). HPLC: Column Symmetry C18, 5 μm, 100 Å, (150 × 3.9 mm), Purity 98%, r.t = 3.66 min, acetonitrile/H<sub>2</sub>O (0.05% H<sub>3</sub>PO<sub>4</sub> + 0.04% Et<sub>3</sub>N) 50/50.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(6-Amino-9<i>H</i>-purin-9-yl)ethanone (<b>31</b>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></h4><div class="NLM_p last">To a solution of adenine (1.23 g, 9.14 mmol) in DMSO anhydrous (50 mL) was added a solution of pyridine anhydrous (20 mL) and acetic anhydride (5 mL). The mixture was stirred for 24 h at room temperature and a white precipitate formed. The precipitate was filtered and washed with several portions of cold pyridine and ether, to afford a white solid (629 mg, 51%), mp 363–364 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 8.61 (s, 1H), 8.28 (s, 1H), 7.52 (s, 2H), 2.88 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 173.97, 162.01, 159.50, 154.36, 144.05, 125.17, 30.41. HPLC: Purity >99%, r.t = 0.55 min. MS (ESI+): <i>m</i>/<i>z</i> 178 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(6-Amino-9<i>H</i>-purin-9-yl)-2-chloroethanone (<b>32</b>)</h4><div class="NLM_p last">To a solution of adenine (1.00 g, 7.4 mmol) in THF anhydrous (50 mL) was added a mixture of pyridine anhydrous (20 mL) and chloroacetic anhydride (1.39 g, 8.14 mmol). The mixture was stirred for 24 h at room temperature and a white precipitate was formed. The precipitate was filtered and washed with several portions of cold pyridine and cold ether. This solid was purified by column chromatography (methanol:dichloromethane 1:10) to afford a white solid (312 mg, 20%), mp 199–200 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 12.28 (s, 1H), 11.48 (s, 2H), 8.65 (s, 1H), 8.45 (s, 1H), 4.55 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 166.32, 151.25, 145.74, 144.20, 118.15, 43.40. HPLC: Purity 95%, r.t = 2.87 min. MS (ESI+): <i>m</i>/<i>z</i> 212 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(4-(4-Methoxyphenylamino)-3-nitrophenyl)ethanone (<b>33</b>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></h4><div class="NLM_p last">To a solution of 1-(4-bromo-3-nitrophenyl)ethanone (1 g, 4.09 mmol) and 4-methoxyaniline (0.504 g, 4.09 mmol) in anhydrous DMF (23 mL) was added sodium acetate (0.504 g, 6.14 mmol). The mixture was heated 2 h at 100 °C and then stirred at room temperature overnight. Ethyl acetate (100 mL) and H<sub>2</sub>O (100 mL) was added to the reaction mixture. The organic layer was washed with H<sub>2</sub>O (2 × 100 mL), dried over MgSO<sub>4</sub>, and the solvent was evaporated. The residue was recrystallized from MeOH/H<sub>2</sub>O to afford <b>33</b> as a red solid (853 mg, 73%), mp 132–133 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.77 (s, 1H), 8.82 (s, 1H), 7.94 (d, <i>J</i> = 8.9 Hz, 1H), 7.21 (d, <i>J</i> = 8.7 Hz, 2H), 7.10 – 6.83 (m, 3H), 3.86 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 194.7, 158.4, 147.6, 134.4, 131.1, 129.8, 128.4, 127.2, 126.1, 115.6, 115.1, 55.4, 25.92. HPLC: Purity >99%, r.t = 5.09 min. MS (ESI+): <i>m</i>/<i>z</i> 287 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(4-(4-Methoxyphenylamino)-3-aminophenyl)ethanone (<b>34</b>)</h4><div class="NLM_p last">To a solution of <b>33</b> (0.23 g, 0.8 mmol) dissolved in THF (20 mL) was added Pd(C) (23 mg). The mixture was stirred at room temperature overnight at 20 psi. The mixture was filtered and the solvent was evaporated to afford a brown solid. The title compound was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43 (m, 1H), 7.40 (s, 1H), 7.37 (m, 1H), 7.26 (m, 1H), 6.96–6.86 (m, 2H), 6.86–6.68 (m, 2H), 5.64 (s, 1H), 3.81 (s, 3H), 2.51 (s, 3H), 1.44 (s, 1H). HPLC: Purity 88%, r.t = 4.15 min. MS (ESI+): <i>m</i>/<i>z</i> 257 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(1-(4-Methoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)ethanone (<b>35</b>)</h4><div class="NLM_p last">A stirred solution of <b>34</b> (0.93 g, 3.64 mmol) and formic acid (1.58 mL, 42 mmol) in HCl 4 N (25 mL) was refluxed for 3 h. Then dichloromethane (25 mL) was added to the mixture. The organic layer was washed with saturated NaHCO<sub>3</sub> solution (3 × 25 mL) and then dried over MgSO<sub>4</sub>. The solvent was evaporated under reduced pressure to give <b>35</b> as a brown solid (803 mg, 83%), mp 139–140 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.46 (d, <i>J</i> = 1.1 Hz, 1H), 8.13 (s, 1H), 7.99 (dd, <i>J</i> = 8.6, 1.5 Hz, 1H), 7.50–7.42 (m, 1H), 7.40 (d, <i>J</i> = 9.0 Hz, 2H), 7.08 (d, <i>J</i> = 9.0 Hz, 2H), 3.89 (s, 3H), 2.69 (s, 3H).<sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 198.0, 159.9, 144.6, 132.6, 128.7, 126.0, 123.9, 122.4, 115.5, 110.6, 55.9, 26.9. HPLC: Purity 99%, r.t = 4.18 min. MS (ESI+): <i>m</i>/<i>z</i> 267 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Bromo-1-(1-(4-methoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)ethanone (<b>36</b>)</h4><div class="NLM_p last">To a solution of <b>35</b> (1.14 g, 4.28 mmol) dissolved in AcOH (25 mL) at reflux was added a solution of bromine (0.23 mL, 4.50 mmol) in AcOH (5 mL). The mixture was refluxed and stirred for 5 h. Dichloromethane (50 mL) and water (50 mL) were added to the mixture. The organic layer was extracted and washed with saturated solutions of NaHCO<sub>3</sub> (2 × 50 mL) and NaCl (50 mL). The organic layer was dried over MgSO<sub>4</sub> and the solvent was evaporated. The product was purified by flash chromatography (hexane:ethyl acetate 1:1), 162 mg (11%) (<b>36</b>), red solid, mp 247–248 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.52 (s, <i>J</i> = 1.1 Hz, 1H), 8.18 (s, 1H), 8.03 (dd, <i>J</i> = 8.6, 1.6 Hz, 1H), 7.51 (d, <i>J</i> = 8.6, 1H), 7.41 (d, <i>J</i> = 9.0 Hz, 2H), 7.10 (d, <i>J</i> = 9.0 Hz, 2H), 4.57 (s, 2H), 3.91 (s, 3H).<sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 191.2, 160.0, 144.9, 126.0, 124.7, 122.9, 115.5, 111.1, 55.9. HPLC: Purity 95%, r.t = 4.70 min. MS (ESI+): <i>m</i>/<i>z</i> 345 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> General Procedure for Maleimide Synthesis (<b>37</b>–<b>38</b>)</h4><div class="NLM_p last">To a solution of acetoacetamide (1 equiv) and <sup>t</sup>BuOK (1 M solution in THF) (3.5 equiv) dissolved in THF (20 mL) at −60 °C was added methyl 3-indoleglyoxylate or methyl 2-(1-methyl-1H-indol-3-yl)-2-oxoacetate (1 equiv). The mixture was stirred until room temperature was reached. Then a concentrated HCl solution (11.5 mL), water (30 mL), and dichlorometane (30 mL) were added in the reaction mixture. The organic layer was washed with a saturated solution of NaHCO<sub>3</sub> (2 × 30 mL), dried over MgSO<sub>4</sub>, and evaporated. Products were purified by recrystallization from ethyl acetate/pentane.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-Acetyl-4-(1<i>H</i>-indol-3-yl)-1<i>H</i>-pyrrole-2,5-dione (<b>37</b>)</h4><div class="NLM_p last">Acetoacetamide (0.372 g, 3.69 mmol), <sup>t</sup>BuOK (1 M solution in THF) (12.9 mL, 12.9 mmol), methyl 3-indoleglyoxylate (0.750 g, 3.69 mmol). 0.70 g (74%) (<b>37</b>), orange solid, mp 225–226 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 12.29 (s, 1H), 11.17 (s, 1H), 8.24 (s, 1H), 7.50 (d, <i>J</i> = 7.01 Hz 1H), 7.27–7.17 (m, 1H), 7.13 (s, 2H), 2.50–2.46 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 195.4, 171.7, 139.8, 137.5, 135.5, 125.5, 124.9, 123.5, 122.6, 121.7, 113.3, 106.0, 31.7. HPLC/MS: Purity >99%, r.t = 3.76 min. MS (ESI+): <i>m</i>/<i>z</i> 255 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-Acetyl-4-(1-methyl-indol-3-yl)-1<i>H</i>-pyrrole-2,5-dione (<b>38</b>)</h4><div class="NLM_p last">Acetoacetamide (0.325 g, 3.22 mmol), <sup>t</sup>BuOK (1 M solution in THF) (11.3 mL, 11.3 mmol), 2-(1-methyl-1H-indol-3-yl)-2-oxoacetate (0.700 g, 3.22 mmol). 0.482 g (56%) (<b>38</b>), red solid, mp 224–225 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 11.19 (s, 1H), 8.27 (s, 1H), 7.58 (d, <i>J</i> = 8.1 Hz, 1H), 7.35–7.06 (m, 3H), 3.92 (s, 3H), 2.51 (s, 3H).<sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 194.6, 170.9, 138.5, 138.1, 137.3, 125.2, 123.8, 122.8, 122.1, 121.3, 111.0, 104.3, 33.3, 30.9. HPLC/MS: Purity 95%, r.t = 4.06 min. MS (ESI+): <i>m</i>/<i>z</i> 269 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> General Procedure for Maleimide Bromation (<b>39</b> and <b>40</b>)</h4><div class="NLM_p last">Maleimide derivative <b>37</b> or <b>38</b> (1 equiv) is dissolved in AcOH. Under reflux conditions, bromine (1.05 equiv) is slowly added diluted in AcOH. The mixture is stirred at reflux temperature for 3 h. Then water and AcOEt are added and the mixture is extracted, and the organic layer washed with several portions of a NaHCO<sub>3</sub> saturated solution and then dried and evaporated. The products are purified by recrystallization MeOH/H<sub>2</sub>O (<b>39</b>) or by flash chromathography (<b>40</b>) using a dichloromethane/methanol 80:1 mixture as eluent.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-(2-Bromoacetyl)-4-(1<i>H</i>-indol-3-yl)-1<i>H</i>-pyrrole-2,5-dione (<b>39</b>)</h4><div class="NLM_p last">Title compound was prepared using the same procedure described for the synthesis of compound <b>36</b>. Maleimide <b>37</b> (0.670 g, 2.63 mmol), bromine (0.135 mL, 2.63 mmol). The residue was recrystallized from methanol/water to give <b>39</b> as a black solid (0.345 g, 39%), mp 260–261 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 12.54 (s, 1H), 11.34 (s, 1H), 8.39 (m, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 7.32–6.98 (m, 3H), 4.75 (s, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub><i>6</i></sub>): δ 186.0, 169.6, 169.4, 142.1, 135.9, 135.7, 124.7, 122.8, 121.0, 112.1, 106.4, 35.0. HPLC/MS: Purity 95%, r.t = 4.35 min. MS (ESI+): <i>m</i>/<i>z</i> 333 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-(2-Bromoacetyl)-4-(1-methyl-1<i>H</i>-indol-3-yl)-1<i>H</i>-pyrrole-2,5-dione (<b>40</b>)</h4><div class="NLM_p last">Title compound was prepared using the same procedure described for the synthesis of compound <b>36</b>. Maleimide <b>38</b> (0.603 g, 2.25 mmol), bromine (0.115 mL, 2.25 mmol). The product was purified by flash chromatography (dichloromethane:methanol 80:1), 120 mg (15%) (<b>40</b>), purple solid, mp 252–253 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.46 (s, 1H), 7.38 (m, 4H), 5.31 (s, 1H), 4.64 (s, 2H), 3.94 (s, 3H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub><i>6</i></sub>): δ 185.80, 169.78, 169.55, 141.80, 139.52, 137.66, 125.37, 122.94, 122.88, 121.34, 119.28, 110.46, 105.53, 35.02, 32.71. HPLC: Purity 99%, r.t = 4.47 min. MS (ESI+): <i>m</i>/<i>z</i> 347 [M+H]<sup>+</sup>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Chemical Reactivity of HMKs</h4><div class="NLM_p last">100 μL of an acetonitrile solution of HMK <b>3</b> or <b>4</b> (50 mM) and 100 μL of an acetonitrile solution of 2-mercaptoethanol (50 mM) were added to a mixture of methanol/water (1/1, 0.8 mL) and stirred for 1 or 18 h. The reaction progress was followed by HPLC-MS. HMK <b>3</b> (MW = 189) showed a retention time of 4.90 min, while retention time for HMK <b>4</b> (MW = 233) was 5.05 min. On the other hand, the <i>S</i>-alkylated derivative (MW = 214) presented a retention time of 4.15 min. An additional experiment was carried out when the 2-mercaptoethanol concentration was increased 10 times. In this case, 100 μL of an acetonitrile solution of 2-mercaptoethanol (500 mM) was added. The same procedure described above was followed when triethylamine was used; 100 μL of an acetonitrile solution of triethylamine (50 mM) was added to a methanol/water (1/1, 0.7 mL) solution.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> MALDI-TOF Analyses</h4><div class="NLM_p last">Human recombinant GSK-3β was purchased from Millipore (Millipore Iberica S.A.U). A stock solution of 10 μg of the enzyme in MiliiQ water (100 μL) was prepared. Compound <b>38</b> (17.8 mM) and compound <b>40</b> (10 μM) were dissolved in MeOH, then 1 μL of each compound solution was added to 10 μL of the enzyme stock solution reproducing IC<sub>50</sub> experimental conditions prior to MALDI-TOF analysis.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Biological Studies</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Inhibition of GSK-3 (Radiometric Assay)</h4><div class="NLM_p last">GSK-3β enzyme (Sigma) was incubated with 15 μM of ATP, 0.2 μCi of [γ-<sup>32</sup>P]ATP, GS-1 substrate, and different concentrations of test compound. GSK-3β activity was assayed in 50 mM Tris, pH 7.5, 10 mM MgCl<sub>2</sub>, 1 mM EGTA, and 1 mM EDTA buffer at 37 °C, in the presence of 15 mM GS-1 (substrate), 15 μM of ATP, 0.2 μCi of [γ-<sup>32</sup>P] ATP in a final volume of 12 μL. After 20 min of incubation at 37 °C, 4 μL aliquots of the supernatant were spotted onto 2 × 2 pieces of Whatman P81 phosphocellulose paper, and the filter was washed four times (at least 10 min each time) in 1% phosphoric acid. The dried filters were transferred into scintillation vials, and the radioactivity was measured in a liquid scintillation counter. Blank values were subtracted, and the GSK-3β activity was expressed in percentage of maximal activity. The IC<sub>50</sub> is defined as the concentration of each compound that reduces enzyme activity by 50% with respect to that without inhibitor present.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Inhibition of GSK-3 (Luminescent Assay)</h4><div class="NLM_p">Human recombinant GSK-3β was purchased from Millipore (Millipore Iberica S.A.U.) The prephosphorylated polypeptide substrate was purchased from Millipore (Millipore Iberica S.A.U.). Kinase-Glo Luminescent Kinase Assay was obtained from Promega (Promega Biotech Ibérica, SL). ATP and all other reagents were from Sigma-Aldrich (St. Louis, MO). Assay buffer contained 50 mM HEPES (pH 7.5), 1 mM EDTA, 1 mM EGTA, and 15 mM magnesium acetate.</div><div class="NLM_p last">The method of Baki et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> was followed for the inhibition of GSK-3β. Kinase-Glo assays were performed in assay buffer using black 96-well plates. In a typical assay, 10 μL (10 μM) of test compound (dissolved in dimethyl sulfoxide [DMSO] at 1 mM concentration and diluted in advance in assay buffer to the desired concentration) and 10 μL (20 ng) of enzyme were added to each well followed by 20 μL of assay buffer containing 25 μM substrate and 1 μM ATP. The final DMSO concentration in the reaction mixture did not exceed 1%. After a 30 min incubation at 30 °C, the enzymatic reaction was stopped with 40 μL of Kinase-Glo reagent. Glow-type luminescence was recorded after 10 min using a FLUOstar Optima (BMG Labtechnologies GmbH, Offenburg, Germany) multimode reader. The activity is proportional to the difference of the total and consumed ATP. The inhibitory activities were calculated on the basis of maximal activities measured in the absence of inhibitor. The IC<sub>50</sub> was defined as the concentration of each compound that reduces a 50% the enzymatic activity with respect to that without inhibitors.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> GSK-3 Reversibility Studies</h4><div class="NLM_p last">To study the type of enzymatic inhibition for the compounds, assays were performed to determine the activity of the enzyme after several times of incubation of the enzyme with the inhibitor. A reversible inhibitor does not increase the inhibition of the enzyme with the time of incubation, while an irreversible inhibitor increases the inhibition percentage as it increases the time of incubation with the enzyme.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Antibodies and Western Blot Analysis</h4><div class="NLM_p">The antibodies used in this study were: anti-β-actin mAb (Sigma); PHF-1, which is an antiphospho Ser<sup>396/404</sup> Tau mAb and Tau monoclonal antibody Tau-1, from Chemicon, that recognizes residues Ser 195, 198, 199, 202 non-phosphorylated.</div><div class="NLM_p last">Cell extracts were prepared from cells washed with 1 × PBS and then resuspended in a buffer containing the following: 20 mM HEPES, pH 7.4; 100 mM NaCl; 100 mM NaF; 1 mM sodium <i>ortho</i>-vanadate; 5 mM EDTA; Okadaic Acid 1 μM; 1% Triton X-100; and a protease inhibitor cocktail (Complete, Roche). The soluble fraction was obtained by centrifugation at 14 000 <i>g</i> for 10 min at 4 °C, and the proteins (10–50 μg) were separated by SDS-PAGE before being transferred to a nitrocellulose filter. The filters were blocked with 5% nonfat milk in PBS and 0.1% Tween-20 (PBS-T) and then incubated with primary antibodies overnight at 4 °C. Subsequently, the filters were rinsed three times in PBST buffer before being exposed to the corresponding peroxidase-conjugated secondary antibody (diluted 1:5000, Promega) for 1 h at room temperature. Immunoreactivity was visualized using an enhanced chemiluminescence detection system (Perkin-Elmer Life Sci.). Each experiment was normalized with respect to the amount of actin present in each cell extract. The data are expressed as the mean of three independent experiments and the data from control cells were considered 100 relative unit (r.u.).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Inhibition of Protein Kinases</h4><div class="NLM_p">The experimental procedures for the inhibition of different protein kinases are described in each paragraph:</div><ul class="NLM_list-list_type-label"><li><p class="inline">Abl kinase:<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Mouse recombinant (<i>E.coli</i>), staurosporine was used as reference compound and poly GT (0.4 μg.mL<sup>–1</sup>) as a substrate. Fluorescence polarization was used as the method of detection for the reaction product (phosphopoly GT).</p></li><li><p class="inline">CAM kinase II:<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> From rat brain, staurosporine was used as reference compound and [γ<sup>33</sup>-P] ATP + autocamtide-2 (5 μM) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] autocamtide-2).</p></li><li><p class="inline">EGFR kinase:<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> From A-431 cells, PD 153035 was used as reference compound and [γ<sup>33</sup>-P] ATP + poly GAT (0.48 mg.mL<sup>–1</sup>) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] poly GAT).</p></li><li><p class="inline">IRK (<i>h</i>):<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Human recombinant, staurosporine was used as reference compound and [γ<sup>33</sup>-P] ATP + poly GT (0.03 mg.mL<sup>–1</sup>) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] poly GT).</p></li><li><p class="inline">MAP kinase (ERK 42):<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Rat recombinant (<i>E.coli</i>), staurosporine was used as reference compound and [γ<sup>33</sup>-P] ATP + MBP (0.5 mg.mL<sup>–1</sup>) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] MBP).</p></li><li><p class="inline">MEK1 kinase:<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Rabbit recombinat (<i>E.coli</i>), staurosporine was used as reference compound and ATP + unactivated MAP kinase (0.01 mg.mL<sup>–1</sup>) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] MBP).</p></li><li><p class="inline">Protein kinase p56<sup>lck</sup>:<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> From bovine thymus, staurosporine was used as reference compound and [γ<sup>33</sup>-P] ATP + poliGT (0.5 mg.mL<sup>–1</sup>) as a substrate. Liquid scintillation was used as method of detection for the reaction product ([γ<sup>33</sup>-P] poliGT).</p></li></ul></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Neurotransmitter Receptors Binding Assays</h4><div class="NLM_p">The neurotransmitter binding assays are described in each paragraph:</div><ul class="NLM_list-list_type-label"><li><p class="inline">α-2 (non selective) adrenergic receptor:<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> From rat cerebral cortex, yohimbine was used as reference compound and [<sup>3</sup>H] RX 821002 as a ligand (0.5 nM).</p></li><li><p class="inline">D2 (<i>h</i>) dopamine receptor:<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Human recombinant (CHO cells), (+)-buctaclamol was used as reference compound and [<sup>3</sup>H] spiperone as a ligand (0.3 nM).</p></li><li><p class="inline">D3 (<i>h</i>) dopamine receptor:<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Human recombinant (CHO cells), (+)-buctaclamol was used as reference compound and [<sup>3</sup>H] spiperone as a ligand (0.3 nM).</p></li><li><p class="inline">AMPA glutaminergic receptor:<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> From rat cerebral cortex, <span class="smallcaps smallerCapital">l</span>-glutamate was used as reference compound and [<sup>3</sup>H] AMPA as a ligand (8 nM).</p></li><li><p class="inline">NMDA glutaminergic receptor:<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> From rat cerebral cortex, CGS 19755 was used as reference compound and [<sup>3</sup>H] CGP 39653 as a ligand (5 nM).</p></li><li><p class="inline">M (nonselective) muscarinic receptor:<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> From rat cerebral cortex, atropine was used as reference compound and [<sup>3</sup>H] QNB as a ligand (0.05 nM).</p></li><li><p class="inline">N (neuronal) (α-BGTX-insensitive) nicotinic receptor:<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> From rat cerebral cortex, nicotine was used as reference compound and [<sup>3</sup>H] cytisine as a ligand (1.5 nM).</p></li><li><p class="inline">N (neuronal) (α-BGTX-sensitive) nicotinic receptor:<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> From rat cerebral cortex, α-bungarotoxin was used as reference compound and [<sup>125</sup>I] α-bungarotoxin as a ligand (1 nM).</p></li><li><p class="inline">5-HT (nonselective) serotoninergic receptor:<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> From rat cerebral cortex, serotonine was used as reference compound and [<sup>3</sup>H] serotonine as a ligand (2 nM).</p></li></ul></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Molecular Modeling</h3><div class="NLM_p last">Docking was performed with the program <i>r</i><i>D</i><i>o</i><i>c</i><i>k</i>, which is an extension of the program <i>RiboDock</i>,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> using an empirical scoring function calibrated on the basis of protein–ligand complexes.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The reliability of <i>r</i><i>D</i><i>o</i><i>c</i><i>k</i> was assessed by docking a set of known GSK-3 inhibitors taking advantage of the X-ray crystallographic structures of their complexes with the enzyme (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q5K">1Q5K</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UV5">1UV5</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O5K">2O5K</a>; see Table S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The docking of the novel HMK-containing adenine, benzimidazole, and maleimide derivatives was made using the X-ray structure of the original compounds that were designed (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>). The docking volume was defined as the space within 10 Å of the ligands found in those GSK-3 complexes. The structure of the ligands was initially energy minimized at the AM1<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> level using <i>Gaussian 03</i>.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Each compound was subjected to 100 docking runs, and the output docking modes were analyzed by visual inspection in conjunction with the docking scores.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/jm1016279">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Poses for selected GSK-3 inhibitors upon docking to their targets; docked poses for derivatives of adenine (<b>32</b>) and maleimide (<b>40</b>) containing the halomethyketone moiety; elemental analyses of compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1016279/suppl_file/jm1016279_si_001.pdf">jm1016279_si_001.pdf (310.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1016279" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Martínez</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f594989487819c9b908fb59c8498db96869c96db9086"><span class="__cf_email__" data-cfemail="a6c7cbc7d4d2cfc8c3dce6cfd7cb88c5d5cfc588c3d5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel I. Perez</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valle Palomo</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Concepción Pérez</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Gil</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo D. Dans</span> - <span class="hlFld-Affiliation affiliation">Biomolecular Simulations Group, Institut Pasteur de Montevideo, Mataojo 2020, 11400 Montevideo (Uruguay)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Javier Luque</span> - <span class="hlFld-Affiliation affiliation">Departamento de Fisicoquímica e Instituto de Biomedicina (IBUB), Facultad de Farmacia, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona (Spain)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Conde</span> - <span class="hlFld-Affiliation affiliation">Instituto de Química Medica-CSIC, Juan de la Cierva 3, 28006 Madrid (Spain)</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from MICINN and ISCiii (projects nos. SAF2009-13015-CO2-01, SAF2008-05595, SAF2006-01249 and RD07-0060/0015) and computational facilities from the CESCA are also acknowledged. D. I. P. acknowledges a postdoctoral grant to the CSIC (JAEDoc program) and V. P. a predoctoral grant (JAEPre program).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i66" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i66"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> Abbreviations</h2><tr><td class="NLM_term">GSK-3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">HMK</td><td class="NLM_def"><p class="first last">halomethylketone</p></td></tr><tr><td class="NLM_term">TDZD</td><td class="NLM_def"><p class="first last">thiadiazolidindione</p></td></tr><tr><td class="NLM_term">CDK-<i>n</i></td><td class="NLM_def"><p class="first last">cyclin dependent kinase <i>n</i>, where <i>n</i> is 1, 2 or 5</p></td></tr><tr><td class="NLM_term">GS-1</td><td class="NLM_def"><p class="first last">glycogen synthase 1</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">protein kinase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases--the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%2D%2Dthe+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases--the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Duckett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span> </span><span class="NLM_article-title">Metabolism considerations for kinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1517%2F17425255.2010.506873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=20684746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1175-1193&author=D.+R.+Duckettauthor=M.+D.+Cameron&title=Metabolism+considerations+for+kinase+inhibitors+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism considerations for kinase inhibitors in cancer treatment</span></div><div class="casAuthors">Duckett, Derek R.; Cameron, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1175-1193</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: A concerted effort by the pharmaceutical industry over the last decade has led to the successful clin. development of protein kinase inhibitors as effective targeted therapies for certain cancers.  Areas covered in this review: This review details eight small mol. kinase inhibitors that have been approved for the treatment of cancer in either the US or Europe as of March 2010: imatinib, sorafenib, gefitinib, erlotinib, dasatinib, lapatinib, sunitinib and nilotinib.  These eight compds. vary from the relatively specific inhibitor lapatinib to the more promiscuous kinase inhibitors dasatinib and sunitinib.  What the reader will gain: A brief discussion on the biol. of each inhibitor, selectivity over other kinases and toxicity is provided.  A more detailed discussion on the metab., drug transporters, drug-drug interactions and possible roles of metab. in compd. toxicity is provided for each compd.  Take home message: The majority of the currently approved kinase inhibitors is heavily influenced by drug transporters and significantly affected by CYP3A4 inhibitors/inducers.  At least three, gefitinib, erlotinib and dasatinib, are metabolized to form reactive metabolites capable of covalently-binding biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBX9QvQ30ARrVg90H21EOLACvtfcHk0lhmQHD5W9SAZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtbfM&md5=5676874cddba2d9218f6f35efc29f6c3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F17425255.2010.506873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2010.506873%26sid%3Dliteratum%253Aachs%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26atitle%3DMetabolism%2520considerations%2520for%2520kinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D1175%26epage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Belani, C. P.</span><span> </span><span class="NLM_article-title">The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitors</span> <span class="citation_source-journal">Cancer Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=413-423&author=C.+P.+Belani&title=The+role+of+irreversible+EGFR+inhibitors+in+the+treatment+of+non-small+cell+lung+cancer%3A+overcoming+resistance+to+reversible+EGFR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DThe%2520role%2520of%2520irreversible%2520EGFR%2520inhibitors%2520in%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%253A%2520overcoming%2520resistance%2520to%2520reversible%2520EGFR%2520inhibitors%26jtitle%3DCancer%2520Invest.%26date%3D2010%26volume%3D28%26spage%3D413%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0ljEHPDohk7cIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span> </span><span class="NLM_article-title">Inhibition of tau phosphorylation: A new therapeutical strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1517%2F13543776.10.10.1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1antr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1519-1527&author=A.+Martinezauthor=A.+Castro&title=Inhibition+of+tau+phosphorylation%3A+A+new+therapeutical+strategy+for+the+treatment+of+Alzheimer%E2%80%99s+disease+and+other+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1519-1527</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 86 refs.  There is some evidence to suggest that hyperphosphorylation of tau protein is an early event in the development of neurofibrillary pathol. and appears to compromise the ability of tau to bind to and stabilize microtubules.  Thus, the blockade of this hyperphosphorylation step may be a prime target at which to interrupt the pathogenic cascade.  Efforts to discover rational targets (mainly tau kinases) and inhibitors of tau hyperphosphorylation (protein kinase inhibitors) are discussed in this paper.  Patenting activity from 1997 to date has focused on two major areas: development of methods for screening new compds. and discovery of tau protein kinases inhibitors.  Some mention is also made regarding Alzheimer's disease (AD) diagnosis methods based on tau hyperphosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsLY48wZC7I7Vg90H21EOLACvtfcHk0ljEHPDohk7cIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1antr0%253D&md5=4df52d5aadb7c07668a518577ecb927a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.10.1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.10.1519%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520tau%2520phosphorylation%253A%2520A%2520new%2520therapeutical%2520strategy%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1519%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Plattner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, K. P.</span><span> </span><span class="NLM_article-title">The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">25457</span><span class="NLM_x">–</span> <span class="NLM_lpage">25465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=25457-25465&author=F.+Plattnerauthor=M.+Angeloauthor=K.+P.+Giese&title=The+roles+of+cyclin-dependent+kinase+5+and+glycogen+synthase+kinase+3+in+tau+hyperphosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlattner%26aufirst%3DF.%26aulast%3DAngelo%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DK.%2BP.%26atitle%3DThe%2520roles%2520of%2520cyclin-dependent%2520kinase%25205%2520and%2520glycogen%2520synthase%2520kinase%25203%2520in%2520tau%2520hyperphosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D25457%26epage%3D25465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perez, D. I.; Gil, C.; Martinez, A.</span><span> </span><span class="NLM_article-title">Tau protein kinases inhibitors: from the bench to the clinical trials</span>. In  <span class="citation_source-book">Emerging Drugs and Targets for Alzheimer’s Disease</span>, <span class="NLM_contrib-group">Martinez, A.</span>, Ed.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1039%2F9781849731065-00173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=173-194&author=D.+I.+Perez&author=C.+Gil&author=A.+Martinezauthor=A.+Martinez&title=Emerging+Drugs+and+Targets+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2F9781849731065-00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731065-00173%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26atitle%3DTau%2520protein%2520kinases%2520inhibitors%253A%2520from%2520the%2520bench%2520to%2520the%2520clinical%2520trials%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2010%26volume%3D1%26spage%3D173%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span> </span><span class="NLM_article-title">GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer’s disease?</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18953107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=181-191&author=A.+Martinezauthor=D.+I.+Perez&title=GSK-3+inhibitors%3A+a+ray+of+hope+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?</span></div><div class="casAuthors">Martinez, Ana; Perez, Daniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia affecting more than 15 millions individuals worldwide.  While the cause is unknown, there are two major neuropathol. abnormalities present in the brains of patients with AD, the extracellular senile plaques and the intracellular neurofibrillary tangles.  There is strong evidence that glycogen synthase kinase-3 (GSK-3) plays an important role in AD being involved in the regulation of these neuropathol. hallmarks.  Increased activity and/or overexpression of this enzyme in AD is assocd. with increased tau hyperphosphorylation and alterations in amyloid-β processing that are thought to precede the formation of neurofibrillary tangles and senile plaques, resp.  Furthermore, over activity of GSK-3 is also involved in neuronal loss.  These data clearly identify GSK-3 inhibitors as one of the most promising new approaches for the future treatment of AD and a redn. of the aberrant over activity of this enzyme might decrease several aspects of the neuronal pathol. in AD.  In this review, we provide an overview of the rationale for the development of GSK-3 inhibitors for the treatment of AD, discussing the risks and benefits of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOLyJI92B9WbVg90H21EOLACvtfcHk0ljimSGJ5l496Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmtrzF&md5=000ca138a0a41334a84a8d794cb98442</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26atitle%3DGSK-3%2520inhibitors%253A%2520a%2520ray%2520of%2520hope%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2008%26volume%3D15%26spage%3D181%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1002%2Fmed.20119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18271054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=773-796&author=A.+Martinez&title=Preclinical+efficacy+on+GSK-3+inhibitors%3A+towards+a+future+generation+of+powerful+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span></div><div class="casAuthors">Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-796</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in glycogen synthase kinase-3 (GSK-3), involved in the mol. pathogenesis of human severe diseases, is focused on the potential of its inhibitors to treat diseases that have significant limitations in their current treatments.  During the last 5 years, a lot of literature discuss progress in the search and pharmacol. actions of GSK-3 inhibitors, but now, evidence have been accumulated showing preclin. efficacy for these new drugs, in very different models of several distinct pathologies.  These studies have been summarized in the present review offering promising examples for new therapies for diabetes, cancer, inflammation, Alzheimer's disease and other neurol. pathologies, and mood disorders.  Now, clin. human trials are awaiting to confirm the ray of hope that GSK-3 inhibitors are arising for the future treatment of severe unmet diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNZASfEwzRLVg90H21EOLACvtfcHk0ljimSGJ5l496Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ&md5=96cd9bc1d03273a8448f455c3cceb32c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fmed.20119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20119%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPreclinical%2520efficacy%2520on%2520GSK-3%2520inhibitors%253A%2520towards%2520a%2520future%2520generation%2520of%2520powerful%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D773%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovestone, S.</span><span> </span><span class="NLM_article-title">The GSK3 hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1471-4159.2007.05194.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18088381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Citbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1433-1439&author=C.+Hooperauthor=R.+Killickauthor=S.+Lovestone&title=The+GSK3+hypothesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The GSK3 hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Hooper, Claudie; Killick, Richard; Lovestone, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1433-1439</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase 3 (GSK3) is a constitutively active, proline-directed serine/threonine kinase that plays a part in a no. of physiol. processes ranging from glycogen metab. to gene transcription.  GSK3 also plays a pivotal and central role in the pathogenesis of both sporadic and familial forms of Alzheimer's disease (AD), an observation that has led us to coin the 'GSK3 hypothesis of AD'.  According to this hypothesis, over-activity of GSK3 accounts for memory impairment, tau hyper-phosphorylation, increased β-amyloid prodn. and local plaque-assocd. microglial-mediated inflammatory responses; all of which are hallmark characteristics of AD.  If our 'GSK3 hypothesis of AD' is substantiated and GSK3 is indeed a causal mediator of AD then inhibitors of GSK3 would provide a novel avenue for therapeutic intervention in this devastating disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9lxWCe90horVg90H21EOLACvtfcHk0lhXnYo9DDzEgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Citbw%253D&md5=6e5f9918668aac2d3127bacad12a8340</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05194.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05194.x%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DC.%26aulast%3DKillick%26aufirst%3DR.%26aulast%3DLovestone%26aufirst%3DS.%26atitle%3DThe%2520GSK3%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1433%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sereno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span> </span><span class="NLM_article-title">A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.nbd.2009.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19523516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=359-367&author=L.+Serenoauthor=M.+Comaauthor=M.+Rodriguezauthor=P.+Sanchez-Ferrerauthor=M.+B.+Sanchezauthor=I.+Gichauthor=J.+M.+Agulloauthor=M.+Perezauthor=J.+Avilaauthor=C.+Guardia-Laguartaauthor=J.+Clarimonauthor=A.+Lleoauthor=T.+Gomez-Isla&title=A+novel+GSK-3beta+inhibitor+reduces+Alzheimer%E2%80%99s+pathology+and+rescues+neuronal+loss+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo</span></div><div class="casAuthors">Sereno, L.; Coma, M.; Rodriguez, M.; Sanchez-Ferrer, P.; Sanchez, M. B.; Gich, I.; Agullo, J. M.; Perez, M.; Avila, J.; Guardia-Laguarta, C.; Clarimon, J.; Lleo, A.; Gomez-Isla, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid deposits, neurofibrillary tangles, and neuronal cell death in selectively vulnerable brain regions are the chief hallmarks in Alzheimer's (AD) brains.  Glycogen synthase kinase-3 (GSK-3) is one of the key kinases required for AD-type abnormal hyperphosphorylation of tau, which is believed to be a crit. event in neurofibrillary tangle formation.  GSK-3 has also been recently implicated in amyloid precursor protein (APP) processing/Aβ prodn., apoptotic cell death, and learning and memory.  Thus, GSK-3 inhibition represents a very attractive drug target in AD and other neurodegenerative disorders.  To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non-ATP competitive GSK-3β inhibitor, NP12.  Treatment with this thiadiazolidinone compd. resulted in lower levels of tau phosphorylation, decreased amyloid deposition and plaque-assocd. astrocytic proliferation, protection of neurons in the entorhinal cortex and CA1 hippocampal subfield against cell death, and prevention of memory deficits in this transgenic mouse model.  These results show that this novel GSK-3 inhibitor has a dual impact on amyloid and tau alterations and, perhaps even more important, on neuronal survival in vivo further suggesting that GSK-3 is a relevant therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDbLMUp5zF7Vg90H21EOLACvtfcHk0lhXnYo9DDzEgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D&md5=b3d6145f5662c989f22113bef022656e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSereno%26aufirst%3DL.%26aulast%3DComa%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSanchez-Ferrer%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DM.%2BB.%26aulast%3DGich%26aufirst%3DI.%26aulast%3DAgullo%26aufirst%3DJ.%2BM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DClarimon%26aufirst%3DJ.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DGomez-Isla%26aufirst%3DT.%26atitle%3DA%2520novel%2520GSK-3beta%2520inhibitor%2520reduces%2520Alzheimer%25E2%2580%2599s%2520pathology%2520and%2520rescues%2520neuronal%2520loss%2520in%2520vivo%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26spage%3D359%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudrimoti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasanna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennaka, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madgula, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, M. T.</span><span> </span><span class="NLM_article-title">Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900672t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=61-76&author=J.+Pengauthor=S.+Kudrimotiauthor=S.+Prasannaauthor=S.+Oddeauthor=R.+J.+Doerksenauthor=H.+K.+Pennakaauthor=Y.+M.+Chooauthor=K.+V.+Raoauthor=B.+L.+Tekwaniauthor=V.+Madgulaauthor=S.+I.+Khanauthor=B.+Wangauthor=A.+M.+Mayerauthor=M.+R.+Jacobauthor=L.+C.+Tuauthor=J.+Gertschauthor=M.+T.+Hamann&title=Structure-activity+relationship+and+mechanism+of+action+studies+of+manzamine+analogues+for+the+control+of+neuroinflammation+and+cerebral+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm900672t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900672t%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DKudrimoti%26aufirst%3DS.%26aulast%3DPrasanna%26aufirst%3DS.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26aulast%3DPennaka%26aufirst%3DH.%2BK.%26aulast%3DChoo%26aufirst%3DY.%2BM.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DMadgula%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMayer%26aufirst%3DA.%2BM.%26aulast%3DJacob%26aufirst%3DM.%2BR.%26aulast%3DTu%26aufirst%3DL.%2BC.%26aulast%3DGertsch%26aufirst%3DJ.%26aulast%3DHamann%26aufirst%3DM.%2BT.%26atitle%3DStructure-activity%2520relationship%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520manzamine%2520analogues%2520for%2520the%2520control%2520of%2520neuroinflammation%2520and%2520cerebral%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D61%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hamann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Aparicio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Puerto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Monte-Millan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaiah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahyuono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer’s disease</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span></span><div class="citationLinks">[<a href="/doi/10.1021/np060092r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1397-1405&author=M.+Hamannauthor=D.+Alonsoauthor=E.+Martin-Aparicioauthor=A.+Fuertesauthor=M.+J.+Perez-Puertoauthor=A.+Castroauthor=S.+Moralesauthor=M.+L.+Navarroauthor=M.+Del+Monte-Millanauthor=M.+Medinaauthor=H.+Pennakaauthor=A.+Balaiahauthor=J.+Pengauthor=J.+Cookauthor=S.+Wahyuonoauthor=A.+Martinez&title=Glycogen+synthase+kinase-3+%28GSK-3%29+inhibitory+activity+and+structure-activity+relationship+%28SAR%29+studies+of+the+manzamine+alkaloids.+Potential+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fnp060092r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp060092r%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DMartin-Aparicio%26aufirst%3DE.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DPerez-Puerto%26aufirst%3DM.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMorales%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DM.%2BL.%26aulast%3DDel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DPennaka%26aufirst%3DH.%26aulast%3DBalaiah%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DWahyuono%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitory%2520activity%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520the%2520manzamine%2520alkaloids.%2520Potential%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1397%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht-Murava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrokovski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenstein, M.</span><span> </span><span class="NLM_article-title">Substrate competitive GSK-3 inhibitors - strategy and implications</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=598-603&author=H.+Eldar-Finkelmanauthor=A.+Licht-Muravaauthor=S.+Pietrokovskiauthor=M.+Eisenstein&title=Substrate+competitive+GSK-3+inhibitors+-+strategy+and+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DLicht-Murava%26aufirst%3DA.%26aulast%3DPietrokovski%26aufirst%3DS.%26aulast%3DEisenstein%26aufirst%3DM.%26atitle%3DSubstrate%2520competitive%2520GSK-3%2520inhibitors%2520-%2520strategy%2520and%2520implications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=495-510&author=A.+Castroauthor=A.+Encinasauthor=C.+Gilauthor=S.+Braseauthor=W.+Porcalauthor=C.+Perezauthor=F.+J.+Morenoauthor=A.+Martinez&title=Non-ATP+competitive+glycogen+synthase+kinase+3beta+%28GSK-3beta%29+inhibitors%3A+study+of+structural+requirements+for+thiadiazolidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DEncinas%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DPorcal%26aufirst%3DW.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DNon-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520study%2520of%2520structural%2520requirements%2520for%2520thiadiazolidinone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D495%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7103</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040895g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7103-7112&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=I.+Dorronsoroauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=C.+Perezauthor=F.+J.+Moreno&title=SAR+and+3D-QSAR+studies+on+thiadiazolidinone+derivatives%3A+exploration+of+structural+requirements+for+glycogen+synthase+kinase+3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Dorronsoro, Isabel; Gelpi, J. Luis; Luque, F. Javier; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7103-7112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2,4-disubstituted thiadiazolidinones (TDZD) are described as the first ATP-noncompetitive GSK-3 inhibitors.  Following an SAR study about TDZD, different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biol. study are here reported here.  Various compds. such as hydantoins, dithiazolidindiones, rhodanines, maleimides, and triazoles were synthesized and screened as GSK-3 inhibitors.  After an extensive SAR study among these different heterocyclic families, TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3.  A Co-MFA anal. was also performed highlighting the mol. electrostatic field interaction in the interaction of TDZDs with GSK-3.  Moreover, first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQ6m_G-n_WLVg90H21EOLACvtfcHk0litsX5ZwlISmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O&md5=35b315178d5e518a64b7a2670d41d27b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm040895g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040895g%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DSAR%2520and%25203D-QSAR%2520studies%2520on%2520thiadiazolidinone%2520derivatives%253A%2520exploration%2520of%2520structural%2520requirements%2520for%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7103%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wandosell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6914</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6914-25&author=D.+I.+Perezauthor=S.+Condeauthor=C.+Perezauthor=C.+Gilauthor=D.+Simonauthor=F.+Wandosellauthor=F.+J.+Morenoauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=A.+Martinez&title=Thienylhalomethylketones%3A+Irreversible+glycogen+synthase+kinase+3+inhibitors+as+useful+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DD.%26aulast%3DWandosell%26aufirst%3DF.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DThienylhalomethylketones%253A%2520Irreversible%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520as%2520useful%2520pharmacological%2520tools%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6914%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mazanetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=464-479&author=M.+P.+Mazanetzauthor=P.+M.+Fischer&title=Untangling+tau+hyperphosphorylation+in+drug+design+for+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazanetz%26aufirst%3DM.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DUntangling%2520tau%2520hyperphosphorylation%2520in%2520drug%2520design%2520for%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D464%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm011020u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1292-1299&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=C.+Perezauthor=F.+J.+Moreno&title=First+non-ATP+competitive+glycogen+synthase+kinase+3+beta+%28GSK-3beta%29+inhibitors%3A+thiadiazolidinones+%28TDZD%29+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm011020u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011020u%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DFirst%2520non-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520thiadiazolidinones%2520%2528TDZD%2529%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1292%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Leproult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barluenga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span> </span><span class="NLM_article-title">Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101396q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1347-1355&author=E.+Leproultauthor=S.+Barluengaauthor=D.+Morasauthor=J.+M.+Wurtzauthor=N.+Winssinger&title=Cysteine+mapping+in+conformationally+distinct+kinase+nucleotide+binding+sites%3A+application+to+the+design+of+selective+covalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors</span></div><div class="casAuthors">Leproult, Emeline; Barluenga, Sofia; Moras, Dino; Wurtz, Jean-Marie; Winssinger, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1347-1355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinases have emerged as one of the most prolific therapeutic targets.  An important criterion in the therapeutic success of inhibitors targeting the nucleotide binding pocket of kinases is the inhibitor residence time.  Recently, covalent kinase inhibitors have attracted attention since they confer terminal inhibition and should thus be more effective than reversible inhibitors with transient inhibition.  The most robust approach to design irreversible inhibitors is to capitalize on the nucleophilicity of a cysteine thiol group present in the target protein.  Herein, the authors report a systematic anal. of cysteine residues present in the nucleotide binding site of kinases, which could be harnessed for irreversible inhibition, taking into consideration the different kinase conformations.  The authors demonstrate the predictive power of this anal. with the design and validation of an irreversible inhibitor of KIT/PDGFR kinases.  This is the first example of a covalent kinase inhibitor that combines a pharmacophore addressing the DFG-out conformation with a covalent trap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzqt0gMrz3rVg90H21EOLACvtfcHk0lgRCTo1WlqYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis70%253D&md5=329ae5eaa6102b6dd34a0d1274631247</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101396q%26sid%3Dliteratum%253Aachs%26aulast%3DLeproult%26aufirst%3DE.%26aulast%3DBarluenga%26aufirst%3DS.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DCysteine%2520mapping%2520in%2520conformationally%2520distinct%2520kinase%2520nucleotide%2520binding%2520sites%253A%2520application%2520to%2520the%2520design%2520of%2520selective%2520covalent%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4631</span><span class="NLM_x">–</span> <span class="NLM_lpage">4633</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034108b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4631-4633&author=S.+Condeauthor=D.+I.+Perezauthor=A.+Martinezauthor=C.+Perezauthor=F.+J.+Moreno&title=Thienyl+and+phenyl+alpha-halomethyl+ketones%3A+new+inhibitors+of+glycogen+synthase+kinase+%28GSK-3beta%29+from+a+library+of+compound+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm034108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034108b%26sid%3Dliteratum%253Aachs%26aulast%3DConde%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DThienyl%2520and%2520phenyl%2520alpha-halomethyl%2520ketones%253A%2520new%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase%2520%2528GSK-3beta%2529%2520from%2520a%2520library%2520of%2520compound%2520searching%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4631%26epage%3D4633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Use of peptide substrates for affinity purification of protein-serine kinases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1989&pages=237-241&author=J.+R.+Woodgett&title=Use+of+peptide+substrates+for+affinity+purification+of+protein-serine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DUse%2520of%2520peptide%2520substrates%2520for%2520affinity%2520purification%2520of%2520protein-serine%2520kinases%26jtitle%3DAnal.%2520Biochem.%26date%3D1989%26volume%3D180%26spage%3D237%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dutta, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritsch, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthasarthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chheda, G. B.</span><span> </span><span class="NLM_article-title">Synthesis and biological activities of some N6- and N9-carbamoyladenines and related ribonucleosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1598</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00222a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1598-1607&author=S.+P.+Duttaauthor=C.+I.+Hongauthor=G.+L.+Tritschauthor=C.+Coxauthor=R.+Parthasarthyauthor=G.+B.+Chheda&title=Synthesis+and+biological+activities+of+some+N6-+and+N9-carbamoyladenines+and+related+ribonucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00222a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00222a013%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DS.%2BP.%26aulast%3DHong%26aufirst%3DC.%2BI.%26aulast%3DTritsch%26aufirst%3DG.%2BL.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DParthasarthy%26aufirst%3DR.%26aulast%3DChheda%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520some%2520N6-%2520and%2520N9-carbamoyladenines%2520and%2520related%2520ribonucleosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1598%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Palmer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatana, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahring, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5457</span><span class="NLM_x">–</span> <span class="NLM_lpage">5465</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804681" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5457-5465&author=B.+D.+Palmerauthor=J.+B.+Smaillauthor=M.+Boydauthor=D.+H.+Boschelliauthor=A.+M.+Dohertyauthor=J.+M.+Hambyauthor=S.+S.+Khatanaauthor=J.+B.+Kramerauthor=A.+J.+Krakerauthor=R.+L.+Panekauthor=G.+H.+Luauthor=T.+K.+Dahringauthor=R.+T.+Wintersauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Structure-activity+relationships+for+1-phenylbenzimidazoles+as+selective+ATP+site+inhibitors+of+the+platelet-derived+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9804681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804681%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DKhatana%26aufirst%3DS.%2BS.%26aulast%3DKramer%26aufirst%3DJ.%2BB.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DDahring%26aufirst%3DT.%2BK.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DStructure-activity%2520relationships%2520for%25201-phenylbenzimidazoles%2520as%2520selective%2520ATP%2520site%2520inhibitors%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5457%26epage%3D5465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new one step synthesis of maleimides by condensation of glyoxylate esters with acetamides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=1109-1112&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new+one+step+synthesis+of+maleimides+by+condensation+of+glyoxylate+esters+with+acetamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%2520one%2520step%2520synthesis%2520of%2520maleimides%2520by%2520condensation%2520of%2520glyoxylate%2520esters%2520with%2520acetamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D1109%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Polgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szendrei, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7959</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050504d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7946-7959&author=T.+Polgarauthor=A.+Bakiauthor=G.+I.+Szendreiauthor=G.+M.+Keseru&title=Comparative+virtual+and+experimental+high-throughput+screening+for+glycogen+synthase+kinase-3beta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm050504d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050504d%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DT.%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DSzendrei%26aufirst%3DG.%2BI.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DComparative%2520virtual%2520and%2520experimental%2520high-throughput%2520screening%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7946%26epage%3D7959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Martínez, A.; Gil, C.; Palomo, V.; Pérez, C.; Perez, D. I.</span><span> </span><span class="NLM_article-title">Inhibidores de GSK-3 útiles en enfermedades neurodegenerativas, inflamatorias, cáncer, diabetes y en procesos regenerativos</span>. ES 201130253, 25th February,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Mart%C3%ADnez&author=C.+Gil&author=V.+Palomo&author=C.+P%C3%A9rez&author=D.+I.+Perez&title=Inhibidores+de+GSK-3+%C3%BAtiles+en+enfermedades+neurodegenerativas%2C+inflamatorias%2C+c%C3%A1ncer%2C+diabetes+y+en+procesos+regenerativos"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DInhibidores%2520de%2520GSK-3%2520%25C3%25BAtiles%2520en%2520enfermedades%2520neurodegenerativas%252C%2520inflamatorias%252C%2520c%25C3%25A1ncer%252C%2520diabetes%2520y%2520en%2520procesos%2520regenerativos%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kafka, A. P.; Kleffmann, T.; Rades, T.; McDowell, A.</span><span> </span><span class="NLM_article-title">The application of MALDI TOF MS in biopharmaceutical research</span>.  <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span>doi:<span class="refDoi"> DOI: 10.1016/j.ijpharm.2010.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.ijpharm.2010.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=21147205" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+P.+Kafka&author=T.+Kleffmann&author=T.+Rades&author=A.+McDowell&title=The+application+of+MALDI+TOF+MS+in+biopharmaceutical+research&doi=10.1016%2Fj.ijpharm.2010.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DKafka%26aufirst%3DA.%2BP.%26atitle%3DThe%2520application%2520of%2520MALDI%2520TOF%2520MS%2520in%2520biopharmaceutical%2520research%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26doi%3D10.1016%2Fj.ijpharm.2010.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kockeritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3--an overview of an over-achieving protein kinase</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.2174%2F1389450110607011377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=17100578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1377-1388&author=L.+Kockeritzauthor=B.+Dobleauthor=S.+Patelauthor=J.+R.+Woodgett&title=Glycogen+synthase+kinase-3%2D%2Dan+overview+of+an+over-achieving+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 - an overview of an over-achieving protein kinase</span></div><div class="casAuthors">Kockeritz, Lisa; Doble, Bradley; Patel, Satish; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1377-1388</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) has attracted much scrutiny due to its plethora of cellular functions, novel mechanisms of regulation, and its potential as a therapeutic target for several common diseases.  In mammals, GSK-3 is encoded by 2 genes, termed GSK-3α and GSK-3β, that yield related but distinct protein-serine kinases.  GSK-3 is unusual in that its protein kinase activity tends to be high in resting cells and cellular stimuli, such as hormones and growth factors, result in its catalytic inactivation.  Further, many of the substrate proteins of GSK-3 are functionally inhibited by phosphorylation.  Thus, signals that inhibit GSK-3 often cause activation of its diverse array of target proteins.  Regulation of GSK-3 is important for normal development, regulation of metab., neuronal growth, and differentiation and modulation of cell death.  Dysregulation of GSK-3 activity has been implicated in human pathologies such as neurodegenerative diseases and type-2 diabetes.  Here, the authors provide a primer on the modes of GSK-3 regulation and a description of the various signaling pathways and cellular processes in which GSK-3 is an active participant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXRwL4DSHwrVg90H21EOLACvtfcHk0li4zpRo6GWODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FK&md5=d6224af09b10ae9769e81dee3ca368c8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F1389450110607011377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450110607011377%26sid%3Dliteratum%253Aachs%26aulast%3DKockeritz%26aufirst%3DL.%26aulast%3DDoble%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGlycogen%2520synthase%2520kinase-3--an%2520overview%2520of%2520an%2520over-achieving%2520protein%2520kinase%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D1377%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paudel, H. K.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3beta phosphorylates Alzheimer’s disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3125</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi051634r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3125-3133&author=T.+Liauthor=H.+K.+Paudel&title=Glycogen+synthase+kinase+3beta+phosphorylates+Alzheimer%E2%80%99s+disease-specific+Ser396+of+microtubule-associated+protein+tau+by+a+sequential+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi051634r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051634r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26atitle%3DGlycogen%2520synthase%2520kinase%25203beta%2520phosphorylates%2520Alzheimer%25E2%2580%2599s%2520disease-specific%2520Ser396%2520of%2520microtubule-associated%2520protein%2520tau%2520by%2520a%2520sequential%2520mechanism%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D3125%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span> </span><span class="NLM_article-title">Protein kinase inhibitors: contributions from structure to clinical compounds</span> <span class="citation_source-journal">Q. Rev. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1017%2FS0033583508004745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19296866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvF2htbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=1-40&author=L.+N.+Johnson&title=Protein+kinase+inhibitors%3A+contributions+from+structure+to+clinical+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase inhibitors: contributions from structure to clinical compounds</span></div><div class="casAuthors">Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Quarterly Reviews of Biophysics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-40</span>CODEN:
                <span class="NLM_cas:coden">QURBAW</span>;
        ISSN:<span class="NLM_cas:issn">0033-5835</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Protein kinases catalyze key phosphorylation reactions in signalling cascades that affect every aspect of cell growth, differentiation and metab.  The kinases have become prime targets for drug intervention in the diseased state, esp. in cancer.  There are currently 10 drugs that have been approved for clin. use and many more in clin. trials.  This review summarises the structural basis for protein kinase inhibition and discusses the mode of action for each of the approved drugs in the light of structural results.  All but one of the approved compds. target the ATP binding site on the kinase.  Both the active and inactive conformations of protein kinases have been used in strategies to produce potent and selective compds.  Targeting the inactive conformation can give high specificity.  Targeting the active conformation is favorable where the diseased state has arisen from activating mutations, but such inhibitors generally target several protein kinases.  Drug resistance mutations are a potential risk for both conformational states, where drug-binding regions are not directly involved in catalysis.  Imatinib (Glivec), the most successful of protein kinase inhibitors, targets the inactive conformation of ABL tyrosine kinase.  Newer compds., such as dasatinib, which targets the ABL active state, have been developed to increase potency and have proved effective for some, but not all, drug-resistant mutations.  The first epidermal growth factor receptor (EGFR) inhibitors in clin. use [gefitinib (Iressa) and erlotinib (Tarceva)] targeted the active form of the kinase, and this proved advantageous for patients whose cancer was caused by mutations that resulted in a constitutively active EGFR kinase domain.  Newer approved compds., such as lapatinib (Tykerb), target the inactive conformation with high potency.  A further compd. that forms a covalent attachment to the kinase has been found to overcome one of the major drug resistance mutations, where the effectiveness of the drug in vivo is dependent on its ability to compete successfully in the presence of cellular concns. of ATP.  Inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase against cancer angiogenesis show the advantage of some relaxation in specificity.  Sorafenib, originally developed as RAF inhibitor, is now in clin. use as a VEGFR inhibitor.  Temsirolimus (a deriv. of rapamycin) is the only example of a drug in clin. use that does not target the kinase ATP site.  Instead rapamycin, when in complex with the protein FKBP12, effectively targets mTOR kinase at a site located on a domain, the FRB domain, that appears to be involved in localization or substrate docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG5I7Tvg482LVg90H21EOLACvtfcHk0li4zpRo6GWODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvF2htbg%253D&md5=ecfbea1f4eb6133f631e36efed2b1f9f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1017%2FS0033583508004745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033583508004745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DProtein%2520kinase%2520inhibitors%253A%2520contributions%2520from%2520structure%2520to%2520clinical%2520compounds%26jtitle%3DQ.%2520Rev.%2520Biophys.%26date%3D2009%26volume%3D42%26spage%3D1%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1038%2Fnchembio.492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=21113170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=22-24&author=M.+Hagelauthor=D.+Niuauthor=T.+St+Martinauthor=M.+P.+Sheetsauthor=L.+Qiaoauthor=H.+Bernardauthor=R.+M.+Karpauthor=Z.+Zhuauthor=M.+T.+Labenskiauthor=P.+Chaturvediauthor=M.+Nachtauthor=W.+F.+Westlinauthor=R.+C.+Petterauthor=J.+Singh&title=Selective+irreversible+inhibition+of+a+protease+by+targeting+a+noncatalytic+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span></div><div class="casAuthors">Hagel, Margit; Niu, Deqiang; St. Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-24</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic app.  We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family.  We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcCQdERpWWLVg90H21EOLACvtfcHk0lim6TJX2KNKpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M&md5=e2b523ebc4e1115beef32093003a10c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.492%26sid%3Dliteratum%253Aachs%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DSt%2BMartin%26aufirst%3DT.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DSelective%2520irreversible%2520inhibition%2520of%2520a%2520protease%2520by%2520targeting%2520a%2520noncatalytic%2520cysteine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D22%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Shaw, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. H.</span><span> </span><span class="NLM_article-title">The mesomorphic state: The mesomorphic 4,4′-di(n)alkoxybenzalazines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2532</span><span class="NLM_x">–</span> <span class="NLM_lpage">2537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01519a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1959&pages=2532-2537&author=W.+G.+Shawauthor=G.+H.+Brown&title=The+mesomorphic+state%3A+The+mesomorphic+4%2C4%E2%80%B2-di%28n%29alkoxybenzalazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja01519a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01519a058%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DW.%2BG.%26aulast%3DBrown%26aufirst%3DG.%2BH.%26atitle%3DThe%2520mesomorphic%2520state%253A%2520The%2520mesomorphic%25204%252C4%25E2%2580%25B2-di%2528n%2529alkoxybenzalazines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1959%26volume%3D81%26spage%3D2532%26epage%3D2537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hill, J. H. M.</span><span> </span><span class="NLM_article-title">Mechanism of the Gabriel-Colman rearrangement</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01013a078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=620-622&author=J.+H.+M.+Hill&title=Mechanism+of+the+Gabriel-Colman+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo01013a078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01013a078%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DMechanism%2520of%2520the%2520Gabriel-Colman%2520rearrangement%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D620%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Weng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.ejphar.2007.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18215659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslaqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2008&pages=262-269&author=Q.+Wengauthor=D.+Wangauthor=P.+Guoauthor=L.+Fangauthor=Y.+Huauthor=Q.+Heauthor=B.+Yang&title=Q39%2C+a+novel+synthetic+Quinoxaline+1%2C4-Di-N-oxide+compound+with+anti-cancer+activity+in+hypoxia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia</span></div><div class="casAuthors">Weng, Qinjie; Wang, Duoduo; Guo, Peng; Fang, Liang; Hu, Yongzhou; He, Qiaojun; Yang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia is one of the inevitable circumstances in various tumors and results in tumor resistance to radiotherapy and chemotherapy.  The present data showed that 3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline 1,4-dioxide (Q39), derived from Quinoxaline 1,4-Di-N-oxide, possessed high anti-cancer activity in hypoxia.  Cytotoxicity assay demonstrated that Q39 is a potential and high efficient anti-cancer compd. in all tested cell lines with IC50 values of 0.18 ± 0.03-8.88 ± 1.12 μM in hypoxia and 0.33 ± 0.04-8.74 ± 1.28 μM in normoxia .  In the following work concerning the mechanism of Q39 in hypoxia, we confirmed that Q39 could cause the apoptosis of K562 cells in a time-dependent manner.  By fluorescence stain assay, Q39-induced mitochondria membrane potential (ΔΨm) loss was obsd. in K562 cells in hypoxia.  Based on the western blotting, Q39 decreased the protein expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in hypoxia.  The compd. caused the activation of caspase-3 and subsequent cleavage of its substrate poly (ADP-ribose) polymerase (PARP) in hypoxia.  Meanwhile, we found the upregulation of Bax by Q39 in K562 cells as well as the downregulation of Bcl-2.  Q39 also influenced the expression of Mitogen-Activated Protein Kinase (MAPKs) and other proteins relative to mitochondria induced apoptosis.  In addn., Q39-mediated apoptosis was not reversed after treatment with the JNK-specific inhibitor.  In summary, the present study demonstrated Q39 was a novel compd. against cancer cells in hypoxia.  The mitochondrial pathway mediated by Bcl-2 protein family and MAPKs and the HIF-1 pathway might be involved in signaling Q39-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofweWFI1728LVg90H21EOLACvtfcHk0ljrmhci3r-stg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslaqs7Y%253D&md5=c32f0715e5c3afebc67a780a85fa02a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DQ39%252C%2520a%2520novel%2520synthetic%2520Quinoxaline%25201%252C4-Di-N-oxide%2520compound%2520with%2520anti-cancer%2520activity%2520in%2520hypoxia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D581%26spage%3D262%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laube, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckman, B. S.</span><span> </span><span class="NLM_article-title">Extrusion of sulfur from [(acylmethyl)thio]pyrimidinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3651</span><span class="NLM_x">–</span> <span class="NLM_lpage">3657</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01306a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3651-3657&author=B.+Rothauthor=R.+Laubeauthor=M.+Y.+Tidwellauthor=B.+S.+Rauckman&title=Extrusion+of+sulfur+from+%5B%28acylmethyl%29thio%5Dpyrimidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo01306a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01306a022%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DLaube%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DM.%2BY.%26aulast%3DRauckman%26aufirst%3DB.%2BS.%26atitle%3DExtrusion%2520of%2520sulfur%2520from%2520%255B%2528acylmethyl%2529thio%255Dpyrimidinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3651%26epage%3D3657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zhuangping, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongmin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhenghai, M.</span><span> </span><span class="NLM_article-title">Indium-mediated reaction in aqueous media. Synthesis of phenacyl sulfides by reactions of a-bromoketones with sodium alkyl thiosulfates</span> <span class="citation_source-journal">J. Chem. Res. Synopses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=130-131&author=Z.+Zhuangpingauthor=Z.+Yongminauthor=M.+Zhenghai&title=Indium-mediated+reaction+in+aqueous+media.+Synthesis+of+phenacyl+sulfides+by+reactions+of+a-bromoketones+with+sodium+alkyl+thiosulfates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuangping%26aufirst%3DZ.%26aulast%3DYongmin%26aufirst%3DZ.%26aulast%3DZhenghai%26aufirst%3DM.%26atitle%3DIndium-mediated%2520reaction%2520in%2520aqueous%2520media.%2520Synthesis%2520of%2520phenacyl%2520sulfides%2520by%2520reactions%2520of%2520a-bromoketones%2520with%2520sodium%2520alkyl%2520thiosulfates%26jtitle%3DJ.%2520Chem.%2520Res.%2520Synopses%26date%3D1998%26volume%3D3%26spage%3D130%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBernardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, D. e. H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young-Sciame, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=21-39&author=N.+Kailaauthor=K.+Janzauthor=S.+DeBernardoauthor=P.+W.+Bedardauthor=R.+T.+Camphausenauthor=S.+Tamauthor=D.+e.+H.+H.+Tsaoauthor=J.+C.+Keithauthor=C.+Nickerson-Nutterauthor=A.+Shillingauthor=R.+Young-Sciameauthor=Q.+Wang&title=Synthesis+and+biological+evaluation+of+quinoline+salicylic+acids+as+P-selectin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DDeBernardo%26aufirst%3DS.%26aulast%3DBedard%26aufirst%3DP.%2BW.%26aulast%3DCamphausen%26aufirst%3DR.%2BT.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2Be.%2BH.%2BH.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%26aulast%3DShilling%26aufirst%3DA.%26aulast%3DYoung-Sciame%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520quinoline%2520salicylic%2520acids%2520as%2520P-selectin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D50%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Paizs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To a, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bódai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novák, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irimie, F.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poppe, L.</span><span> </span><span class="NLM_article-title">Chemo-enzymatic preparation of hydroxymethyl ketones</span> <span class="citation_source-journal">J. Chem. Soc. Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2400-2402&author=C.+Paizsauthor=M.+To+aauthor=C.+Majdikauthor=V.+B%C3%B3daiauthor=L.+Nov%C3%A1kauthor=F.-D.+Irimieauthor=L.+Poppe&title=Chemo-enzymatic+preparation+of+hydroxymethyl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaizs%26aufirst%3DC.%26aulast%3DTo%2Ba%26aufirst%3DM.%26aulast%3DMajdik%26aufirst%3DC.%26aulast%3DB%25C3%25B3dai%26aufirst%3DV.%26aulast%3DNov%25C3%25A1k%26aufirst%3DL.%26aulast%3DIrimie%26aufirst%3DF.-D.%26aulast%3DPoppe%26aufirst%3DL.%26atitle%3DChemo-enzymatic%2520preparation%2520of%2520hydroxymethyl%2520ketones%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D2002%26volume%3D21%26spage%3D2400%26epage%3D2402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nakaiida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niyomura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koketsu, J.</span><span> </span><span class="NLM_article-title">Te-1-Acylmethyl and Te-1-Iminoalkyl Telluroesters: Synthesis and Thermolysis Leading to 1,3-Diketones and O-Alkenyl and O-Imino Esters</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1080%2F10426501003769728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslGgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=930-946&author=S.+Nakaiidaauthor=S.+Katoauthor=O.+Niyomuraauthor=M.+Ishidaauthor=F.+Andoauthor=J.+Koketsu&title=Te-1-Acylmethyl+and+Te-1-Iminoalkyl+Telluroesters%3A+Synthesis+and+Thermolysis+Leading+to+1%2C3-Diketones+and+O-Alkenyl+and+O-Imino+Esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Te-1-Acylmethyl and Te-1-Iminoalkyl Telluroesters: Synthesis and Thermolysis Leading to 1,3-Diketones and O-Alkenyl and O-Imino Esters</span></div><div class="casAuthors">Nakaiida, Shoho; Kato, Shinzi; Niyomura, Osamu; Ishida, Masaru; Ando, Fumio; Koketsu, Jugo</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">930-946</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1042-6507</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A series of Te-1-acylmethyl carbotelluroates was prepd. in good isolated yields from the reaction of potassium carbotelluroates with α-haloketones in acetonitrile.  Thermolysis of the telluroesters afforded vinyl esters in 20-50% yields, while treatment of the carbotelluroates with potassium t-butanolate led to 1,3-diketones in 30-75% yields with the liberation of black tellurium.  The reaction of potassium carbotelluroates with α-haloaceto oximes gave O-acyl oximes in 50-70% yields via Te-1-iminomethylcarbotelluroates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOFRUnKN3iDbVg90H21EOLACvtfcHk0ligxOsYg6Ws0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslGgtrc%253D&md5=3eabbc9264dd0daf91f1196c45b5211f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F10426501003769728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426501003769728%26sid%3Dliteratum%253Aachs%26aulast%3DNakaiida%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DNiyomura%26aufirst%3DO.%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DAndo%26aufirst%3DF.%26aulast%3DKoketsu%26aufirst%3DJ.%26atitle%3DTe-1-Acylmethyl%2520and%2520Te-1-Iminoalkyl%2520Telluroesters%253A%2520Synthesis%2520and%2520Thermolysis%2520Leading%2520to%25201%252C3-Diketones%2520and%2520O-Alkenyl%2520and%2520O-Imino%2520Esters%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem.%26date%3D2010%26volume%3D185%26spage%3D930%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Artyomov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shestopalov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinov, V. P.</span><span> </span><span class="NLM_article-title">Synthesis of Imidazo[1,2-a]pyridines from Pyridines and p-Bromophenacyl Bromide O-Methyloxime</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1055%2Fs-1996-4322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=927-929&author=V.+A.+Artyomovauthor=A.+M.+Shestopalovauthor=V.+P.+Litvinov&title=Synthesis+of+Imidazo%5B1%2C2-a%5Dpyridines+from+Pyridines+and+p-Bromophenacyl+Bromide+O-Methyloxime"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-4322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-4322%26sid%3Dliteratum%253Aachs%26aulast%3DArtyomov%26aufirst%3DV.%2BA.%26aulast%3DShestopalov%26aufirst%3DA.%2BM.%26aulast%3DLitvinov%26aufirst%3DV.%2BP.%26atitle%3DSynthesis%2520of%2520Imidazo%255B1%252C2-a%255Dpyridines%2520from%2520Pyridines%2520and%2520p-Bromophenacyl%2520Bromide%2520O-Methyloxime%26jtitle%3DSynthesis%26date%3D1996%26volume%3D8%26spage%3D927%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. J.</span><span> </span><span class="NLM_article-title">Facile one–pot synthesis of α-chloro sulfoxides from sulfides</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1055%2Fs-1993-25831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3sXitFamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=209-210&author=Y.+H.+Kimauthor=H.+H.+Shinauthor=Y.+J.+Park&title=Facile+one%E2%80%93pot+synthesis+of+%CE%B1-chloro+sulfoxides+from+sulfides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Facile one-pot synthesis of α-chloro sulfoxides from sulfides</span></div><div class="casAuthors">Kim, Yong Hae; Shin, Hyun Ho; Park, Young Jun</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-10</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Sulfides R1SCH2R2 (R1 = Me, (substituted) Ph; R2 = H, Me) reacted with sulfuryl chloride in the presence of metal nitrates in acetonitriles under mild conditions to give the corresponding α-chloro sulfoxides R1SOCHClR2 in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fjcK6uawtbVg90H21EOLACvtfcHk0lgvYbqnp270Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitFamtbs%253D&md5=f42af41b802580efebc4e40ba753a879</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25831%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DShin%26aufirst%3DH.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26atitle%3DFacile%2520one%25E2%2580%2593pot%2520synthesis%2520of%2520%25CE%25B1-chloro%2520sulfoxides%2520from%2520sulfides%26jtitle%3DSynthesis%26date%3D1993%26spage%3D209%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kallmayer, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span> </span><span class="NLM_article-title">Zur Farbe der N-(4′-Nitrophenacyl)-arylamine</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1002%2Fardp.19803130407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFCgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=1980&pages=315-323&author=H.-J.+Kallmayerauthor=E.+Wagner&title=Zur+Farbe+der+N-%284%E2%80%B2-Nitrophenacyl%29-arylamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Color of N-(4'-nitrophenacyl)arylamines</span></div><div class="casAuthors">Kallmayer, Hans Joerg; Wagner, Eugen</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-23</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">4-O2NC6H4COCH2NHR [I; R = (un)substituted Ph, 2-naphthyl] were prepd. and their UV absorption max. detd.  Their color is explained by intramol. interaction of the electron-accepting nitrobenzoyl group and the electron-donating arylamine part of the mol.  The color is lost on acetylation of the amino group.  There is no indication of an equil. between I and 4-O2NC6H4C(OH):CHNHR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZUUY11RT1wbVg90H21EOLACvtfcHk0lgvYbqnp270Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFCgtbw%253D&md5=7b01d57f916f8a40485df4825fde9aa3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fardp.19803130407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19803130407%26sid%3Dliteratum%253Aachs%26aulast%3DKallmayer%26aufirst%3DH.-J.%26aulast%3DWagner%26aufirst%3DE.%26atitle%3DZur%2520Farbe%2520der%2520N-%25284%25E2%2580%25B2-Nitrophenacyl%2529-arylamine%26jtitle%3DArch.%2520Pharm.%26date%3D1980%26volume%3D313%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kyongtae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeeock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheol, Y. S.</span><span> </span><span class="NLM_article-title">Reactions of tetrasulfur tetranitride with aryl dibromomethyl ketones: one-pot synthesis of 3-aroylformamido-4-aryl-1,2,5-thiadiazoles and their reactions</span> <span class="citation_source-journal">J. Chem. Soc. Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=253-260&author=K.+Kyongtaeauthor=C.+Jaeeockauthor=Y.+S.+Cheol&title=Reactions+of+tetrasulfur+tetranitride+with+aryl+dibromomethyl+ketones%3A+one-pot+synthesis+of+3-aroylformamido-4-aryl-1%2C2%2C5-thiadiazoles+and+their+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKyongtae%26aufirst%3DK.%26aulast%3DJaeeock%26aufirst%3DC.%26aulast%3DCheol%26aufirst%3DY.%2BS.%26atitle%3DReactions%2520of%2520tetrasulfur%2520tetranitride%2520with%2520aryl%2520dibromomethyl%2520ketones%253A%2520one-pot%2520synthesis%2520of%25203-aroylformamido-4-aryl-1%252C2%252C5-thiadiazoles%2520and%2520their%2520reactions%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D1995%26spage%3D253%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschesche, H.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3231</span><span class="NLM_x">–</span> <span class="NLM_lpage">3243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010887p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3231-3243&author=J.+Schr%C3%B6derauthor=A.+Henkeauthor=H.+Wenzelauthor=H.+Brandstetterauthor=H.+G.+Stammlerauthor=A.+Stammlerauthor=W.+D.+Pfeifferauthor=H.+Tschesche&title=Structure-based+design+and+synthesis+of+potent+matrix+metalloproteinase+inhibitors+derived+from+a+6H-1%2C3%2C4-thiadiazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm010887p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010887p%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DHenke%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DH.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DStammler%26aufirst%3DH.%2BG.%26aulast%3DStammler%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DW.%2BD.%26aulast%3DTschesche%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520potent%2520matrix%2520metalloproteinase%2520inhibitors%2520derived%2520from%2520a%25206H-1%252C3%252C4-thiadiazine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3231%26epage%3D3243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Conde, S.; Martinez, A.; Perez, D. I.; Perez, C.; Moreno, F. J.; Wandosell, F.</span><span> </span><span class="NLM_article-title">Compounds and their therapeutic use</span>. US2003/199508 A1.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conde%2C+S.%3B+Martinez%2C+A.%3B+Perez%2C+D.+I.%3B+Perez%2C+C.%3B+Moreno%2C+F.+J.%3B+Wandosell%2C+F.+Compounds+and+their+therapeutic+use.+US2003%2F199508+A1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConde%26aufirst%3DS.%26atitle%3DCompounds%2520and%2520their%2520therapeutic%2520use" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Diwu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachdel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaubert, D. H.</span><span> </span><span class="NLM_article-title">A facile protocol for the convenient preparation of amino-substituted [alpha]-bromo- and [alpha],[alpha]-dibromo arylmethylketones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=4987-4990&author=Z.+Diwuauthor=C.+Beachdelauthor=D.+H.+Klaubert&title=A+facile+protocol+for+the+convenient+preparation+of+amino-substituted+%5Balpha%5D-bromo-+and+%5Balpha%5D%2C%5Balpha%5D-dibromo+arylmethylketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiwu%26aufirst%3DZ.%26aulast%3DBeachdel%26aufirst%3DC.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26atitle%3DA%2520facile%2520protocol%2520for%2520the%2520convenient%2520preparation%2520of%2520amino-substituted%2520%255Balpha%255D-bromo-%2520and%2520%255Balpha%255D%252C%255Balpha%255D-dibromo%2520arylmethylketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D4987%26epage%3D4990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Mathivanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayner, D. D. M.</span><span> </span><span class="NLM_article-title">Photochemical generation of radical anions of photolabile aryl ketones</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">8190</span><span class="NLM_x">–</span> <span class="NLM_lpage">8195</span></span><div class="citationLinks">[<a href="/doi/10.1021/j100020a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1995&pages=8190-8195&author=N.+Mathivananauthor=L.+J.+Johnstonauthor=D.+D.+M.+Wayner&title=Photochemical+generation+of+radical+anions+of+photolabile+aryl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fj100020a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100020a048%26sid%3Dliteratum%253Aachs%26aulast%3DMathivanan%26aufirst%3DN.%26aulast%3DJohnston%26aufirst%3DL.%2BJ.%26aulast%3DWayner%26aufirst%3DD.%2BD.%2BM.%26atitle%3DPhotochemical%2520generation%2520of%2520radical%2520anions%2520of%2520photolabile%2520aryl%2520ketones%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1995%26volume%3D99%26spage%3D8190%26epage%3D8195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Watson, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whish, W. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threadgill, M. D.</span><span> </span><span class="NLM_article-title">Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=721-734&author=C.+Y.+Watsonauthor=W.+J.+D.+Whishauthor=M.+D.+Threadgill&title=Synthesis+of+3-substituted+benzamides+and+5-substituted+isoquinolin-1%282H%29-ones+and+preliminary+evaluation+as+inhibitors+of+poly%28ADP-ribose%29polymerase+%28PARP%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%2BY.%26aulast%3DWhish%26aufirst%3DW.%2BJ.%2BD.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520of%25203-substituted%2520benzamides%2520and%25205-substituted%2520isoquinolin-1%25282H%2529-ones%2520and%2520preliminary%2520evaluation%2520as%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529polymerase%2520%2528PARP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D721%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Nobuta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, A.</span><span> </span><span class="NLM_article-title">Facile aerobic photo-oxidative syntheses of [alpha],[alpha]-dibromoacetophenones from aromatic alkynes with 48% aq HBr</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4576</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=4576-4578&author=T.+Nobutaauthor=S.-i.+Hirashimaauthor=N.+Tadaauthor=T.+Miuraauthor=A.+Itoh&title=Facile+aerobic+photo-oxidative+syntheses+of+%5Balpha%5D%2C%5Balpha%5D-dibromoacetophenones+from+aromatic+alkynes+with+48%25+aq+HBr"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNobuta%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.-i.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DA.%26atitle%3DFacile%2520aerobic%2520photo-oxidative%2520syntheses%2520of%2520%255Balpha%255D%252C%255Balpha%255D-dibromoacetophenones%2520from%2520aromatic%2520alkynes%2520with%252048%2525%2520aq%2520HBr%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D4576%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kartinos, N.; Normington, J. B.</span><span> </span><span class="NLM_article-title">Coloration of textile fibers with nitro keto arylamines</span>. US 2708149 19550510.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kartinos%2C+N.%3B+Normington%2C+J.+B.+Coloration+of+textile+fibers+with+nitro+keto+arylamines.+US+2708149+19550510."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKartinos%26aufirst%3DN.%26atitle%3DColoration%2520of%2520textile%2520fibers%2520with%2520nitro%2520keto%2520arylamines" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Baki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szendrei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=75-83&author=A.+Bakiauthor=A.+Bielikauthor=L.+Molnarauthor=G.+Szendreiauthor=G.+M.+Keseru&title=A+high+throughput+luminescent+assay+for+glycogen+synthase+kinase-3beta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DBielik%26aufirst%3DA.%26aulast%3DMolnar%26aufirst%3DL.%26aulast%3DSzendrei%26aufirst%3DG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520high%2520throughput%2520luminescent%2520assay%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Parker, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenoch, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, R. E.</span><span> </span><span class="NLM_article-title">Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1177%2F108705710000500204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=10803607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtF2ls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=77-88&author=G.+J.+Parkerauthor=T.+L.+Lawauthor=F.+J.+Lenochauthor=R.+E.+Bolger&title=Development+of+high+throughput+screening+assays+using+fluorescence+polarization%3A+nuclear+receptor-ligand-binding+and+kinase%2Fphosphatase+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays</span></div><div class="casAuthors">Parker, Gregory J.; Law, Tong Lin; Lenoch, Francis J.; Bolger, Randall E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-88</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Fluorescence polarization (FP) was used to develop high throughput screening (HTS) assays for nuclear receptor-ligand displacement and kinase inhibition.  FP is a soln.-based, homogeneous technique requiring no immobilization or sepn. of reaction components.  The FP-based estrogen receptor (ER) assay is based on the competition of fluorescein-labeled estradiol and estrogen-like compds. for binding to ER.  These studies detd. the Kd for this interaction to be 3 nM for ERα and 2 nM for ERβ; IC50 values for 17β-estradiol, tamoxifen, 4-OH-tamoxifen, and diethylstilbestrol were detd. to be 5.6, 189, 26, and 3.5 nM, resp.  In a screen of 50 lead compds. from a transcriptional activation screen, 21 compds. had IC50 values below 10 μM, with 1 having an almost 100-fold higher affinity for ERβ over ERα.  These data show that an FP-based competitive binding assay can be used to screen diverse compds. with a broad range of binding affinities for ERs.  The FP-based protein-tyrosine kinase (PTK) assay uses fluorescein-labeled phosphopeptides bound to anti-phosphotyrosine antibodies.  Phosphopeptides generated by a kinase compete for this binding.  In c-Src kinase reactions, polarization decreased with time as reaction products displaced the fluorescein-labeled phosphopeptide from the anti-phosphotyrosine antibodies.  The exptl. detd. IC50 of AG 1478 was 400 pM, while genistein did not inhibit the epidermal growth factor receptor at similar concns.  Like the FP-based PTK assay, the protein kinase C (PKC) assay utilizes competition.  PKC isoforms had different turnover rates for the peptide substrate.  The IC50 for staurosporine was < 10 nM for all PKC isoforms.  Tyr phosphatase assays use direct binding rather than competition.  Increasing concns. of T-cell protein-Tyr phosphatase (TC PTP) increased the rate of dephosphorylation.  This change in polarization was dependent on TC PTP and was inhibited by 50 μM Na3VO4.  The IC50 of Na3VO4 was 4 nM for TC PTP.  These data demonstrate that a FP-based assay can detect kinase and phosphatase activity.  Homogeneous, fluorescent techniques such as FP are now methods of choice for screening many types of drug targets.  New HTS instrumentation and assay methods like these make FP a technol. easily incorporated into HTS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrff2kgYgHixLVg90H21EOLACvtfcHk0lhNXrPS5j2pFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtF2ls74%253D&md5=2e6ac4aa8d4d1ef192e6acc70aaef86e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1177%2F108705710000500204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710000500204%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DG.%2BJ.%26aulast%3DLaw%26aufirst%3DT.%2BL.%26aulast%3DLenoch%26aufirst%3DF.%2BJ.%26aulast%3DBolger%26aufirst%3DR.%2BE.%26atitle%3DDevelopment%2520of%2520high%2520throughput%2520screening%2520assays%2520using%2520fluorescence%2520polarization%253A%2520nuclear%2520receptor-ligand-binding%2520and%2520kinase%252Fphosphatase%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2000%26volume%3D5%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Lengyel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostas, J.</span><span> </span><span class="NLM_article-title">Auto-inhibition of Ca(2+)/calmodulin-dependent protein kinase II by its ATP-binding domain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1046%2Fj.1471-4159.2001.00139.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=11181826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhs12gurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2001&pages=1066-1072&author=I.+Lengyelauthor=A.+Nairnauthor=A.+McCluskeyauthor=G.+Tothauthor=B.+Penkeauthor=J.+Rostas&title=Auto-inhibition+of+Ca%282%2B%29%2Fcalmodulin-dependent+protein+kinase+II+by+its+ATP-binding+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Auto-inhibition of Ca2+/calmodulin-dependent protein kinase II by its ATP-binding domain</span></div><div class="casAuthors">Lengyel, I.; Nairn, A. C.; McCluskey, A.; Toth, G.; Penke, B.; Rostas, J. A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Ca2+/calmodulin dependent protein kinase (CaMPK) II is a key enzyme in many physiol. processes.  The enzyme is inactive unless Ca2+/CaM binds to it.  In this inactive form CaMPK-II does not bind ATP suggesting that the ATP-binding domain is involved in an intramol. interaction.  We show here that F12, a 12 amino acid long peptide fragment of the ATP-binding domain (CaMPK-II23-34, GAFSVVRRCVKV) can inhibit the Ca2+/CaM-dependent activity (IC50 of 3 μM) but has no effect on the Ca2+/CaM-independent activity of CaMPK-II.  Kinetic anal. exhibited mixed inhibition with respect to autocamtide-2 and ATP.  The inhibition by F12 showed specificity towards CaMPK-II, but also inhibited CaMPK-I (IC50 = 12.5 μM), while CaMPK-IV (IC50 = 85 μM) was inhibited poorly and cAMP-dependent protein kinase (PKA) was not inhibited.  Substitution of phenylalanine at position 25 to alanine (A12), had little effect on the inhibition of different Ca2+/CaM-dependent protein kinases, suggesting that phenylalanine 25 does not play a crucial role in the interactions involving F12.  Thus the mol. interactions involving the ATP-binding domain appears to play a role in the regulation of nonphosphorylated CaMPK-II activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT35MiHcrSUrVg90H21EOLACvtfcHk0lhNXrPS5j2pFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhs12gurc%253D&md5=7ad7518c0f9a155e3f37de201f4bc9a7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00139.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00139.x%26sid%3Dliteratum%253Aachs%26aulast%3DLengyel%26aufirst%3DI.%26aulast%3DNairn%26aufirst%3DA.%26aulast%3DMcCluskey%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DPenke%26aufirst%3DB.%26aulast%3DRostas%26aufirst%3DJ.%26atitle%3DAuto-inhibition%2520of%2520Ca%25282%252B%2529%252Fcalmodulin-dependent%2520protein%2520kinase%2520II%2520by%2520its%2520ATP-binding%2520domain%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D76%26spage%3D1066%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Carpenter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">4884</span><span class="NLM_x">–</span> <span class="NLM_lpage">4891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=4884-4891&author=G.+Carpenterauthor=L.+Kingauthor=S.+Cohen&title=Rapid+enhancement+of+protein+phosphorylation+in+A-431+cell+membrane+preparations+by+epidermal+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DG.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DRapid%2520enhancement%2520of%2520protein%2520phosphorylation%2520in%2520A-431%2520cell%2520membrane%2520preparations%2520by%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D4884%26epage%3D4891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Al-Hasani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passlack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. W.</span><span> </span><span class="NLM_article-title">Phosphoryl exchange is involved in the mechanism of the insulin receptor kinase</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1994&pages=17-22&author=H.+Al-Hasaniauthor=W.+Passlackauthor=H.+W.+Klein&title=Phosphoryl+exchange+is+involved+in+the+mechanism+of+the+insulin+receptor+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Hasani%26aufirst%3DH.%26aulast%3DPasslack%26aufirst%3DW.%26aulast%3DKlein%26aufirst%3DH.%2BW.%26atitle%3DPhosphoryl%2520exchange%2520is%2520involved%2520in%2520the%2520mechanism%2520of%2520the%2520insulin%2520receptor%2520kinase%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D349%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderbilt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppert, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5097</span><span class="NLM_x">–</span> <span class="NLM_lpage">5106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=8444886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVKlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=5097-5106&author=D.+J.+Robbinsauthor=E.+Zhenauthor=H.+Owakiauthor=C.+A.+Vanderbiltauthor=D.+Ebertauthor=T.+D.+Geppertauthor=M.+H.+Cobb&title=Regulation+and+properties+of+extracellular+signal-regulated+protein+kinases+1+and+2+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro</span></div><div class="casAuthors">Robbins, David J.; Zhen, Erzhen; Owaki, Hajime; Vanderbilt, Colleen A.; Ebert, Douglas; Geppert, Thomas D.; Cobb, Melanie H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5097-106</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Extracellular signal-regulated protein kinases (ERK) 1 and 2 and mutants of each were expressed in bacteria with a hexahistidine tag and purified using Ni-chelate chromatog.  Basal activity of wild-type ERK2 was ∼2 nmol/min/mg.  Self-catalyzed phosphorylation occurred in vitro on the major physiol. site of tyrosine phosphorylation in an intramol. reaction.  Rabbit muscle ERK activator activated ERK2 500-1000-fold up to a specific activity (∼2 μmol/min/mg) approximating that of ERK1 purified from stimulated cells (Boulton, T.G. et al., 1991).  ERK1 could also be activated by the ERK activator to the same extent.  Mutants lacking the major site of tyrosine phosphorylation were autophosphorylated at a greatly reduced rate and were no longer highly activated by the ERK kinase.  Mutants lacking the major site of threonine phosphorylation were autophosphorylated at the same or an enhanced rate, but the kinase activity of these mutants depended on the residue used to replace the threonine.  Replacement by glutamate rendered the kinase capable of being activated by ERK activator, whereas replacement by alanine did not.  Thus, the carboxyl group of glutamate can provide at least some of the features introduced by phosphothreonine in activated ERKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mgX0PJZ_iLVg90H21EOLACvtfcHk0lih9oH0jsIxzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVKlsbk%253D&md5=b2a966b47a7da7c369c1337af9829dc0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DZhen%26aufirst%3DE.%26aulast%3DOwaki%26aufirst%3DH.%26aulast%3DVanderbilt%26aufirst%3DC.%2BA.%26aulast%3DEbert%26aufirst%3DD.%26aulast%3DGeppert%26aufirst%3DT.%2BD.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DRegulation%2520and%2520properties%2520of%2520extracellular%2520signal-regulated%2520protein%2520kinases%25201%2520and%25202%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D5097%26epage%3D5106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flotow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span> </span><span class="NLM_article-title">Ro 09–2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">9579</span><span class="NLM_x">–</span> <span class="NLM_lpage">9585</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi972914c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=9579-9585&author=D.+H.+Williamsauthor=S.+E.+Wilkinsonauthor=T.+Purtonauthor=A.+Lamontauthor=H.+Flotowauthor=E.+J.+Murray&title=Ro+09%E2%80%932210+exhibits+potent+anti-proliferative+effects+on+activated+T+cells+by+selectively+blocking+MKK+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi972914c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi972914c%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DWilkinson%26aufirst%3DS.%2BE.%26aulast%3DPurton%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DA.%26aulast%3DFlotow%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26atitle%3DRo%252009%25E2%2580%25932210%2520exhibits%2520potent%2520anti-proliferative%2520effects%2520on%2520activated%2520T%2520cells%2520by%2520selectively%2520blocking%2520MKK%2520activity%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D9579%26epage%3D9585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Cheng, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatase, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span> </span><span class="NLM_article-title">A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">9248</span><span class="NLM_x">–</span> <span class="NLM_lpage">9256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=9248-9256&author=H.+C.+Chengauthor=H.+Nishioauthor=O.+Hataseauthor=S.+Ralphauthor=J.+H.+Wang&title=A+synthetic+peptide+derived+from+p34cdc2+is+a+specific+and+efficient+substrate+of+src-family+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BC.%26aulast%3DNishio%26aufirst%3DH.%26aulast%3DHatase%26aufirst%3DO.%26aulast%3DRalph%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26atitle%3DA%2520synthetic%2520peptide%2520derived%2520from%2520p34cdc2%2520is%2520a%2520specific%2520and%2520efficient%2520substrate%2520of%2520src-family%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D9248%26epage%3D9256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Uhlen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, J. E.</span><span> </span><span class="NLM_article-title">Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding</span> <span class="citation_source-journal">Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1600-0773.1991.tb01308.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1687079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK38Xlt1Sqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1991&pages=341-350&author=S.+Uhlenauthor=J.+E.+Wikberg&title=Rat+spinal+cord+alpha+2-adrenoceptors+are+of+the+alpha+2A-subtype%3A+comparison+with+alpha+2A-+and+alpha+2B-adrenoceptors+in+rat+spleen%2C+cerebral+cortex+and+kidney+using+3H-RX821002+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Rat spinal cord α2-adrenoceptors are of the α2A-subtype:  comparison with α2A- and α2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding</span></div><div class="casAuthors">Uhlen, Staffan; Wikberg, Jarl E. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-50</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">Binding of the α2-adrenoceptor antagonist radioligand 3H-labeled RX821002 (I) was investigated in membranes from rat spinal cord, spleen, cerebral cortex, and kidney.  The ligand was bound to saturable binding sites with apparent uniform affinities within each tissue.  Seven compds., some of which have previously been reported to be selective for either α2A- or α2B-adrenoceptors, were used in competition with [3H]RX811002.  By using computer modeling, competition curves generated for 3 of these compds. (ARC 239, prazosin, and oxymetazoline) could be resolved into 2-site fits in the kidney; Kd's of the drugs were compatible with the notion that these sites corresponded to α2A- and α2B-adrenoceptors. Moreover, rauwolscine and yohimbine were about 14- and 9-fold selective for α2B-adrenoceptors in the kidney.  In all other tissues studied, drug competition curves were uniphasic and computer modelled into 1-site fits; drug Kd2 were well correlated to those for the α2A-adrenoceptor.  In rat spinal cord, 26 further drugs, which showed wide variation in structure, were evaluated in competition with [3H]RX821002.  Of these compds., competition curves of the agonists UK-14,304, (-) and (+)adrenaline were modelled into 2-site fits whereas those of the remaining compds. could be modelled only into 1-site fits.  Since the high affinity site for UK-14,304 and (-) and (+) adrenaline was eliminated when EDTA, Gpp(NH)p, and 140 mM NaCll was present in the assay, the heterogeneity obsd. in the spinal cord was considered to be due to the formation of high and low affinity conformations of the α2-adrenoceptor for agonists.  Thus, [3H]RX821002 is useful to label both α2A- and α2B-adrenoceptors in the rat.  Moreover, the binding sites labeled by [3H]RX821002 in the spinal cord appear to consist of a single population of α2-adrenoceptors of the α2A-type.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtig83D_yaLrVg90H21EOLACvtfcHk0lik3CXtfLlGWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xlt1Sqsg%253D%253D&md5=49dada36f50ee7bdc9d14561613159a6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1991.tb01308.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1991.tb01308.x%26sid%3Dliteratum%253Aachs%26aulast%3DUhlen%26aufirst%3DS.%26aulast%3DWikberg%26aufirst%3DJ.%2BE.%26atitle%3DRat%2520spinal%2520cord%2520alpha%25202-adrenoceptors%2520are%2520of%2520the%2520alpha%25202A-subtype%253A%2520comparison%2520with%2520alpha%25202A-%2520and%2520alpha%25202B-adrenoceptors%2520in%2520rat%2520spleen%252C%2520cerebral%2520cortex%2520and%2520kidney%2520using%25203H-RX821002%2520ligand%2520binding%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1991%26volume%3D69%26spage%3D341%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">–</span> <span class="NLM_lpage">9766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">MacKenzie, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanLeeuwen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugsley, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demattos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span> </span><span class="NLM_article-title">Characterization of the human dopamine D3 receptor expressed in transfected cell lines</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2F0922-4106%2894%2990212-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=7907989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK2cXps1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=79-85&author=R.+G.+MacKenzieauthor=D.+VanLeeuwenauthor=T.+A.+Pugsleyauthor=Y.+H.+Shihauthor=S.+Demattosauthor=L.+Tangauthor=R.+D.+Toddauthor=K.+L.+O%E2%80%99Malley&title=Characterization+of+the+human+dopamine+D3+receptor+expressed+in+transfected+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human dopamine D3 receptor expressed in transfected cell lines</span></div><div class="casAuthors">MacKenzie, Robert G.; VanLeeuwen, Donald; Pugsley, Thomas A.; Shih, Yu Hsin; Demattos, Steve; Tang, Lei; Todd, Richard D.; O'Malley, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">A full-length cDNA clone of the human dopamine D3 receptor was obtained by the polymerase chain reaction using reverse-transcribed RNA from human brain as the template.  The cDNA was inserted into an expression vector which was then stably transfected into either Chinese hamster ovary (CHO), SK-N-MC human epithelioma or mouse CCL1.3 fibroblast cell lines.  Post-transfection, the Bmax for D3 receptor expression was 1.9, 1.1 and 0.4 pmol/mg protein in the CHO-K1, SK-N-MC and CCL1.3 cell lines, resp.  The D3 receptor expressed in CHO-K1 and CCL1.3 cells exhibited similar radioligand binding profiles, esp. for the D3-selective compd., 7-hydroxy-2-(di-n-propylamino)tetralin (7-OH-DPAT).  Radioligand-binding competition curves of presumed D3 agonists were shifted to the right by the addn. of guanine nucleotides and Na+ to the assay buffer.  Presumed D3-receptor agonists had no effect on cAMP accumulation in any of the D3-transfected cell lines although cAMP accumulation was inhibited by dopamine D2 receptor activation in D2-transfected CHO and CCL1.3 cells and by activation of the exogenously expressed neuropeptide Y receptor in SK-N-MC cells.  Also, D3 receptor activation neither potentiated ATP-stimulated arachidonic acid release from CHO cells nor stimulated inositol phosphate prodn. in CCL1.3-cells although both of these responses were elicited by D2 agonists in D2-transfected cells.  The authors conclude that the signalling properties of the D3 receptor differ from those of its closest homolog, the D2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Y89qF3KkyLVg90H21EOLACvtfcHk0liMkRlZjLupXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXps1OjtA%253D%253D&md5=d63ed27e6550f53e765d5ebb35f8b323</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990212-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990212-7%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26aulast%3DVanLeeuwen%26aufirst%3DD.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DShih%26aufirst%3DY.%2BH.%26aulast%3DDemattos%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520expressed%2520in%2520transfected%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D266%26spage%3D79%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Murphy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snowhill, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1007%2FBF00971514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=2890112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFSlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=775-781&author=D.+E.+Murphyauthor=E.+W.+Snowhillauthor=M.+Williams&title=Characterization+of+quisqualate+recognition+sites+in+rat+brain+tissue+using+DL-%5B3H%5Dalpha-amino-3-hydroxy-5-methylisoxazole-4-propionic+acid+%28AMPA%29+and+a+filtration+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay</span></div><div class="casAuthors">Murphy, Deborah E.; Snowhill, Elaine W.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">775-82</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The binding of [3H]AMPA (DL-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid), a ligand for the putative quisqualate excitatory amino acid receptor subtype, was evaluated by using centrifugation and filtration receptor binding techniques in rat brain crude synaptosomal membrane prepns.  Maximal specific binding of [3H]AMPA occurred in Triton X-100 treated membranes in the presence of the chaotropic agent KSCN.  The effects of KSCN on binding were reversible and optimal at 100 mM.  Supernatant obtained from detergent-treated membranes inhibited specific [3H]AMPA and [3H]kainic acid binding, suggesting the presence of an inhibitory agent which was tentatively identified as glutamate.  By using centrifugation, satn. anal. revealed 2 distinct binding sites in both the absence and presence of KSCN.  The chaotrope was most effective in increasing binding at the low-affinity binding site, enhancing the affinity (Kd) without a concomitant change in the total no. of binding sites.  By using filtration, a single binding site was detected in Triton-treated membranes.  Like the data obtained by centrifugation, KSCN enhanced the affinity of the receptor (Kd value = 10 nM) without altering the no. of binding sites (Bmax = 1.2 pmol/mg protein).  The rank order of potency of various glutamate analogs in the [3H]AMPA binding assay was quisqualate > AMPA > L-glutamate > kainate > D-glutamate, consistent with the labeling of a quisqualate-type excitatory amino acid receptor subtype.  L-Glutamic acid di-Et ester and 2-amino-7-phosphonoheptanoic acid were inactive.  The present technique provides a rapid, reliable assay for the evaluation of quisqualate-type excitatory amino acid agonists and(or) antagonists that may be used to discover more potent and selective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67fm2hn_iG7Vg90H21EOLACvtfcHk0liMkRlZjLupXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFSlsLo%253D&md5=0601f24a2117628ae6b8d19ce788f64a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2FBF00971514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00971514%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BE.%26aulast%3DSnowhill%26aufirst%3DE.%2BW.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520quisqualate%2520recognition%2520sites%2520in%2520rat%2520brain%2520tissue%2520using%2520DL-%255B3H%255Dalpha-amino-3-hydroxy-5-methylisoxazole-4-propionic%2520acid%2520%2528AMPA%2529%2520and%2520a%2520filtration%2520assay%26jtitle%3DNeurochem.%2520Res.%26date%3D1987%26volume%3D12%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Sills, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brundish, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilusz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">[3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2F0014-2999%2891%2990063-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1674916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFGmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=1991&pages=19-24&author=M.+A.+Sillsauthor=G.+Faggauthor=M.+Pozzaauthor=C.+Angstauthor=D.+E.+Brundishauthor=S.+D.+Hurtauthor=E.+J.+Wiluszauthor=M.+Williams&title=%5B3H%5DCGP+39653%3A+a+new+N-methyl-D-aspartate+antagonist+radioligand+with+low+nanomolar+affinity+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]CGP 39653:  a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain</span></div><div class="casAuthors">Sills, Matthew A.; Fagg, Graham; Pozza, Mario; Angst, Christof; Brundish, Derek E.; Hurt, Stephen D.; Wilusz, E. Jay; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">CGP 39653 (D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) was initially discovered to inhibit the binding of [3H]L-glutamate and [3H]3-((±)2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid ([3H]CPP) with Ki values of 230 and 5 nM, resp.  The radiolabeled compd. [3H]CGP 39653 binds to rat frontal cortical membranes in a saturable and reversible manner.  Anal. of satn. expts. revealed that the ligand labels one binding site with a Kd value of 6 nM.  Competition expts. indicated that the order of potency of a no. of competitive excitatory amino acid agonist and antagonist compds. was similar to that found previously for other N-methyl-D-aspartate (NMDA) receptor ligands.  In contrast to these competitive inhibitors, which produced steep inhibition curves, glycine inhibited binding in a complex manner.  When the functional activity of the unlabeled compd. was explored, CGP 39653 blocked NMDA-evoked depolarizations in the rat cortical wedge in vitro and inhibited L-glutamate-stimulated [3H]N(1-[2-thienyl]cyclohexyl)3,4-piperidine ([3H]TCP) binding in cortical membranes.  These results suggest that [3H]CGP 39653 selectively binds to the NMDA receptor as an antagonist with high affinity and is currently the ligand of choice for labeling the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHj03Ynmvs4LVg90H21EOLACvtfcHk0ljWmGcxw5xSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFGmtLw%253D&md5=6e8faa38104681b1e5b8c35b0eb54c60</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2891%2990063-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252891%252990063-V%26sid%3Dliteratum%253Aachs%26aulast%3DSills%26aufirst%3DM.%2BA.%26aulast%3DFagg%26aufirst%3DG.%26aulast%3DPozza%26aufirst%3DM.%26aulast%3DAngst%26aufirst%3DC.%26aulast%3DBrundish%26aufirst%3DD.%2BE.%26aulast%3DHurt%26aufirst%3DS.%2BD.%26aulast%3DWilusz%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3D%255B3H%255DCGP%252039653%253A%2520a%2520new%2520N-methyl-D-aspartate%2520antagonist%2520radioligand%2520with%2520low%2520nanomolar%2520affinity%2520in%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D192%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Richards, M. H.</span><span> </span><span class="NLM_article-title">Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1476-5381.1990.tb13002.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1694463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1990&pages=753-761&author=M.+H.+Richards&title=Rat+hippocampal+muscarinic+autoreceptors+are+similar+to+the+M2+%28cardiac%29+subtype%3A+comparison+with+hippocampal+M1%2C+atrial+M2+and+ileal+M3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype:  comparison with hippocampal M1, atrial M2 and ileal M3 receptors</span></div><div class="casAuthors">Richards, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-61</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Affinity consts. for 15 non-selective or putatively selective muscarinic antagonists were detd. at muscarinic autoreceptors and postsynaptic receptors (linked to phosphatidylinositol (PI) hydrolysis) in rat hippocampal slices, at muscarinic receptors mediating contractility in guinea pig atria or ileal smooth muscle, and at binding sites in rat cerebral cortical membranes labeled with [3H]-1-quinuclidinyl benzilate or [3H]pirenzepine.  Comparison of the affinities of these antagonists at central M1 receptors (inositol-monophosphate formation in rat hippocampal slices) with their affinities at peripheral M1 receptors (inhibition by McN-A-343 of elec. stimulated twitches in rabbit vas deferens) provides support for the suggestion that these receptors may differ pharmacol.  Comparison of affinity consts. obtained by displacement of specifically bound [3H]pirenzepine from rat cerebral cortical membranes with those obtained in functional tests showed poor correlations between affinities for binding sites and for functional atrial receptors or for hippocampal autoreceptors.  A correlation was found between affinities for [3H]pirenzepine binding and those detd. at muscarinic receptors linked to PI turnover in rat hippocampus.  A correlation was also obtained between the affinities for specific [3H]pirenzepine binding sites in cortical membranes and the affinities at ileal receptors.  Comparison of the affinity values for muscarinic autoreceptors in rat hippocampus with affinity values obtained from in vitro models of muscarinic receptor subtypes showed no correlations between those autoreceptors and either M1 or M3 receptors.  A correlation was found between antagonist affinities for hippocampal autoreceptors and muscarinic receptors in the heart.  Therefore, muscarinic autoreceptors in rat hippocampus are pharmacol. similar to the M2 (cardiac) muscarinic receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbrJ_5EoHibrVg90H21EOLACvtfcHk0ljWmGcxw5xSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFansb8%253D&md5=fdec2ce6085afb564726f91294916192</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1990.tb13002.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1990.tb13002.x%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BH.%26atitle%3DRat%2520hippocampal%2520muscarinic%2520autoreceptors%2520are%2520similar%2520to%2520the%2520M2%2520%2528cardiac%2529%2520subtype%253A%2520comparison%2520with%2520hippocampal%2520M1%252C%2520atrial%2520M2%2520and%2520ileal%2520M3%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D99%26spage%3D753%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Pabreza, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">[3H]cytisine binding to nicotinic cholinergic receptors in brain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=9-12&author=L.+A.+Pabrezaauthor=S.+Dhawanauthor=K.+J.+Kellar&title=%5B3H%5Dcytisine+binding+to+nicotinic+cholinergic+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPabreza%26aufirst%3DL.%2BA.%26aulast%3DDhawan%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3D%255B3H%255Dcytisine%2520binding%2520to%2520nicotinic%2520cholinergic%2520receptors%2520in%2520brain%26jtitle%3DMol.%2520Pharmacol.%26date%3D1991%26volume%3D39%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Sharples, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliakov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span> </span><span class="NLM_article-title">UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=10751429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVert7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=2783-2791&author=C.+G.+Sharplesauthor=S.+Kaiserauthor=L.+Soliakovauthor=M.+J.+Marksauthor=A.+C.+Collinsauthor=M.+Washburnauthor=E.+Wrightauthor=J.+A.+Spencerauthor=T.+Gallagherauthor=P.+Whiteakerauthor=S.+Wonnacott&title=UB-165%3A+a+novel+nicotinic+agonist+with+subtype+selectivity+implicates+the+alpha4beta2*+subtype+in+the+modulation+of+dopamine+release+from+rat+striatal+synaptosomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes</span></div><div class="casAuthors">Sharples, Christopher G. V.; Kaiser, Sergio; Soliakov, Lev; Marks, Michael J.; Collins, Allan C.; Washburn, Mark; Wright, Emma; Spencer, James A.; Gallagher, Timothy; Whiteaker, Paul; Wonnacott, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2783-2791</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Presynaptic nicotinic acetylcholine receptors (nAChRs) on striatal synaptosomes stimulate dopamine release.  Partial inhibition by the α3β2-selective α-conotoxin-MII indicates heterogeneity of presynaptic nAChRs on dopamine terminals.  We have used this α-conotoxin and UB-165, a novel hybrid of epibatidine and anatoxin-1, to address the hypothesis that the α-conotoxin-MII-insensitive subtype is composed of α4 and β2 subunits.  UB-165 shows intermediate potency, compared with the parent mols., at α4β2* and α3-contg. binding sites, and resembles epibatidine in its high discrimination of these sites over α7-type and muscle binding sites.  (±)-Epibatidine, (±)-anatoxin-a, and (±)-UB-165 stimulated [3H]-dopamine release from striatal synaptosomes with EC50 values of 2.4, 134, and 88 nM, and relative efficacies of 1:0.4:0.2, resp.  α-Conotoxin-MII inhibited release evoked by these agonists by 48, 56, and 88%, resp., suggesting that (±)-UB-165 is a very poor agonist at the α-conotoxin-MII-insensitive nAChR subtype.  In assays of 86Rb+ efflux from thalamic synaptosomes, a model of an α4β2* nAChR response, (±)-UB-165 was a very weak partial agonist; the low efficacy of (±)-UB-165 at α4β2 nAChR was confirmed in Xenopus oocytes expressing various combinations of human nAChR subunits.  In contrast, (±)-UB-165 and (±)-anatoxin-a were similarly efficacious and similarly sensitive to α-conotoxin-MII in increasing intracellular Ca2+ in SH-SY5Y cells, a functional assay for native α3-contg. nAChR.  These data support the involvement of α4β2* nAChR in the presynaptic modulation of striatal dopamine release and illustrate the utility of exploiting a novel partial agonist, together with a selective antagonist, to dissect the functional roles of nAChR subtypes in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2MBUMY6viQ7Vg90H21EOLACvtfcHk0ljjLMrqTBXQBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVert7s%253D&md5=f93c15d79098ecf79b07bd526dfcfc97</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharples%26aufirst%3DC.%2BG.%26aulast%3DKaiser%26aufirst%3DS.%26aulast%3DSoliakov%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DJ.%2BA.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DUB-165%253A%2520a%2520novel%2520nicotinic%2520agonist%2520with%2520subtype%2520selectivity%2520implicates%2520the%2520alpha4beta2%252A%2520subtype%2520in%2520the%2520modulation%2520of%2520dopamine%2520release%2520from%2520rat%2520striatal%2520synaptosomes%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D2783%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=687-699&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Multiple+serotonin+receptors%3A+differential+binding+of+%5B3H%5D5-hydroxytryptamine%2C+%5B3H%5Dlysergic+acid+diethylamide+and+%5B3H%5Dspiroperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520differential%2520binding%2520of%2520%255B3H%255D5-hydroxytryptamine%252C%2520%255B3H%255Dlysergic%2520acid%2520diethylamide%2520and%2520%255B3H%255Dspiroperidol%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Morley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshar, M.</span><span> </span><span class="NLM_article-title">Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock</span> <span class="citation_source-journal">J. Comput. Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1023%2FB%3AJCAM.0000035199.48747.1e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=15368919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsl2qtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=189-208&author=S.+D.+Morleyauthor=M.+Afshar&title=Validation+of+an+empirical+RNA-ligand+scoring+function+for+fast+flexible+docking+using+Ribodock"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock</span></div><div class="casAuthors">Morley, S. David; Afshar, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-208</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We report the design and validation of a fast empirical function for scoring RNA-ligand interactions, and describe its implementation within RiboDock, a virtual screening system for automated flexible docking.  Building on well-known protein-ligand scoring function foundations, features were added to describe the interactions of common RNA-binding functional groups that were not handled adequately by conventional terms, to disfavor non-complementary polar contacts, and to control non-specific charged interactions.  The results of validation expts. against known structures of RNA-ligand complexes compare favorably with previously reported methods.  Binding modes were well predicted in most cases and good discrimination was achieved between native and non-native ligands for each binding site, and between native and non-native binding sites for each ligand.  Further evidence of the ability of the method to identify true RNA binders is provided by compd. selection ('enrichment factor') expts. based around a series of HIV-1 TAR RNA-binding ligands.  Significant enrichment in true binders was achieved amongst high scoring docking hits, even when selection was from a library of structurally related, pos. charged mols.  Coupled with a semi-automated cavity detection algorithm for identification of putative ligand binding sites, also described here, the method is suitable for the screening of very large databases of mols. against RNA and RNA-protein interfaces, such as those presented by the bacterial ribosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1tsnKXC_oVbVg90H21EOLACvtfcHk0lgur8yQmanZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsl2qtrk%253D&md5=c8e8c73d0e65330f44d1d97a50b62a0d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1023%2FB%3AJCAM.0000035199.48747.1e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AJCAM.0000035199.48747.1e%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DS.%2BD.%26aulast%3DAfshar%26aufirst%3DM.%26atitle%3DValidation%2520of%2520an%2520empirical%2520RNA-ligand%2520scoring%2520function%2520for%2520fast%2520flexible%2520docking%2520using%2520Ribodock%26jtitle%3DJ.%2520Comput.%2520Aided%2520Mol.%2520Des.%26date%3D2004%26volume%3D18%26spage%3D189%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">Virtual screening in structure-based drug discovery</span> <span class="citation_source-journal">Mini Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=15379645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=779-791&author=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=Virtual+screening+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening in structure-based drug discovery</span></div><div class="casAuthors">Barril, X.; Hubbard, R. E.; Morley, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in structure detn. and computational methods have encouraged the development of structure-based virtual screening.  Here we survey progress in the field and review the most recent methods, validation expts. and real applications, including an inhouse example of hit identification for the oncol. target Hsp90.  These results provide a basis for discussing the current state of structure-based virtual screening and to outline the developments that are expected to have a major impact in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy7o9-h9rF3bVg90H21EOLACvtfcHk0lgur8yQmanZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D&md5=2625c1aec0337bcc67d6b62dd9b8a737</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DVirtual%2520screening%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D779%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Dewar, M. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoebisch, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. J. P.</span><span> </span><span class="NLM_article-title">Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3902</span><span class="NLM_x">–</span> <span class="NLM_lpage">3909</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00299a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL2MXktFWlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1985&pages=3902-3909&author=M.+J.+S.+Dewarauthor=E.+G.+Zoebischauthor=E.+F.+Healyauthor=J.+J.+P.+Stewart&title=Development+and+use+of+quantum+mechanical+molecular+models.+76.+AM1%3A+a+new+general+purpose+quantum+mechanical+molecular+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development and use of quantum mechanical molecular models.  76.  AM1:  a new general purpose quantum mechanical molecular model</span></div><div class="casAuthors">Dewar, Michael J. S.; Zoebisch, Eve G.; Healy, Eamonn F.; Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3902-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new parametric quantum mech. mol. model, AM1 (Austin Model 1), based on the NDDO approxn., is described.  In it the major weaknesses of MNDO, in particular failure to reproduce H bonds, are overcome without any increase in computing time.  Results for 167 mols. are reported.  Parameters are currently available for C, H, O, and N.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB-oi6B_HZY7Vg90H21EOLACvtfcHk0lgur8yQmanZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktFWlsLk%253D&md5=5733ca359609184eb3d58fc52c73d2de</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00299a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00299a024%26sid%3Dliteratum%253Aachs%26aulast%3DDewar%26aufirst%3DM.%2BJ.%2BS.%26aulast%3DZoebisch%26aufirst%3DE.%2BG.%26aulast%3DHealy%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DDevelopment%2520and%2520use%2520of%2520quantum%2520mechanical%2520molecular%2520models.%252076.%2520AM1%253A%2520a%2520new%2520general%2520purpose%2520quantum%2520mechanical%2520molecular%2520model%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1985%26volume%3D107%26spage%3D3902%26epage%3D3909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.,  Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.</span>Gaussian 03, rev B.04; <span class="NLM_publisher-name">Gaussian, Inc.</span>, <span class="NLM_publisher-loc">Pittsburgh PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=J.+A.+Montgomery&author=T.+Vreven&author=K.+N.+Kudin&author=J.+C.+Burant&author=J.+M.+Millam&author=S.+S.+Iyengar&author=J.+Tomasi&author=V.+Barone&author=B.+Mennucci&author=M.+Cossi&author=G.+Scalmani&author=N.+Rega&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=M.+Klene&author=X.+Li&author=J.+E.+Knox&author=H.+P.+Hratchian&author=J.+B.+Cross&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=P.+Y.+Ayala&author=K.+Morokuma&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=V.+G.+Zakrzewski&author=S.+Dapprich&author=A.+D.+Daniels&author=M.+C.+Strain&author=O.+Farkas&author=D.+K.+Malick&author=A.+D.+Rabuck&author=K.+Raghavachari&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=Q.+Cui&author=A.+G.+Baboul&author=S.+Clifford&author=J.+Cioslowski&author=B.+B.+Stefanov&author=G.+Liu&author=A.+Liashenko&author=P.+Piskorz&author=I.+Komaromi&author=R.+L.+Martin&author=D.+J.+Fox&author=T.+Keith&author=M.+A.+Al-Laham&author=C.+Y.+Peng&author=A.+Nanayakkara&author=M.+Challacombe&author=P.+M.+W.+Gill&author=B.+Johnson&author=W.+Chen&author=M.+W.+Wong&author=C.+Gonzalez&author=J.+A.+Pople&title=Gaussian+03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252003%26pub%3DGaussian%252C%2520Inc%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matthew P. Davies, Rocio Benitez, Concepción Perez, Sven Jakupovic, Philip Welsby, Klaudia Rzepecka, Jane Alder, Colin Davidson, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Joseph M. Hayes</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1497-1509. <a href="https://doi.org/10.1021/acs.jmedchem.0c01568" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01568%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252BSelective%252BNanomolar%252BType-II%252BInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%26aulast%3DDavies%26aufirst%3DMatthew%2BP.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D08092020%26date%3D27012021%26volume%3D64%26issue%3D3%26spage%3D1497%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlos Roca, Loreto Martinez-González, Miguel Daniel-Mozo, Javier Sastre, Lourdes Infantes, Alicia Mansilla, Antonio Chaves-Sanjuan, Juana María González-Rubio, Carmen Gil, F. Javier Cañada, Ana Martinez, María José Sanchez-Barrena, <span class="NLM_string-name hlFld-ContribAuthor">Nuria E. Campillo</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5910-5921. <a href="https://doi.org/10.1021/acs.jmedchem.8b00088" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeciphering%252Bthe%252BInhibition%252Bof%252Bthe%252BNeuronal%252BCalcium%252BSensor%252B1%252Band%252Bthe%252BGuanine%252BExchange%252BFactor%252BRic8a%252Bwith%252Ba%252BSmall%252BPhenothiazine%252BMolecule%252Bfor%252Bthe%252BRational%252BGeneration%252Bof%252BTherapeutic%252BSynapse%252BFunction%252BRegulators%26aulast%3DRoca%26aufirst%3DCarlos%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18012018%26date%3D17072018%26date%3D02072018%26volume%3D61%26issue%3D14%26spage%3D5910%26epage%3D5921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Schulz</span>, <span class="hlFld-ContribAuthor ">Amira  Atef</span>, <span class="hlFld-ContribAuthor ">Daniel  Becker</span>, <span class="hlFld-ContribAuthor ">Franziska  Gottschalk</span>, <span class="hlFld-ContribAuthor ">Carolin  Tauber</span>, <span class="hlFld-ContribAuthor ">Stefan  Wagner</span>, <span class="hlFld-ContribAuthor ">Christoph  Arkona</span>, <span class="hlFld-ContribAuthor ">Atef A.  Abdel-Hafez</span>, <span class="hlFld-ContribAuthor ">Hassan H.  Farag</span>, <span class="hlFld-ContribAuthor ">Jörg  Rademann</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>  . </span><span class="cited-content_cbyCitation_article-title">Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1218-1230. <a href="https://doi.org/10.1021/acs.jmedchem.7b01440" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01440%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhenylthiomethyl%252BKetone-Based%252BFragments%252BShow%252BSelective%252Band%252BIrreversible%252BInhibition%252Bof%252BEnteroviral%252B3C%252BProteases%26aulast%3DSchulz%26aufirst%3DRobert%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D14112017%26date%3D27012018%26date%3D08022018%26date%3D12012018%26volume%3D61%26issue%3D3%26spage%3D1218%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita Maria Concetta  Di Martino</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Paola  Bisignano</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>, <span class="hlFld-ContribAuthor ">Angela  Rampa</span>, <span class="hlFld-ContribAuthor ">Romana  Fato</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Federica  Belluti</span>  . </span><span class="cited-content_cbyCitation_article-title">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 531-544. <a href="https://doi.org/10.1021/acs.jmedchem.5b00894" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVersatility%252Bof%252Bthe%252BCurcumin%252BScaffold%25253A%252BDiscovery%252Bof%252BPotent%252Band%252BBalanced%252BDual%252BBACE-1%252Band%252BGSK-3%2525CE%2525B2%252BInhibitors%26aulast%3DDi%2BMartino%26aufirst%3DRita%2BMaria%2BConcetta%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D10062015%26date%3D07012016%26date%3D28012016%26date%3D22122015%26volume%3D59%26issue%3D2%26spage%3D531%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Allen F.  Brooks</span>, <span class="hlFld-ContribAuthor ">Katarina J.  Makaravage</span>, <span class="hlFld-ContribAuthor ">Jason M.  Miller</span>, <span class="hlFld-ContribAuthor ">Naoko  Ichiishi</span>, <span class="hlFld-ContribAuthor ">Melanie S.  Sanford</span>, and <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (23)
                                     , 5780-5783. <a href="https://doi.org/10.1021/acs.orglett.5b02875" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b02875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b02875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b02875%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B%25255B18F%25255DArenes%252Bvia%252Bthe%252BCopper-Mediated%252B%25255B18F%25255DFluorination%252Bof%252BBoronic%252BAcids%26aulast%3DMossine%26aufirst%3DAndrew%2BV.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04102015%26date%3D14112015%26date%3D04122015%26volume%3D17%26issue%3D23%26spage%3D5780%26epage%3D5783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Xiao-Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Hyosung  Lee</span>, <span class="hlFld-ContribAuthor ">Erik T.  Dustrude</span>, <span class="hlFld-ContribAuthor ">Yuying  Wang</span>, <span class="hlFld-ContribAuthor ">Rajesh  Khanna</span>, and <span class="hlFld-ContribAuthor ">Harold  Kohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Lacosamide Affinity Bait Agents That Exhibit Potent Voltage-Gated Sodium Channel Blocking Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     , 463-474. <a href="https://doi.org/10.1021/cn300188h" title="DOI URL">https://doi.org/10.1021/cn300188h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300188h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300188h%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Bof%252BLacosamide%252BAffinity%252BBait%252BAgents%252BThat%252BExhibit%252BPotent%252BVoltage-Gated%252BSodium%252BChannel%252BBlocking%252BProperties%26aulast%3DPark%26aufirst%3DKi%2BDuk%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D25102012%26date%3D29122012%26date%3D16012013%26date%3D20032013%26date%3D29122012%26volume%3D4%26issue%3D3%26spage%3D463%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">C.  Susín</span>, <span class="hlFld-ContribAuthor ">S.  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">D. I.  Pérez</span>, <span class="hlFld-ContribAuthor ">V.  Palomo</span>, <span class="hlFld-ContribAuthor ">C.  Pérez</span>, <span class="hlFld-ContribAuthor ">S.  Conde</span>, <span class="hlFld-ContribAuthor ">A.  Santos</span>, <span class="hlFld-ContribAuthor ">C.  Gil</span>, <span class="hlFld-ContribAuthor ">A.  Martínez</span>, and <span class="hlFld-ContribAuthor ">A.  Pérez-Castillo</span>  . </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 350-360. <a href="https://doi.org/10.1021/cn300182g" title="DOI URL">https://doi.org/10.1021/cn300182g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300182g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300182g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DGlycogen%252BSynthase%252BKinase-3%252BInhibitors%252Bas%252BPotent%252BTherapeutic%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%252BDisease.%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15102012%26date%3D26112012%26date%3D05122012%26date%3D20022013%26date%3D26112012%26volume%3D4%26issue%3D2%26spage%3D350%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose A.  Morales-Garcia</span>, <span class="hlFld-ContribAuthor ">Rosario  Luna-Medina</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Marina  Sanz-SanCristobal</span>, <span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Angel  Santos</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, and <span class="hlFld-ContribAuthor ">Ana  Perez-Castillo</span>  . </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2012,</strong> <em>3 </em>
                                    (11)
                                     , 963-971. <a href="https://doi.org/10.1021/cn300110c" title="DOI URL">https://doi.org/10.1021/cn300110c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300110c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300110c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%252BInhibition%252BPromotes%252BAdult%252BHippocampal%252BNeurogenesis%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DMorales-Garcia%26aufirst%3DJose%2BA.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D27072012%26date%3D24092012%26date%3D05102012%26date%3D21112012%26date%3D24092012%26volume%3D3%26issue%3D11%26spage%3D963%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Concepcion  Perez</span>, <span class="hlFld-ContribAuthor ">Jose A.  Morales-Garcia</span>, <span class="hlFld-ContribAuthor ">Ignacio  Soteras</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Arantxa  Encinas</span>, <span class="hlFld-ContribAuthor ">Ana  Castro</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Ana  Perez-Castillo</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, and <span class="hlFld-ContribAuthor ">Ana  Martinez</span>  . </span><span class="cited-content_cbyCitation_article-title">5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (4)
                                     , 1645-1661. <a href="https://doi.org/10.1021/jm201463v" title="DOI URL">https://doi.org/10.1021/jm201463v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201463v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201463v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Imino-1%25252C2%25252C4-Thiadiazoles%25253A%252BFirst%252BSmall%252BMolecules%252BAs%252BSubstrate%252BCompetitive%252BInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase%252B3%26aulast%3DPalomo%26aufirst%3DValle%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D31102011%26date%3D03022012%26date%3D23022012%26date%3D18012012%26volume%3D55%26issue%3D4%26spage%3D1645%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Ignacio  Soteras</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Concepción  Perez</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Nuria Eugenia  Campillo</span>, and <span class="hlFld-ContribAuthor ">Ana  Martinez</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8461-8470. <a href="https://doi.org/10.1021/jm200996g" title="DOI URL">https://doi.org/10.1021/jm200996g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200996g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200996g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252Bthe%252BBinding%252BSites%252Bof%252BGlycogen%252BSynthase%252BKinase%252B3.%252BIdentification%252Band%252BCharacterization%252Bof%252BAllosteric%252BModulation%252BCavities%26aulast%3DPalomo%26aufirst%3DValle%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D26072011%26date%3D16112011%26date%3D22122011%26date%3D03112011%26volume%3D54%26issue%3D24%26spage%3D8461%26epage%3D8470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arramshetti  Venkanna</span>, <span class="hlFld-ContribAuthor ">Lalita  Subedi</span>, <span class="hlFld-ContribAuthor ">Mahesh K.  Teli</span>, <span class="hlFld-ContribAuthor ">Prema Dhorma  Lama</span>, <span class="hlFld-ContribAuthor ">Bhargav Gupta  Nangunuri</span>, <span class="hlFld-ContribAuthor ">Sang-Yoon  Lee</span>, <span class="hlFld-ContribAuthor ">Sun Yeou  Kim</span>, <span class="hlFld-ContribAuthor ">Mi-hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-78158-9" title="DOI URL">https://doi.org/10.1038/s41598-020-78158-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-78158-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-78158-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPositioning%252Bof%252Ban%252Bunprecedented%252Bspiro%25255B5.5%25255Dundeca%252Bring%252Bsystem%252Binto%252Bkinase%252Binhibitor%252Bspace%26aulast%3DVenkanna%26aufirst%3DArramshetti%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuo  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia. </span><span class="cited-content_cbyCitation_journal-name">Arteriosclerosis, Thrombosis, and Vascular Biology</span><span> <strong>2020,</strong> <em>73 </em><a href="https://doi.org/10.1161/ATVBAHA.120.314804" title="DOI URL">https://doi.org/10.1161/ATVBAHA.120.314804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/ATVBAHA.120.314804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FATVBAHA.120.314804%26sid%3Dliteratum%253Aachs%26jtitle%3DArteriosclerosis%252C%2520Thrombosis%252C%2520and%2520Vascular%2520Biology%26atitle%3DTargeting%252BTranscription%252BFactor%252BNrf2%252B%252528Nuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252529%252Bfor%252Bthe%252BIntervention%252Bof%252BVascular%252BCognitive%252BImpairment%252Band%252BDementia%26aulast%3DYang%26aufirst%3DTuo%26date%3D2020%26date%3D2020%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Martínez de Iturrate</span>, <span class="hlFld-ContribAuthor ">Victor  Sebastián-Pérez</span>, <span class="hlFld-ContribAuthor ">Montserrat  Nácher-Vázquez</span>, <span class="hlFld-ContribAuthor ">Catherine S.  Tremper</span>, <span class="hlFld-ContribAuthor ">Despina  Smirlis</span>, <span class="hlFld-ContribAuthor ">Julio  Martín</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Luis  Rivas</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>. </span><span class="cited-content_cbyCitation_article-title">Towards discovery of new leishmanicidal scaffolds able to inhibit
              Leishmania
              GSK-3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 199-210. <a href="https://doi.org/10.1080/14756366.2019.1693704" title="DOI URL">https://doi.org/10.1080/14756366.2019.1693704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1693704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1693704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DTowards%252Bdiscovery%252Bof%252Bnew%252Bleishmanicidal%252Bscaffolds%252Bable%252Bto%252Binhibit%252BLeishmania%252BGSK-3%26aulast%3DMart%25C3%25ADnez%2Bde%2BIturrate%26aufirst%3DPaula%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D199%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nimshitha  Pavathuparambil Abdul Manaph</span>, <span class="hlFld-ContribAuthor ">Kisha N.  Sivanathan</span>, <span class="hlFld-ContribAuthor ">Jodie  Nitschke</span>, <span class="hlFld-ContribAuthor ">Xin-Fu  Zhou</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Coates</span>, <span class="hlFld-ContribAuthor ">Christopher John  Drogemuller</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy. </span><span class="cited-content_cbyCitation_journal-name">Stem Cell Research & Therapy</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13287-019-1396-5" title="DOI URL">https://doi.org/10.1186/s13287-019-1396-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13287-019-1396-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13287-019-1396-5%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cell%2520Research%2520%2526%2520Therapy%26atitle%3DAn%252Boverview%252Bon%252Bsmall%252Bmolecule-induced%252Bdifferentiation%252Bof%252Bmesenchymal%252Bstem%252Bcells%252Binto%252Bbeta%252Bcells%252Bfor%252Bdiabetic%252Btherapy%26aulast%3DPavathuparambil%2BAbdul%2BManaph%26aufirst%3DNimshitha%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu‐Chun  Wu</span>, <span class="hlFld-ContribAuthor ">Yi  Jhong</span>, <span class="hlFld-ContribAuthor ">Hui‐Jie  Lin</span>, <span class="hlFld-ContribAuthor ">Sharada Prasanna  Swain</span>, <span class="hlFld-ContribAuthor ">Hui‐Hsu Gavin  Tsai</span>, <span class="hlFld-ContribAuthor ">Duen‐Ren  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalyzed Enantioselective Michael Addition of 2‐Hydroxypyridines and α,β‐Unsaturated 1,4‐Dicarbonyl Compounds. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (21)
                                     , 4966-4982. <a href="https://doi.org/10.1002/adsc.201900997" title="DOI URL">https://doi.org/10.1002/adsc.201900997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900997%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOrganocatalyzed%252BEnantioselective%252BMichael%252BAddition%252Bof%252B2%2525E2%252580%252590Hydroxypyridines%252Band%252B%2525CE%2525B1%25252C%2525CE%2525B2%2525E2%252580%252590Unsaturated%252B1%25252C4%2525E2%252580%252590Dicarbonyl%252BCompounds%26aulast%3DWu%26aufirst%3DYu%25E2%2580%2590Chun%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D21%26spage%3D4966%26epage%3D4982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Venter</span>, <span class="hlFld-ContribAuthor ">Concepción  Perez</span>, <span class="hlFld-ContribAuthor ">Willem A.L.  van Otterlo</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Margaret A.L.  Blackie</span>. </span><span class="cited-content_cbyCitation_article-title">1-Aryl-3-(4-methoxybenzyl)ureas as potentially irreversible glycogen synthase kinase 3 inhibitors: Synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (13)
                                     , 1597-1600. <a href="https://doi.org/10.1016/j.bmcl.2019.04.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D1-Aryl-3-%2525284-methoxybenzyl%252529ureas%252Bas%252Bpotentially%252Birreversible%252Bglycogen%252Bsynthase%252Bkinase%252B3%252Binhibitors%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DVenter%26aufirst%3DJana%26date%3D2019%26volume%3D29%26issue%3D13%26spage%3D1597%26epage%3D1600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuo  Yang</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Leilei  Mao</span>, <span class="hlFld-ContribAuthor ">Meijuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Li</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Yejie  Shi</span>, <span class="hlFld-ContribAuthor ">Rehana K.  Leak</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Brain ischemic preconditioning protects against ischemic injury and preserves the blood-brain barrier via oxidative signaling and Nrf2 activation. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2018,</strong> <em>17 </em>, 323-337. <a href="https://doi.org/10.1016/j.redox.2018.05.001" title="DOI URL">https://doi.org/10.1016/j.redox.2018.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2018.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DBrain%252Bischemic%252Bpreconditioning%252Bprotects%252Bagainst%252Bischemic%252Binjury%252Band%252Bpreserves%252Bthe%252Bblood-brain%252Bbarrier%252Bvia%252Boxidative%252Bsignaling%252Band%252BNrf2%252Bactivation%26aulast%3DYang%26aufirst%3DTuo%26date%3D2018%26volume%3D17%26spage%3D323%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joon Young  Hwang</span>, <span class="hlFld-ContribAuthor ">Jung Ha  Shin</span>, <span class="hlFld-ContribAuthor ">Eun Young  Seong</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">FeCl
              2
              -mediated Nucleophilic Chlorination of Iodoalkanes Accelerated by Phenanthroline Ligand. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2018,</strong> <em>39 </em>
                                    (5)
                                     , 695-698. <a href="https://doi.org/10.1002/bkcs.11453" title="DOI URL">https://doi.org/10.1002/bkcs.11453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11453%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DFeCl%252B2%252B-mediated%252BNucleophilic%252BChlorination%252Bof%252BIodoalkanes%252BAccelerated%252Bby%252BPhenanthroline%252BLigand%26aulast%3DHwang%26aufirst%3DJoon%2BYoung%26date%3D2018%26date%3D2018%26volume%3D39%26issue%3D5%26spage%3D695%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahar  Bano</span>, <span class="hlFld-ContribAuthor ">Arif-ullah  Khan</span>, <span class="hlFld-ContribAuthor ">Faiza  Asghar</span>, <span class="hlFld-ContribAuthor ">Muhammad  Usman</span>, <span class="hlFld-ContribAuthor ">Amin  Badshah</span>, <span class="hlFld-ContribAuthor ">Saqib  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Computational and Pharmacological Evaluation of Ferrocene-Based Acyl Ureas and Homoleptic Cadmium Carboxylate Derivatives for Anti-diabetic Potential. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.01001" title="DOI URL">https://doi.org/10.3389/fphar.2017.01001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.01001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.01001%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DComputational%252Band%252BPharmacological%252BEvaluation%252Bof%252BFerrocene-Based%252BAcyl%252BUreas%252Band%252BHomoleptic%252BCadmium%252BCarboxylate%252BDerivatives%252Bfor%252BAnti-diabetic%252BPotential%26aulast%3DBano%26aufirst%3DShahar%26date%3D2018%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhimin  Yang</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Botao  Pan</span>, <span class="hlFld-ContribAuthor ">Fengli  He</span>, <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (22)
                                     , 4127-4140. <a href="https://doi.org/10.1039/C8OB00642C" title="DOI URL">https://doi.org/10.1039/C8OB00642C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00642C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00642C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B%252528aza%252529indolyl%252Bmaleimide-based%252Bcovalent%252Binhibitors%252Bof%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%26aulast%3DYang%26aufirst%3DZhimin%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D22%26spage%3D4127%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Allen F.  Brooks</span>, <span class="hlFld-ContribAuthor ">Naoko  Ichiishi</span>, <span class="hlFld-ContribAuthor ">Katarina J.  Makaravage</span>, <span class="hlFld-ContribAuthor ">Melanie S.  Sanford</span>, <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Customized [18F]Fluoride Elution Techniques for the Enhancement of Copper-Mediated Late-Stage Radiofluorination. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-00110-1" title="DOI URL">https://doi.org/10.1038/s41598-017-00110-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-00110-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-00110-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDevelopment%252Bof%252BCustomized%252B%25255B18F%25255DFluoride%252BElution%252BTechniques%252Bfor%252Bthe%252BEnhancement%252Bof%252BCopper-Mediated%252BLate-Stage%252BRadiofluorination%26aulast%3DMossine%26aufirst%3DAndrew%2BV.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akhil  Kumar</span>, <span class="hlFld-ContribAuthor ">Gaurava  Srivastava</span>, <span class="hlFld-ContribAuthor ">Swati  Srivastava</span>, <span class="hlFld-ContribAuthor ">Seema  Verma</span>, <span class="hlFld-ContribAuthor ">Arvind S.  Negi</span>, <span class="hlFld-ContribAuthor ">Ashok  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2017,</strong> <em>23 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s00894-017-3396-7" title="DOI URL">https://doi.org/10.1007/s00894-017-3396-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-017-3396-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-017-3396-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DInvestigation%252Bof%252Bnaphthofuran%252Bmoiety%252Bas%252Bpotential%252Bdual%252Binhibitor%252Bagainst%252BBACE-1%252Band%252BGSK-3%2525CE%2525B2%25253A%252Bmolecular%252Bdynamics%252Bsimulations%25252C%252Bbinding%252Benergy%25252C%252Band%252Bnetwork%252Banalysis%252Bto%252Bidentify%252Bfirst-in-class%252Bdual%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKumar%26aufirst%3DAkhil%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reem K.  Arafa</span>, <span class="hlFld-ContribAuthor ">Nehal H.  Elghazawy</span>. </span><span class="cited-content_cbyCitation_article-title">Personalized Medicine and Resurrected Hopes for the Management of Alzheimer’s Disease: A Modular Approach Based on GSK-3β Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 199-224. <a href="https://doi.org/10.1007/978-3-319-60733-7_11" title="DOI URL">https://doi.org/10.1007/978-3-319-60733-7_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-60733-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-60733-7_11%26sid%3Dliteratum%253Aachs%26atitle%3DPersonalized%252BMedicine%252Band%252BResurrected%252BHopes%252Bfor%252Bthe%252BManagement%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BModular%252BApproach%252BBased%252Bon%252BGSK-3%2525CE%2525B2%252BInhibitors%26aulast%3DArafa%26aufirst%3DReem%2BK.%26date%3D2017%26date%3D2017%26spage%3D199%26epage%3D224%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPersonalised%252BMedicine%26aulast%3DEl-Khamisy%26aufirst%3DSherif%26date%3D2017%26volume%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurbet Çelik  Turgut</span>, <span class="hlFld-ContribAuthor ">Doğukan  Doyduk</span>, <span class="hlFld-ContribAuthor ">Yılmaz  Yıldırır</span>, <span class="hlFld-ContribAuthor ">Serkan  Yavuz</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Ali  Dişli</span>, <span class="hlFld-ContribAuthor ">Alaattin  Şen</span>. </span><span class="cited-content_cbyCitation_article-title">Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 483-495. <a href="https://doi.org/10.1016/j.bmc.2016.11.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DComputer%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbioactivity%252Banalyses%252Bof%252Bdrugs%252Blike%252Bfingolimod%252Bused%252Bin%252Bthe%252Btreatment%252Bof%252Bmultiple%252Bsclerosis%26aulast%3DTurgut%26aufirst%3DGurbet%2B%25C3%2587elik%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Marchena</span>, <span class="hlFld-ContribAuthor ">Beatriz  Villarejo-Zori</span>, <span class="hlFld-ContribAuthor ">Josefa  Zaldivar-Diez</span>, <span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Catalina  Hernández-Sánchez</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Enrique J.  de la Rosa</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 522-526. <a href="https://doi.org/10.1080/14756366.2016.1265522" title="DOI URL">https://doi.org/10.1080/14756366.2016.1265522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1265522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1265522%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecules%252Btargeting%252Bglycogen%252Bsynthase%252Bkinase%252B3%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252Bretinitis%252Bpigmentosa%26aulast%3DMarchena%26aufirst%3DMiguel%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D522%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Strelow</span>. </span><span class="cited-content_cbyCitation_article-title">A Perspective on the Kinetics of Covalent and Irreversible Inhibition. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2017,</strong> <em>22 </em>
                                    (1)
                                     , 3-20. <a href="https://doi.org/10.1177/1087057116671509" title="DOI URL">https://doi.org/10.1177/1087057116671509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057116671509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057116671509%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DA%252BPerspective%252Bon%252Bthe%252BKinetics%252Bof%252BCovalent%252Band%252BIrreversible%252BInhibition%26aulast%3DStrelow%26aufirst%3DJohn%2BM.%26date%3D2017%26date%3D2016%26volume%3D22%26issue%3D1%26spage%3D3%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (43)
                                     , 13606-13619. <a href="https://doi.org/10.1002/ange.201601091" title="DOI URL">https://doi.org/10.1002/ange.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DZielgerichtete%252Bkovalente%252BInhibitoren%252Bf%2525C3%2525BCr%252Bdas%252BWirkstoffdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D43%26spage%3D13606%26epage%3D13619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibitors for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (43)
                                     , 13408-13421. <a href="https://doi.org/10.1002/anie.201601091" title="DOI URL">https://doi.org/10.1002/anie.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DTargeted%252BCovalent%252BInhibitors%252Bfor%252BDrug%252BDesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D43%26spage%3D13408%26epage%3D13421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estefanía  de Munck</span>, <span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Emma  Muñoz-Sáez</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Begoña  Gómez-Miguel</span>, <span class="hlFld-ContribAuthor ">M. Teresa  Solas</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Rosa M.  Arahuetes</span>, . </span><span class="cited-content_cbyCitation_article-title">Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (9)
                                     , e0162723. <a href="https://doi.org/10.1371/journal.pone.0162723" title="DOI URL">https://doi.org/10.1371/journal.pone.0162723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0162723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0162723%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSmall%252BGSK-3%252BInhibitor%252BShows%252BEfficacy%252Bin%252Ba%252BMotor%252BNeuron%252BDisease%252BMurine%252BModel%252BModulating%252BAutophagy%26aulast%3Dde%2BMunck%26aufirst%3DEstefan%25C3%25ADa%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D9%26spage%3De0162723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudasir  Maqbool</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mobashir</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>. </span><span class="cited-content_cbyCitation_article-title">Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>107 </em>, 63-81. <a href="https://doi.org/10.1016/j.ejmech.2015.10.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPivotal%252Brole%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%25253A%252BA%252Btherapeutic%252Btarget%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMaqbool%26aufirst%3DMudasir%26date%3D2016%26volume%3D107%26spage%3D63%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Errika  Voutyritsa</span>, <span class="hlFld-ContribAuthor ">Alexis  Theodorou</span>, <span class="hlFld-ContribAuthor ">Christoforos G.  Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Green organocatalytic α-hydroxylation of ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (24)
                                     , 5708-5713. <a href="https://doi.org/10.1039/C6OB00036C" title="DOI URL">https://doi.org/10.1039/C6OB00036C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00036C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00036C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DGreen%252Borganocatalytic%252B%2525CE%2525B1-hydroxylation%252Bof%252Bketones%26aulast%3DVoutyritsa%26aufirst%3DErrika%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D24%26spage%3D5708%26epage%3D5713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petrakis N.  Chalikidi</span>, <span class="hlFld-ContribAuthor ">Tatyana A.  Nevolina</span>, <span class="hlFld-ContribAuthor ">Maxim G.  Uchuskin</span>, <span class="hlFld-ContribAuthor ">Vladimir T.  Abaev</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Butin</span>. </span><span class="cited-content_cbyCitation_article-title">A simple method for the synthesis of furfuryl ketones and furylacetic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2015,</strong> <em>51 </em>
                                    (7)
                                     , 621-629. <a href="https://doi.org/10.1007/s10593-015-1744-z" title="DOI URL">https://doi.org/10.1007/s10593-015-1744-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-015-1744-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-015-1744-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DA%252Bsimple%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bfurfuryl%252Bketones%252Band%252Bfurylacetic%252Bacid%252Bderivatives%26aulast%3DChalikidi%26aufirst%3DPetrakis%2BN.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D7%26spage%3D621%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ri-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Ying-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yi-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Ze-Mei  Ge</span>, <span class="hlFld-ContribAuthor ">Run-Tao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>93 </em>, 381-391. <a href="https://doi.org/10.1016/j.ejmech.2015.02.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bdual%252Bdithiocarbamates%252Bas%252Bpotent%252Banticancer%252Bagents%26aulast%3DLi%26aufirst%3DRi-Dong%26date%3D2015%26volume%3D93%26spage%3D381%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheril  Tapia-Rojas</span>, <span class="hlFld-ContribAuthor ">Andreas  Schüller</span>, <span class="hlFld-ContribAuthor ">Carolina B.  Lindsay</span>, <span class="hlFld-ContribAuthor ">Roxana C.  Ureta</span>, <span class="hlFld-ContribAuthor ">Cristóbal  Mejías-Reyes</span>, <span class="hlFld-ContribAuthor ">Juan  Hancke</span>, <span class="hlFld-ContribAuthor ">Francisco  Melo</span>, <span class="hlFld-ContribAuthor ">Nibaldo C.  Inestrosa</span>. </span><span class="cited-content_cbyCitation_article-title">Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2015,</strong> <em>466 </em>
                                    (2)
                                     , 415-430. <a href="https://doi.org/10.1042/BJ20140207" title="DOI URL">https://doi.org/10.1042/BJ20140207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20140207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20140207%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DAndrographolide%252Bactivates%252Bthe%252Bcanonical%252BWnt%252Bsignalling%252Bpathway%252Bby%252Ba%252Bmechanism%252Bthat%252Bimplicates%252Bthe%252Bnon-ATP%252Bcompetitive%252Binhibition%252Bof%252BGSK-3%2525CE%2525B2%25253A%252Bautoregulation%252Bof%252BGSK-3%2525CE%2525B2%252Bin%2525C2%2525A0vivo%26aulast%3DTapia-Rojas%26aufirst%3DCheril%26date%3D2015%26date%3D2015%26volume%3D466%26issue%3D2%26spage%3D415%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam M  Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in irreversible kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (4)
                                     , 375-386. <a href="https://doi.org/10.4155/ppa.14.24" title="DOI URL">https://doi.org/10.4155/ppa.14.24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.24%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DRecent%252Badvances%252Bin%252Birreversible%252Bkinase%252Binhibitors%26aulast%3DGilbert%26aufirst%3DAdam%2BM%26date%3D2014%26volume%3D3%26issue%3D4%26spage%3D375%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rok  Prebil</span>, <span class="hlFld-ContribAuthor ">Stojan  Stavber</span>. </span><span class="cited-content_cbyCitation_article-title">The α-Chlorination of Aryl Methyl Ketones under Aerobic Oxidative Conditions. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2014,</strong> <em>356 </em>
                                    (6)
                                     , 1266-1274. <a href="https://doi.org/10.1002/adsc.201301012" title="DOI URL">https://doi.org/10.1002/adsc.201301012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201301012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201301012%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DThe%252B%2525CE%2525B1-Chlorination%252Bof%252BAryl%252BMethyl%252BKetones%252Bunder%252BAerobic%252BOxidative%252BConditions%26aulast%3DPrebil%26aufirst%3DRok%26date%3D2014%26date%3D2014%26volume%3D356%26issue%3D6%26spage%3D1266%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targets and Small Molecules Against Tauopathies. Part 1: From Genes to Soluble, Aggregation-Prone Tau Proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 643-715. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50015-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50015-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50015-5%26sid%3Dliteratum%253Aachs%26atitle%3DTargets%252Band%252BSmall%252BMolecules%252BAgainst%252BTauopathies.%252BPart%252B1%25253A%252BFrom%252BGenes%252Bto%252BSoluble%25252C%252BAggregation-Prone%252BTau%252BProteins%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2014%26spage%3D643%26epage%3D715%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Rong  Hu</span>, <span class="hlFld-ContribAuthor ">Shi-Hui  Bian</span>, <span class="hlFld-ContribAuthor ">Zhao-Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Yong  Chu</span>, <span class="hlFld-ContribAuthor ">De-Yong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>61 </em>, 95-103. <a href="https://doi.org/10.1016/j.ejmech.2012.09.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.09.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.09.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbenzothiazepinones%252B%252528BTZs%252529%252Bas%252Bnovel%252Bnon-ATP%252Bcompetitive%252Binhibitors%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252B%252528GSK-3%2525CE%2525B2%252529%26aulast%3DZhang%26aufirst%3DPeng%26date%3D2013%26volume%3D61%26spage%3D95%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Bidon-Chanal</span>, <span class="hlFld-ContribAuthor ">Ana  Fuertes</span>, <span class="hlFld-ContribAuthor ">Diana  Alonso</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Pérez</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Miguel  Medina</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence for a new binding mode to GSK-3: Allosteric regulation by the marine compound palinurin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>60 </em>, 479-489. <a href="https://doi.org/10.1016/j.ejmech.2012.12.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvidence%252Bfor%252Ba%252Bnew%252Bbinding%252Bmode%252Bto%252BGSK-3%25253A%252BAllosteric%252Bregulation%252Bby%252Bthe%252Bmarine%252Bcompound%252Bpalinurin%26aulast%3DBidon-Chanal%26aufirst%3DAxel%26date%3D2013%26volume%3D60%26spage%3D479%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Rong  Hu</span>, <span class="hlFld-ContribAuthor ">Zhao-Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Jia-Yi  Lei</span>, <span class="hlFld-ContribAuthor ">Yong  Chu</span>, <span class="hlFld-ContribAuthor ">De-Yong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (23)
                                     , 7232-7236. <a href="https://doi.org/10.1016/j.bmcl.2012.09.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.09.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.09.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnovel%252Bscaffold%252Bof%252Bbenzothiazepinones%252Bas%252Bnon-ATP%252Bcompetitive%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%252Bthrough%252Bvirtual%252Bscreening%26aulast%3DZhang%26aufirst%3DPeng%26date%3D2012%26volume%3D22%26issue%3D23%26spage%3D7232%26epage%3D7236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Weïwer</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Bittker</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Lewis</span>, <span class="hlFld-ContribAuthor ">Kenichi  Shimada</span>, <span class="hlFld-ContribAuthor ">Wan Seok  Yang</span>, <span class="hlFld-ContribAuthor ">Lawrence  MacPherson</span>, <span class="hlFld-ContribAuthor ">Sivaraman  Dandapani</span>, <span class="hlFld-ContribAuthor ">Michelle  Palmer</span>, <span class="hlFld-ContribAuthor ">Brent R.  Stockwell</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Schreiber</span>, <span class="hlFld-ContribAuthor ">Benito  Munoz</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small-molecule probes that selectively kill cells induced to express mutant RAS. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (4)
                                     , 1822-1826. <a href="https://doi.org/10.1016/j.bmcl.2011.09.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.09.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.09.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bsmall-molecule%252Bprobes%252Bthat%252Bselectively%252Bkill%252Bcells%252Binduced%252Bto%252Bexpress%252Bmutant%252BRAS%26aulast%3DWe%25C3%25AFwer%26aufirst%3DMichel%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1822%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark C.  Noe</span>, <span class="hlFld-ContribAuthor ">Adam M.  Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 413-439. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00027-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00027-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00027-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BCovalent%252BEnzyme%252BInhibitors%26aulast%3DNoe%26aufirst%3DMark%2BC.%26date%3D2012%26spage%3D413%26epage%3D439%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Kramer</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>, <span class="hlFld-ContribAuthor ">Fabio  Lo Monte</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Alzheimer's Disease</span><span> <strong>2012,</strong> <em>2012 </em>, 1-32. <a href="https://doi.org/10.1155/2012/381029" title="DOI URL">https://doi.org/10.1155/2012/381029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/381029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F381029%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BGSK-3%25253A%252BStructural%252BInsights%252Band%252BTheir%252BApplication%252Bto%252BAlzheimer%252527s%252BDisease%252BModels%26aulast%3DKramer%26aufirst%3DThomas%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Shigenaga</span>, <span class="hlFld-ContribAuthor ">Ko  Morishita</span>, <span class="hlFld-ContribAuthor ">Keiko  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Hao  Ding</span>, <span class="hlFld-ContribAuthor ">Koji  Ebisuno</span>, <span class="hlFld-ContribAuthor ">Kohei  Sato</span>, <span class="hlFld-ContribAuthor ">Jun  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kenichi  Akaji</span>, <span class="hlFld-ContribAuthor ">Akira  Otaka</span>. </span><span class="cited-content_cbyCitation_article-title">Development of UV-responsive catch-and-release system of a cysteine protease model peptide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (46)
                                     , 8879-8886. <a href="https://doi.org/10.1016/j.tet.2011.09.062" title="DOI URL">https://doi.org/10.1016/j.tet.2011.09.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.09.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDevelopment%252Bof%252BUV-responsive%252Bcatch-and-release%252Bsystem%252Bof%252Ba%252Bcysteine%252Bprotease%252Bmodel%252Bpeptide%26aulast%3DShigenaga%26aufirst%3DAkira%26date%3D2011%26volume%3D67%26issue%3D46%26spage%3D8879%26epage%3D8886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) KI, acetone, Δ; (ii) potassium phthalimide, AcN, Δ; (iii) RSH, K<sub>2</sub>CO<sub>3</sub>, EtOH; (iv) (AcO)<sub>2</sub>O, NaAcO, AcOH, Δ; (v) CAL-B, <sup>t</sup>BuOH:citrate-phosphate buffer (9:1); (vi) NH<sub>2</sub>OH·HCl or NH<sub>2</sub>OMe·HCl, EtOH, pyr; (vii) SO<sub>2</sub>Cl<sub>2</sub>, AgNO<sub>3</sub>, AcN.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. </div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (Top) Representation of the binding mode of an ATP analogue (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a>), and two reversible inhibitors (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88">3F88</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E">1R0E</a>; shown in sticks) in the ATP-binding site of GSK-3. Cys199 is shown in spheres. (Bottom) Structure-based design of novel compounds with potential GSK-3 inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked pose for compound <b>36</b> with the halomethyketone moitey suitably positioned for chemical modification by Cys199 (shown in spheres; distance from S atom in Cys199 to the C<sub>α</sub> atom around or less than 4 Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Acetic anhydride, DMSO, rt; (ii) Chloroacetic anhydride, THF, rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) Sodium acetate, DMF, 100 °C; (ii) H<sub>2</sub>, Pd(C), 20 psi THF, rt; (iii) Formic acid, HCl; (iv) Br<sub>2</sub>, acetic acid, Δ.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">(i) <sup>t</sup>BuOK, THF, −60 °C to 20 °C; (ii) Br<sub>2</sub>, acetic acid, Δ.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time-dependent GSK-3 inhibition of controls (alsterpaullone and HMK-32) and the newly synthetized protein kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Maldi-TOF spectra. (A) Reversible inhibitor <b>38</b> (MW = 268) with GSK-3 (MW = 48 794) showed a 48 794 mass peak. (B) Irreversible inhibitor <b>40</b> (MW = 346) with GSK-3 showed a 49 036 mass peak corresponding to the covalent bond S–C formed between the GSK-3 enzyme and the inhibitor <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/medium/jm-2010-016279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative Western blot of soluble extracts from Granule cerebellar neurons (GCNs), obtained after 16 h in the presence of lithium chloride (Li) or different phenylhalomethylketones (<b>6</b> and <b>8</b>). C represents cell extracts from control GCNs. Identical samples were incubated with antitau-1, anti PHF-1, or anti-β-actin, which was used as a loading control. In each experiment, PHF-1 was normalized with respect to the amount of actin present in each cell extract.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-12/jm1016279/production/images/large/jm-2010-016279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016279&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases--the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%2D%2Dthe+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases--the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Duckett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span> </span><span class="NLM_article-title">Metabolism considerations for kinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1517%2F17425255.2010.506873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=20684746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1175-1193&author=D.+R.+Duckettauthor=M.+D.+Cameron&title=Metabolism+considerations+for+kinase+inhibitors+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism considerations for kinase inhibitors in cancer treatment</span></div><div class="casAuthors">Duckett, Derek R.; Cameron, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1175-1193</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: A concerted effort by the pharmaceutical industry over the last decade has led to the successful clin. development of protein kinase inhibitors as effective targeted therapies for certain cancers.  Areas covered in this review: This review details eight small mol. kinase inhibitors that have been approved for the treatment of cancer in either the US or Europe as of March 2010: imatinib, sorafenib, gefitinib, erlotinib, dasatinib, lapatinib, sunitinib and nilotinib.  These eight compds. vary from the relatively specific inhibitor lapatinib to the more promiscuous kinase inhibitors dasatinib and sunitinib.  What the reader will gain: A brief discussion on the biol. of each inhibitor, selectivity over other kinases and toxicity is provided.  A more detailed discussion on the metab., drug transporters, drug-drug interactions and possible roles of metab. in compd. toxicity is provided for each compd.  Take home message: The majority of the currently approved kinase inhibitors is heavily influenced by drug transporters and significantly affected by CYP3A4 inhibitors/inducers.  At least three, gefitinib, erlotinib and dasatinib, are metabolized to form reactive metabolites capable of covalently-binding biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBX9QvQ30ARrVg90H21EOLACvtfcHk0lgXy22XkXEAjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtbfM&md5=5676874cddba2d9218f6f35efc29f6c3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F17425255.2010.506873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2010.506873%26sid%3Dliteratum%253Aachs%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26atitle%3DMetabolism%2520considerations%2520for%2520kinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D1175%26epage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Belani, C. P.</span><span> </span><span class="NLM_article-title">The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitors</span> <span class="citation_source-journal">Cancer Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=413-423&author=C.+P.+Belani&title=The+role+of+irreversible+EGFR+inhibitors+in+the+treatment+of+non-small+cell+lung+cancer%3A+overcoming+resistance+to+reversible+EGFR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DThe%2520role%2520of%2520irreversible%2520EGFR%2520inhibitors%2520in%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%253A%2520overcoming%2520resistance%2520to%2520reversible%2520EGFR%2520inhibitors%26jtitle%3DCancer%2520Invest.%26date%3D2010%26volume%3D28%26spage%3D413%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0lj9aEQTSWZSXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span> </span><span class="NLM_article-title">Inhibition of tau phosphorylation: A new therapeutical strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1517%2F13543776.10.10.1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1antr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1519-1527&author=A.+Martinezauthor=A.+Castro&title=Inhibition+of+tau+phosphorylation%3A+A+new+therapeutical+strategy+for+the+treatment+of+Alzheimer%E2%80%99s+disease+and+other+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1519-1527</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 86 refs.  There is some evidence to suggest that hyperphosphorylation of tau protein is an early event in the development of neurofibrillary pathol. and appears to compromise the ability of tau to bind to and stabilize microtubules.  Thus, the blockade of this hyperphosphorylation step may be a prime target at which to interrupt the pathogenic cascade.  Efforts to discover rational targets (mainly tau kinases) and inhibitors of tau hyperphosphorylation (protein kinase inhibitors) are discussed in this paper.  Patenting activity from 1997 to date has focused on two major areas: development of methods for screening new compds. and discovery of tau protein kinases inhibitors.  Some mention is also made regarding Alzheimer's disease (AD) diagnosis methods based on tau hyperphosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsLY48wZC7I7Vg90H21EOLACvtfcHk0lj9aEQTSWZSXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1antr0%253D&md5=4df52d5aadb7c07668a518577ecb927a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.10.1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.10.1519%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520tau%2520phosphorylation%253A%2520A%2520new%2520therapeutical%2520strategy%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1519%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Plattner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, K. P.</span><span> </span><span class="NLM_article-title">The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">25457</span><span class="NLM_x">–</span> <span class="NLM_lpage">25465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=25457-25465&author=F.+Plattnerauthor=M.+Angeloauthor=K.+P.+Giese&title=The+roles+of+cyclin-dependent+kinase+5+and+glycogen+synthase+kinase+3+in+tau+hyperphosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlattner%26aufirst%3DF.%26aulast%3DAngelo%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DK.%2BP.%26atitle%3DThe%2520roles%2520of%2520cyclin-dependent%2520kinase%25205%2520and%2520glycogen%2520synthase%2520kinase%25203%2520in%2520tau%2520hyperphosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D25457%26epage%3D25465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perez, D. I.; Gil, C.; Martinez, A.</span><span> </span><span class="NLM_article-title">Tau protein kinases inhibitors: from the bench to the clinical trials</span>. In  <span class="citation_source-book">Emerging Drugs and Targets for Alzheimer’s Disease</span>, <span class="NLM_contrib-group">Martinez, A.</span>, Ed.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1039%2F9781849731065-00173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=173-194&author=D.+I.+Perez&author=C.+Gil&author=A.+Martinezauthor=A.+Martinez&title=Emerging+Drugs+and+Targets+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2F9781849731065-00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731065-00173%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26atitle%3DTau%2520protein%2520kinases%2520inhibitors%253A%2520from%2520the%2520bench%2520to%2520the%2520clinical%2520trials%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2010%26volume%3D1%26spage%3D173%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span> </span><span class="NLM_article-title">GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer’s disease?</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18953107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=181-191&author=A.+Martinezauthor=D.+I.+Perez&title=GSK-3+inhibitors%3A+a+ray+of+hope+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?</span></div><div class="casAuthors">Martinez, Ana; Perez, Daniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia affecting more than 15 millions individuals worldwide.  While the cause is unknown, there are two major neuropathol. abnormalities present in the brains of patients with AD, the extracellular senile plaques and the intracellular neurofibrillary tangles.  There is strong evidence that glycogen synthase kinase-3 (GSK-3) plays an important role in AD being involved in the regulation of these neuropathol. hallmarks.  Increased activity and/or overexpression of this enzyme in AD is assocd. with increased tau hyperphosphorylation and alterations in amyloid-β processing that are thought to precede the formation of neurofibrillary tangles and senile plaques, resp.  Furthermore, over activity of GSK-3 is also involved in neuronal loss.  These data clearly identify GSK-3 inhibitors as one of the most promising new approaches for the future treatment of AD and a redn. of the aberrant over activity of this enzyme might decrease several aspects of the neuronal pathol. in AD.  In this review, we provide an overview of the rationale for the development of GSK-3 inhibitors for the treatment of AD, discussing the risks and benefits of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOLyJI92B9WbVg90H21EOLACvtfcHk0lh5enxcL6eeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmtrzF&md5=000ca138a0a41334a84a8d794cb98442</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26atitle%3DGSK-3%2520inhibitors%253A%2520a%2520ray%2520of%2520hope%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2008%26volume%3D15%26spage%3D181%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1002%2Fmed.20119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18271054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=773-796&author=A.+Martinez&title=Preclinical+efficacy+on+GSK-3+inhibitors%3A+towards+a+future+generation+of+powerful+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span></div><div class="casAuthors">Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-796</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in glycogen synthase kinase-3 (GSK-3), involved in the mol. pathogenesis of human severe diseases, is focused on the potential of its inhibitors to treat diseases that have significant limitations in their current treatments.  During the last 5 years, a lot of literature discuss progress in the search and pharmacol. actions of GSK-3 inhibitors, but now, evidence have been accumulated showing preclin. efficacy for these new drugs, in very different models of several distinct pathologies.  These studies have been summarized in the present review offering promising examples for new therapies for diabetes, cancer, inflammation, Alzheimer's disease and other neurol. pathologies, and mood disorders.  Now, clin. human trials are awaiting to confirm the ray of hope that GSK-3 inhibitors are arising for the future treatment of severe unmet diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNZASfEwzRLVg90H21EOLACvtfcHk0lh5enxcL6eeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ&md5=96cd9bc1d03273a8448f455c3cceb32c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fmed.20119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20119%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPreclinical%2520efficacy%2520on%2520GSK-3%2520inhibitors%253A%2520towards%2520a%2520future%2520generation%2520of%2520powerful%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D773%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovestone, S.</span><span> </span><span class="NLM_article-title">The GSK3 hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1471-4159.2007.05194.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18088381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Citbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1433-1439&author=C.+Hooperauthor=R.+Killickauthor=S.+Lovestone&title=The+GSK3+hypothesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The GSK3 hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Hooper, Claudie; Killick, Richard; Lovestone, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1433-1439</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase 3 (GSK3) is a constitutively active, proline-directed serine/threonine kinase that plays a part in a no. of physiol. processes ranging from glycogen metab. to gene transcription.  GSK3 also plays a pivotal and central role in the pathogenesis of both sporadic and familial forms of Alzheimer's disease (AD), an observation that has led us to coin the 'GSK3 hypothesis of AD'.  According to this hypothesis, over-activity of GSK3 accounts for memory impairment, tau hyper-phosphorylation, increased β-amyloid prodn. and local plaque-assocd. microglial-mediated inflammatory responses; all of which are hallmark characteristics of AD.  If our 'GSK3 hypothesis of AD' is substantiated and GSK3 is indeed a causal mediator of AD then inhibitors of GSK3 would provide a novel avenue for therapeutic intervention in this devastating disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9lxWCe90horVg90H21EOLACvtfcHk0lh5enxcL6eeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Citbw%253D&md5=6e5f9918668aac2d3127bacad12a8340</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05194.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05194.x%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DC.%26aulast%3DKillick%26aufirst%3DR.%26aulast%3DLovestone%26aufirst%3DS.%26atitle%3DThe%2520GSK3%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1433%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sereno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span> </span><span class="NLM_article-title">A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.nbd.2009.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19523516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=359-367&author=L.+Serenoauthor=M.+Comaauthor=M.+Rodriguezauthor=P.+Sanchez-Ferrerauthor=M.+B.+Sanchezauthor=I.+Gichauthor=J.+M.+Agulloauthor=M.+Perezauthor=J.+Avilaauthor=C.+Guardia-Laguartaauthor=J.+Clarimonauthor=A.+Lleoauthor=T.+Gomez-Isla&title=A+novel+GSK-3beta+inhibitor+reduces+Alzheimer%E2%80%99s+pathology+and+rescues+neuronal+loss+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo</span></div><div class="casAuthors">Sereno, L.; Coma, M.; Rodriguez, M.; Sanchez-Ferrer, P.; Sanchez, M. B.; Gich, I.; Agullo, J. M.; Perez, M.; Avila, J.; Guardia-Laguarta, C.; Clarimon, J.; Lleo, A.; Gomez-Isla, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid deposits, neurofibrillary tangles, and neuronal cell death in selectively vulnerable brain regions are the chief hallmarks in Alzheimer's (AD) brains.  Glycogen synthase kinase-3 (GSK-3) is one of the key kinases required for AD-type abnormal hyperphosphorylation of tau, which is believed to be a crit. event in neurofibrillary tangle formation.  GSK-3 has also been recently implicated in amyloid precursor protein (APP) processing/Aβ prodn., apoptotic cell death, and learning and memory.  Thus, GSK-3 inhibition represents a very attractive drug target in AD and other neurodegenerative disorders.  To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non-ATP competitive GSK-3β inhibitor, NP12.  Treatment with this thiadiazolidinone compd. resulted in lower levels of tau phosphorylation, decreased amyloid deposition and plaque-assocd. astrocytic proliferation, protection of neurons in the entorhinal cortex and CA1 hippocampal subfield against cell death, and prevention of memory deficits in this transgenic mouse model.  These results show that this novel GSK-3 inhibitor has a dual impact on amyloid and tau alterations and, perhaps even more important, on neuronal survival in vivo further suggesting that GSK-3 is a relevant therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDbLMUp5zF7Vg90H21EOLACvtfcHk0ljkZ7VBNvNmjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFylsrY%253D&md5=b3d6145f5662c989f22113bef022656e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSereno%26aufirst%3DL.%26aulast%3DComa%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSanchez-Ferrer%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DM.%2BB.%26aulast%3DGich%26aufirst%3DI.%26aulast%3DAgullo%26aufirst%3DJ.%2BM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DClarimon%26aufirst%3DJ.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DGomez-Isla%26aufirst%3DT.%26atitle%3DA%2520novel%2520GSK-3beta%2520inhibitor%2520reduces%2520Alzheimer%25E2%2580%2599s%2520pathology%2520and%2520rescues%2520neuronal%2520loss%2520in%2520vivo%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26spage%3D359%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudrimoti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasanna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennaka, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madgula, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, M. T.</span><span> </span><span class="NLM_article-title">Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900672t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=61-76&author=J.+Pengauthor=S.+Kudrimotiauthor=S.+Prasannaauthor=S.+Oddeauthor=R.+J.+Doerksenauthor=H.+K.+Pennakaauthor=Y.+M.+Chooauthor=K.+V.+Raoauthor=B.+L.+Tekwaniauthor=V.+Madgulaauthor=S.+I.+Khanauthor=B.+Wangauthor=A.+M.+Mayerauthor=M.+R.+Jacobauthor=L.+C.+Tuauthor=J.+Gertschauthor=M.+T.+Hamann&title=Structure-activity+relationship+and+mechanism+of+action+studies+of+manzamine+analogues+for+the+control+of+neuroinflammation+and+cerebral+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm900672t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900672t%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DKudrimoti%26aufirst%3DS.%26aulast%3DPrasanna%26aufirst%3DS.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26aulast%3DPennaka%26aufirst%3DH.%2BK.%26aulast%3DChoo%26aufirst%3DY.%2BM.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DMadgula%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMayer%26aufirst%3DA.%2BM.%26aulast%3DJacob%26aufirst%3DM.%2BR.%26aulast%3DTu%26aufirst%3DL.%2BC.%26aulast%3DGertsch%26aufirst%3DJ.%26aulast%3DHamann%26aufirst%3DM.%2BT.%26atitle%3DStructure-activity%2520relationship%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520manzamine%2520analogues%2520for%2520the%2520control%2520of%2520neuroinflammation%2520and%2520cerebral%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D61%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hamann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Aparicio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Puerto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Monte-Millan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaiah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahyuono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer’s disease</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span></span><div class="citationLinks">[<a href="/doi/10.1021/np060092r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1397-1405&author=M.+Hamannauthor=D.+Alonsoauthor=E.+Martin-Aparicioauthor=A.+Fuertesauthor=M.+J.+Perez-Puertoauthor=A.+Castroauthor=S.+Moralesauthor=M.+L.+Navarroauthor=M.+Del+Monte-Millanauthor=M.+Medinaauthor=H.+Pennakaauthor=A.+Balaiahauthor=J.+Pengauthor=J.+Cookauthor=S.+Wahyuonoauthor=A.+Martinez&title=Glycogen+synthase+kinase-3+%28GSK-3%29+inhibitory+activity+and+structure-activity+relationship+%28SAR%29+studies+of+the+manzamine+alkaloids.+Potential+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fnp060092r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp060092r%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DMartin-Aparicio%26aufirst%3DE.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DPerez-Puerto%26aufirst%3DM.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMorales%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DM.%2BL.%26aulast%3DDel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DPennaka%26aufirst%3DH.%26aulast%3DBalaiah%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DWahyuono%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitory%2520activity%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520the%2520manzamine%2520alkaloids.%2520Potential%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1397%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht-Murava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrokovski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenstein, M.</span><span> </span><span class="NLM_article-title">Substrate competitive GSK-3 inhibitors - strategy and implications</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=598-603&author=H.+Eldar-Finkelmanauthor=A.+Licht-Muravaauthor=S.+Pietrokovskiauthor=M.+Eisenstein&title=Substrate+competitive+GSK-3+inhibitors+-+strategy+and+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DLicht-Murava%26aufirst%3DA.%26aulast%3DPietrokovski%26aufirst%3DS.%26aulast%3DEisenstein%26aufirst%3DM.%26atitle%3DSubstrate%2520competitive%2520GSK-3%2520inhibitors%2520-%2520strategy%2520and%2520implications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=495-510&author=A.+Castroauthor=A.+Encinasauthor=C.+Gilauthor=S.+Braseauthor=W.+Porcalauthor=C.+Perezauthor=F.+J.+Morenoauthor=A.+Martinez&title=Non-ATP+competitive+glycogen+synthase+kinase+3beta+%28GSK-3beta%29+inhibitors%3A+study+of+structural+requirements+for+thiadiazolidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DEncinas%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DPorcal%26aufirst%3DW.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DNon-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520study%2520of%2520structural%2520requirements%2520for%2520thiadiazolidinone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D495%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7103</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040895g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7103-7112&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=I.+Dorronsoroauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=C.+Perezauthor=F.+J.+Moreno&title=SAR+and+3D-QSAR+studies+on+thiadiazolidinone+derivatives%3A+exploration+of+structural+requirements+for+glycogen+synthase+kinase+3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Dorronsoro, Isabel; Gelpi, J. Luis; Luque, F. Javier; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7103-7112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2,4-disubstituted thiadiazolidinones (TDZD) are described as the first ATP-noncompetitive GSK-3 inhibitors.  Following an SAR study about TDZD, different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biol. study are here reported here.  Various compds. such as hydantoins, dithiazolidindiones, rhodanines, maleimides, and triazoles were synthesized and screened as GSK-3 inhibitors.  After an extensive SAR study among these different heterocyclic families, TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3.  A Co-MFA anal. was also performed highlighting the mol. electrostatic field interaction in the interaction of TDZDs with GSK-3.  Moreover, first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQ6m_G-n_WLVg90H21EOLACvtfcHk0lhYV9b_iKce5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O&md5=35b315178d5e518a64b7a2670d41d27b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm040895g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040895g%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DSAR%2520and%25203D-QSAR%2520studies%2520on%2520thiadiazolidinone%2520derivatives%253A%2520exploration%2520of%2520structural%2520requirements%2520for%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7103%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wandosell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6914</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6914-25&author=D.+I.+Perezauthor=S.+Condeauthor=C.+Perezauthor=C.+Gilauthor=D.+Simonauthor=F.+Wandosellauthor=F.+J.+Morenoauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=A.+Martinez&title=Thienylhalomethylketones%3A+Irreversible+glycogen+synthase+kinase+3+inhibitors+as+useful+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DD.%26aulast%3DWandosell%26aufirst%3DF.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DThienylhalomethylketones%253A%2520Irreversible%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520as%2520useful%2520pharmacological%2520tools%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6914%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mazanetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=464-479&author=M.+P.+Mazanetzauthor=P.+M.+Fischer&title=Untangling+tau+hyperphosphorylation+in+drug+design+for+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazanetz%26aufirst%3DM.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DUntangling%2520tau%2520hyperphosphorylation%2520in%2520drug%2520design%2520for%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D464%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm011020u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1292-1299&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=C.+Perezauthor=F.+J.+Moreno&title=First+non-ATP+competitive+glycogen+synthase+kinase+3+beta+%28GSK-3beta%29+inhibitors%3A+thiadiazolidinones+%28TDZD%29+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm011020u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011020u%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DFirst%2520non-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520thiadiazolidinones%2520%2528TDZD%2529%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1292%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Leproult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barluenga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span> </span><span class="NLM_article-title">Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101396q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1347-1355&author=E.+Leproultauthor=S.+Barluengaauthor=D.+Morasauthor=J.+M.+Wurtzauthor=N.+Winssinger&title=Cysteine+mapping+in+conformationally+distinct+kinase+nucleotide+binding+sites%3A+application+to+the+design+of+selective+covalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors</span></div><div class="casAuthors">Leproult, Emeline; Barluenga, Sofia; Moras, Dino; Wurtz, Jean-Marie; Winssinger, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1347-1355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinases have emerged as one of the most prolific therapeutic targets.  An important criterion in the therapeutic success of inhibitors targeting the nucleotide binding pocket of kinases is the inhibitor residence time.  Recently, covalent kinase inhibitors have attracted attention since they confer terminal inhibition and should thus be more effective than reversible inhibitors with transient inhibition.  The most robust approach to design irreversible inhibitors is to capitalize on the nucleophilicity of a cysteine thiol group present in the target protein.  Herein, the authors report a systematic anal. of cysteine residues present in the nucleotide binding site of kinases, which could be harnessed for irreversible inhibition, taking into consideration the different kinase conformations.  The authors demonstrate the predictive power of this anal. with the design and validation of an irreversible inhibitor of KIT/PDGFR kinases.  This is the first example of a covalent kinase inhibitor that combines a pharmacophore addressing the DFG-out conformation with a covalent trap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzqt0gMrz3rVg90H21EOLACvtfcHk0ljEllLz3I1LaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis70%253D&md5=329ae5eaa6102b6dd34a0d1274631247</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101396q%26sid%3Dliteratum%253Aachs%26aulast%3DLeproult%26aufirst%3DE.%26aulast%3DBarluenga%26aufirst%3DS.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DCysteine%2520mapping%2520in%2520conformationally%2520distinct%2520kinase%2520nucleotide%2520binding%2520sites%253A%2520application%2520to%2520the%2520design%2520of%2520selective%2520covalent%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4631</span><span class="NLM_x">–</span> <span class="NLM_lpage">4633</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034108b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4631-4633&author=S.+Condeauthor=D.+I.+Perezauthor=A.+Martinezauthor=C.+Perezauthor=F.+J.+Moreno&title=Thienyl+and+phenyl+alpha-halomethyl+ketones%3A+new+inhibitors+of+glycogen+synthase+kinase+%28GSK-3beta%29+from+a+library+of+compound+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm034108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034108b%26sid%3Dliteratum%253Aachs%26aulast%3DConde%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DThienyl%2520and%2520phenyl%2520alpha-halomethyl%2520ketones%253A%2520new%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase%2520%2528GSK-3beta%2529%2520from%2520a%2520library%2520of%2520compound%2520searching%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4631%26epage%3D4633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Use of peptide substrates for affinity purification of protein-serine kinases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1989&pages=237-241&author=J.+R.+Woodgett&title=Use+of+peptide+substrates+for+affinity+purification+of+protein-serine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DUse%2520of%2520peptide%2520substrates%2520for%2520affinity%2520purification%2520of%2520protein-serine%2520kinases%26jtitle%3DAnal.%2520Biochem.%26date%3D1989%26volume%3D180%26spage%3D237%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dutta, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritsch, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthasarthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chheda, G. B.</span><span> </span><span class="NLM_article-title">Synthesis and biological activities of some N6- and N9-carbamoyladenines and related ribonucleosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1598</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00222a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1598-1607&author=S.+P.+Duttaauthor=C.+I.+Hongauthor=G.+L.+Tritschauthor=C.+Coxauthor=R.+Parthasarthyauthor=G.+B.+Chheda&title=Synthesis+and+biological+activities+of+some+N6-+and+N9-carbamoyladenines+and+related+ribonucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00222a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00222a013%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DS.%2BP.%26aulast%3DHong%26aufirst%3DC.%2BI.%26aulast%3DTritsch%26aufirst%3DG.%2BL.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DParthasarthy%26aufirst%3DR.%26aulast%3DChheda%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520some%2520N6-%2520and%2520N9-carbamoyladenines%2520and%2520related%2520ribonucleosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1598%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Palmer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatana, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahring, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5457</span><span class="NLM_x">–</span> <span class="NLM_lpage">5465</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804681" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5457-5465&author=B.+D.+Palmerauthor=J.+B.+Smaillauthor=M.+Boydauthor=D.+H.+Boschelliauthor=A.+M.+Dohertyauthor=J.+M.+Hambyauthor=S.+S.+Khatanaauthor=J.+B.+Kramerauthor=A.+J.+Krakerauthor=R.+L.+Panekauthor=G.+H.+Luauthor=T.+K.+Dahringauthor=R.+T.+Wintersauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Structure-activity+relationships+for+1-phenylbenzimidazoles+as+selective+ATP+site+inhibitors+of+the+platelet-derived+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9804681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804681%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DKhatana%26aufirst%3DS.%2BS.%26aulast%3DKramer%26aufirst%3DJ.%2BB.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DDahring%26aufirst%3DT.%2BK.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DStructure-activity%2520relationships%2520for%25201-phenylbenzimidazoles%2520as%2520selective%2520ATP%2520site%2520inhibitors%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5457%26epage%3D5465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new one step synthesis of maleimides by condensation of glyoxylate esters with acetamides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=1109-1112&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new+one+step+synthesis+of+maleimides+by+condensation+of+glyoxylate+esters+with+acetamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%2520one%2520step%2520synthesis%2520of%2520maleimides%2520by%2520condensation%2520of%2520glyoxylate%2520esters%2520with%2520acetamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D1109%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Polgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szendrei, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7959</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050504d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7946-7959&author=T.+Polgarauthor=A.+Bakiauthor=G.+I.+Szendreiauthor=G.+M.+Keseru&title=Comparative+virtual+and+experimental+high-throughput+screening+for+glycogen+synthase+kinase-3beta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm050504d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050504d%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DT.%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DSzendrei%26aufirst%3DG.%2BI.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DComparative%2520virtual%2520and%2520experimental%2520high-throughput%2520screening%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7946%26epage%3D7959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Martínez, A.; Gil, C.; Palomo, V.; Pérez, C.; Perez, D. I.</span><span> </span><span class="NLM_article-title">Inhibidores de GSK-3 útiles en enfermedades neurodegenerativas, inflamatorias, cáncer, diabetes y en procesos regenerativos</span>. ES 201130253, 25th February,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Mart%C3%ADnez&author=C.+Gil&author=V.+Palomo&author=C.+P%C3%A9rez&author=D.+I.+Perez&title=Inhibidores+de+GSK-3+%C3%BAtiles+en+enfermedades+neurodegenerativas%2C+inflamatorias%2C+c%C3%A1ncer%2C+diabetes+y+en+procesos+regenerativos"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DInhibidores%2520de%2520GSK-3%2520%25C3%25BAtiles%2520en%2520enfermedades%2520neurodegenerativas%252C%2520inflamatorias%252C%2520c%25C3%25A1ncer%252C%2520diabetes%2520y%2520en%2520procesos%2520regenerativos%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kafka, A. P.; Kleffmann, T.; Rades, T.; McDowell, A.</span><span> </span><span class="NLM_article-title">The application of MALDI TOF MS in biopharmaceutical research</span>.  <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span>doi:<span class="refDoi"> DOI: 10.1016/j.ijpharm.2010.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.ijpharm.2010.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=21147205" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+P.+Kafka&author=T.+Kleffmann&author=T.+Rades&author=A.+McDowell&title=The+application+of+MALDI+TOF+MS+in+biopharmaceutical+research&doi=10.1016%2Fj.ijpharm.2010.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DKafka%26aufirst%3DA.%2BP.%26atitle%3DThe%2520application%2520of%2520MALDI%2520TOF%2520MS%2520in%2520biopharmaceutical%2520research%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26doi%3D10.1016%2Fj.ijpharm.2010.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kockeritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3--an overview of an over-achieving protein kinase</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.2174%2F1389450110607011377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=17100578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1377-1388&author=L.+Kockeritzauthor=B.+Dobleauthor=S.+Patelauthor=J.+R.+Woodgett&title=Glycogen+synthase+kinase-3%2D%2Dan+overview+of+an+over-achieving+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 - an overview of an over-achieving protein kinase</span></div><div class="casAuthors">Kockeritz, Lisa; Doble, Bradley; Patel, Satish; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1377-1388</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) has attracted much scrutiny due to its plethora of cellular functions, novel mechanisms of regulation, and its potential as a therapeutic target for several common diseases.  In mammals, GSK-3 is encoded by 2 genes, termed GSK-3α and GSK-3β, that yield related but distinct protein-serine kinases.  GSK-3 is unusual in that its protein kinase activity tends to be high in resting cells and cellular stimuli, such as hormones and growth factors, result in its catalytic inactivation.  Further, many of the substrate proteins of GSK-3 are functionally inhibited by phosphorylation.  Thus, signals that inhibit GSK-3 often cause activation of its diverse array of target proteins.  Regulation of GSK-3 is important for normal development, regulation of metab., neuronal growth, and differentiation and modulation of cell death.  Dysregulation of GSK-3 activity has been implicated in human pathologies such as neurodegenerative diseases and type-2 diabetes.  Here, the authors provide a primer on the modes of GSK-3 regulation and a description of the various signaling pathways and cellular processes in which GSK-3 is an active participant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXRwL4DSHwrVg90H21EOLACvtfcHk0lgJ4TSn7ZpIbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFensL%252FK&md5=d6224af09b10ae9769e81dee3ca368c8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F1389450110607011377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450110607011377%26sid%3Dliteratum%253Aachs%26aulast%3DKockeritz%26aufirst%3DL.%26aulast%3DDoble%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGlycogen%2520synthase%2520kinase-3--an%2520overview%2520of%2520an%2520over-achieving%2520protein%2520kinase%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D1377%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paudel, H. K.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3beta phosphorylates Alzheimer’s disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3125</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi051634r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3125-3133&author=T.+Liauthor=H.+K.+Paudel&title=Glycogen+synthase+kinase+3beta+phosphorylates+Alzheimer%E2%80%99s+disease-specific+Ser396+of+microtubule-associated+protein+tau+by+a+sequential+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi051634r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051634r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26atitle%3DGlycogen%2520synthase%2520kinase%25203beta%2520phosphorylates%2520Alzheimer%25E2%2580%2599s%2520disease-specific%2520Ser396%2520of%2520microtubule-associated%2520protein%2520tau%2520by%2520a%2520sequential%2520mechanism%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D3125%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span> </span><span class="NLM_article-title">Protein kinase inhibitors: contributions from structure to clinical compounds</span> <span class="citation_source-journal">Q. Rev. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1017%2FS0033583508004745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=19296866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvF2htbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=1-40&author=L.+N.+Johnson&title=Protein+kinase+inhibitors%3A+contributions+from+structure+to+clinical+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase inhibitors: contributions from structure to clinical compounds</span></div><div class="casAuthors">Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Quarterly Reviews of Biophysics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-40</span>CODEN:
                <span class="NLM_cas:coden">QURBAW</span>;
        ISSN:<span class="NLM_cas:issn">0033-5835</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Protein kinases catalyze key phosphorylation reactions in signalling cascades that affect every aspect of cell growth, differentiation and metab.  The kinases have become prime targets for drug intervention in the diseased state, esp. in cancer.  There are currently 10 drugs that have been approved for clin. use and many more in clin. trials.  This review summarises the structural basis for protein kinase inhibition and discusses the mode of action for each of the approved drugs in the light of structural results.  All but one of the approved compds. target the ATP binding site on the kinase.  Both the active and inactive conformations of protein kinases have been used in strategies to produce potent and selective compds.  Targeting the inactive conformation can give high specificity.  Targeting the active conformation is favorable where the diseased state has arisen from activating mutations, but such inhibitors generally target several protein kinases.  Drug resistance mutations are a potential risk for both conformational states, where drug-binding regions are not directly involved in catalysis.  Imatinib (Glivec), the most successful of protein kinase inhibitors, targets the inactive conformation of ABL tyrosine kinase.  Newer compds., such as dasatinib, which targets the ABL active state, have been developed to increase potency and have proved effective for some, but not all, drug-resistant mutations.  The first epidermal growth factor receptor (EGFR) inhibitors in clin. use [gefitinib (Iressa) and erlotinib (Tarceva)] targeted the active form of the kinase, and this proved advantageous for patients whose cancer was caused by mutations that resulted in a constitutively active EGFR kinase domain.  Newer approved compds., such as lapatinib (Tykerb), target the inactive conformation with high potency.  A further compd. that forms a covalent attachment to the kinase has been found to overcome one of the major drug resistance mutations, where the effectiveness of the drug in vivo is dependent on its ability to compete successfully in the presence of cellular concns. of ATP.  Inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase against cancer angiogenesis show the advantage of some relaxation in specificity.  Sorafenib, originally developed as RAF inhibitor, is now in clin. use as a VEGFR inhibitor.  Temsirolimus (a deriv. of rapamycin) is the only example of a drug in clin. use that does not target the kinase ATP site.  Instead rapamycin, when in complex with the protein FKBP12, effectively targets mTOR kinase at a site located on a domain, the FRB domain, that appears to be involved in localization or substrate docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG5I7Tvg482LVg90H21EOLACvtfcHk0liptfhslcBWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvF2htbg%253D&md5=ecfbea1f4eb6133f631e36efed2b1f9f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1017%2FS0033583508004745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033583508004745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DProtein%2520kinase%2520inhibitors%253A%2520contributions%2520from%2520structure%2520to%2520clinical%2520compounds%26jtitle%3DQ.%2520Rev.%2520Biophys.%26date%3D2009%26volume%3D42%26spage%3D1%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1038%2Fnchembio.492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=21113170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=22-24&author=M.+Hagelauthor=D.+Niuauthor=T.+St+Martinauthor=M.+P.+Sheetsauthor=L.+Qiaoauthor=H.+Bernardauthor=R.+M.+Karpauthor=Z.+Zhuauthor=M.+T.+Labenskiauthor=P.+Chaturvediauthor=M.+Nachtauthor=W.+F.+Westlinauthor=R.+C.+Petterauthor=J.+Singh&title=Selective+irreversible+inhibition+of+a+protease+by+targeting+a+noncatalytic+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span></div><div class="casAuthors">Hagel, Margit; Niu, Deqiang; St. Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-24</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic app.  We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family.  We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcCQdERpWWLVg90H21EOLACvtfcHk0liptfhslcBWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M&md5=e2b523ebc4e1115beef32093003a10c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.492%26sid%3Dliteratum%253Aachs%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DSt%2BMartin%26aufirst%3DT.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DSelective%2520irreversible%2520inhibition%2520of%2520a%2520protease%2520by%2520targeting%2520a%2520noncatalytic%2520cysteine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D22%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Shaw, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. H.</span><span> </span><span class="NLM_article-title">The mesomorphic state: The mesomorphic 4,4′-di(n)alkoxybenzalazines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2532</span><span class="NLM_x">–</span> <span class="NLM_lpage">2537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01519a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1959&pages=2532-2537&author=W.+G.+Shawauthor=G.+H.+Brown&title=The+mesomorphic+state%3A+The+mesomorphic+4%2C4%E2%80%B2-di%28n%29alkoxybenzalazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja01519a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01519a058%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DW.%2BG.%26aulast%3DBrown%26aufirst%3DG.%2BH.%26atitle%3DThe%2520mesomorphic%2520state%253A%2520The%2520mesomorphic%25204%252C4%25E2%2580%25B2-di%2528n%2529alkoxybenzalazines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1959%26volume%3D81%26spage%3D2532%26epage%3D2537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hill, J. H. M.</span><span> </span><span class="NLM_article-title">Mechanism of the Gabriel-Colman rearrangement</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01013a078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=620-622&author=J.+H.+M.+Hill&title=Mechanism+of+the+Gabriel-Colman+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo01013a078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01013a078%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DMechanism%2520of%2520the%2520Gabriel-Colman%2520rearrangement%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D620%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Weng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2Fj.ejphar.2007.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=18215659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslaqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2008&pages=262-269&author=Q.+Wengauthor=D.+Wangauthor=P.+Guoauthor=L.+Fangauthor=Y.+Huauthor=Q.+Heauthor=B.+Yang&title=Q39%2C+a+novel+synthetic+Quinoxaline+1%2C4-Di-N-oxide+compound+with+anti-cancer+activity+in+hypoxia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia</span></div><div class="casAuthors">Weng, Qinjie; Wang, Duoduo; Guo, Peng; Fang, Liang; Hu, Yongzhou; He, Qiaojun; Yang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia is one of the inevitable circumstances in various tumors and results in tumor resistance to radiotherapy and chemotherapy.  The present data showed that 3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline 1,4-dioxide (Q39), derived from Quinoxaline 1,4-Di-N-oxide, possessed high anti-cancer activity in hypoxia.  Cytotoxicity assay demonstrated that Q39 is a potential and high efficient anti-cancer compd. in all tested cell lines with IC50 values of 0.18 ± 0.03-8.88 ± 1.12 μM in hypoxia and 0.33 ± 0.04-8.74 ± 1.28 μM in normoxia .  In the following work concerning the mechanism of Q39 in hypoxia, we confirmed that Q39 could cause the apoptosis of K562 cells in a time-dependent manner.  By fluorescence stain assay, Q39-induced mitochondria membrane potential (ΔΨm) loss was obsd. in K562 cells in hypoxia.  Based on the western blotting, Q39 decreased the protein expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in hypoxia.  The compd. caused the activation of caspase-3 and subsequent cleavage of its substrate poly (ADP-ribose) polymerase (PARP) in hypoxia.  Meanwhile, we found the upregulation of Bax by Q39 in K562 cells as well as the downregulation of Bcl-2.  Q39 also influenced the expression of Mitogen-Activated Protein Kinase (MAPKs) and other proteins relative to mitochondria induced apoptosis.  In addn., Q39-mediated apoptosis was not reversed after treatment with the JNK-specific inhibitor.  In summary, the present study demonstrated Q39 was a novel compd. against cancer cells in hypoxia.  The mitochondrial pathway mediated by Bcl-2 protein family and MAPKs and the HIF-1 pathway might be involved in signaling Q39-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofweWFI1728LVg90H21EOLACvtfcHk0liptfhslcBWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslaqs7Y%253D&md5=c32f0715e5c3afebc67a780a85fa02a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DQ39%252C%2520a%2520novel%2520synthetic%2520Quinoxaline%25201%252C4-Di-N-oxide%2520compound%2520with%2520anti-cancer%2520activity%2520in%2520hypoxia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D581%26spage%3D262%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laube, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckman, B. S.</span><span> </span><span class="NLM_article-title">Extrusion of sulfur from [(acylmethyl)thio]pyrimidinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3651</span><span class="NLM_x">–</span> <span class="NLM_lpage">3657</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01306a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3651-3657&author=B.+Rothauthor=R.+Laubeauthor=M.+Y.+Tidwellauthor=B.+S.+Rauckman&title=Extrusion+of+sulfur+from+%5B%28acylmethyl%29thio%5Dpyrimidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo01306a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01306a022%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DLaube%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DM.%2BY.%26aulast%3DRauckman%26aufirst%3DB.%2BS.%26atitle%3DExtrusion%2520of%2520sulfur%2520from%2520%255B%2528acylmethyl%2529thio%255Dpyrimidinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3651%26epage%3D3657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zhuangping, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongmin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhenghai, M.</span><span> </span><span class="NLM_article-title">Indium-mediated reaction in aqueous media. Synthesis of phenacyl sulfides by reactions of a-bromoketones with sodium alkyl thiosulfates</span> <span class="citation_source-journal">J. Chem. Res. Synopses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=130-131&author=Z.+Zhuangpingauthor=Z.+Yongminauthor=M.+Zhenghai&title=Indium-mediated+reaction+in+aqueous+media.+Synthesis+of+phenacyl+sulfides+by+reactions+of+a-bromoketones+with+sodium+alkyl+thiosulfates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuangping%26aufirst%3DZ.%26aulast%3DYongmin%26aufirst%3DZ.%26aulast%3DZhenghai%26aufirst%3DM.%26atitle%3DIndium-mediated%2520reaction%2520in%2520aqueous%2520media.%2520Synthesis%2520of%2520phenacyl%2520sulfides%2520by%2520reactions%2520of%2520a-bromoketones%2520with%2520sodium%2520alkyl%2520thiosulfates%26jtitle%3DJ.%2520Chem.%2520Res.%2520Synopses%26date%3D1998%26volume%3D3%26spage%3D130%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBernardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, D. e. H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young-Sciame, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=21-39&author=N.+Kailaauthor=K.+Janzauthor=S.+DeBernardoauthor=P.+W.+Bedardauthor=R.+T.+Camphausenauthor=S.+Tamauthor=D.+e.+H.+H.+Tsaoauthor=J.+C.+Keithauthor=C.+Nickerson-Nutterauthor=A.+Shillingauthor=R.+Young-Sciameauthor=Q.+Wang&title=Synthesis+and+biological+evaluation+of+quinoline+salicylic+acids+as+P-selectin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DDeBernardo%26aufirst%3DS.%26aulast%3DBedard%26aufirst%3DP.%2BW.%26aulast%3DCamphausen%26aufirst%3DR.%2BT.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2Be.%2BH.%2BH.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%26aulast%3DShilling%26aufirst%3DA.%26aulast%3DYoung-Sciame%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520quinoline%2520salicylic%2520acids%2520as%2520P-selectin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D50%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Paizs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To a, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bódai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novák, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irimie, F.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poppe, L.</span><span> </span><span class="NLM_article-title">Chemo-enzymatic preparation of hydroxymethyl ketones</span> <span class="citation_source-journal">J. Chem. Soc. Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2400-2402&author=C.+Paizsauthor=M.+To+aauthor=C.+Majdikauthor=V.+B%C3%B3daiauthor=L.+Nov%C3%A1kauthor=F.-D.+Irimieauthor=L.+Poppe&title=Chemo-enzymatic+preparation+of+hydroxymethyl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaizs%26aufirst%3DC.%26aulast%3DTo%2Ba%26aufirst%3DM.%26aulast%3DMajdik%26aufirst%3DC.%26aulast%3DB%25C3%25B3dai%26aufirst%3DV.%26aulast%3DNov%25C3%25A1k%26aufirst%3DL.%26aulast%3DIrimie%26aufirst%3DF.-D.%26aulast%3DPoppe%26aufirst%3DL.%26atitle%3DChemo-enzymatic%2520preparation%2520of%2520hydroxymethyl%2520ketones%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D2002%26volume%3D21%26spage%3D2400%26epage%3D2402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nakaiida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niyomura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koketsu, J.</span><span> </span><span class="NLM_article-title">Te-1-Acylmethyl and Te-1-Iminoalkyl Telluroesters: Synthesis and Thermolysis Leading to 1,3-Diketones and O-Alkenyl and O-Imino Esters</span> <span class="citation_source-journal">Phosphorus, Sulfur Silicon Relat. Elem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1080%2F10426501003769728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslGgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=930-946&author=S.+Nakaiidaauthor=S.+Katoauthor=O.+Niyomuraauthor=M.+Ishidaauthor=F.+Andoauthor=J.+Koketsu&title=Te-1-Acylmethyl+and+Te-1-Iminoalkyl+Telluroesters%3A+Synthesis+and+Thermolysis+Leading+to+1%2C3-Diketones+and+O-Alkenyl+and+O-Imino+Esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Te-1-Acylmethyl and Te-1-Iminoalkyl Telluroesters: Synthesis and Thermolysis Leading to 1,3-Diketones and O-Alkenyl and O-Imino Esters</span></div><div class="casAuthors">Nakaiida, Shoho; Kato, Shinzi; Niyomura, Osamu; Ishida, Masaru; Ando, Fumio; Koketsu, Jugo</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus, Sulfur and Silicon and the Related Elements</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">930-946</span>CODEN:
                <span class="NLM_cas:coden">PSSLEC</span>;
        ISSN:<span class="NLM_cas:issn">1042-6507</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A series of Te-1-acylmethyl carbotelluroates was prepd. in good isolated yields from the reaction of potassium carbotelluroates with α-haloketones in acetonitrile.  Thermolysis of the telluroesters afforded vinyl esters in 20-50% yields, while treatment of the carbotelluroates with potassium t-butanolate led to 1,3-diketones in 30-75% yields with the liberation of black tellurium.  The reaction of potassium carbotelluroates with α-haloaceto oximes gave O-acyl oximes in 50-70% yields via Te-1-iminomethylcarbotelluroates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOFRUnKN3iDbVg90H21EOLACvtfcHk0lgC68NkDn3lVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslGgtrc%253D&md5=3eabbc9264dd0daf91f1196c45b5211f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F10426501003769728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10426501003769728%26sid%3Dliteratum%253Aachs%26aulast%3DNakaiida%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DNiyomura%26aufirst%3DO.%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DAndo%26aufirst%3DF.%26aulast%3DKoketsu%26aufirst%3DJ.%26atitle%3DTe-1-Acylmethyl%2520and%2520Te-1-Iminoalkyl%2520Telluroesters%253A%2520Synthesis%2520and%2520Thermolysis%2520Leading%2520to%25201%252C3-Diketones%2520and%2520O-Alkenyl%2520and%2520O-Imino%2520Esters%26jtitle%3DPhosphorus%252C%2520Sulfur%2520Silicon%2520Relat.%2520Elem.%26date%3D2010%26volume%3D185%26spage%3D930%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Artyomov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shestopalov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinov, V. P.</span><span> </span><span class="NLM_article-title">Synthesis of Imidazo[1,2-a]pyridines from Pyridines and p-Bromophenacyl Bromide O-Methyloxime</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1055%2Fs-1996-4322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=927-929&author=V.+A.+Artyomovauthor=A.+M.+Shestopalovauthor=V.+P.+Litvinov&title=Synthesis+of+Imidazo%5B1%2C2-a%5Dpyridines+from+Pyridines+and+p-Bromophenacyl+Bromide+O-Methyloxime"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-4322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-4322%26sid%3Dliteratum%253Aachs%26aulast%3DArtyomov%26aufirst%3DV.%2BA.%26aulast%3DShestopalov%26aufirst%3DA.%2BM.%26aulast%3DLitvinov%26aufirst%3DV.%2BP.%26atitle%3DSynthesis%2520of%2520Imidazo%255B1%252C2-a%255Dpyridines%2520from%2520Pyridines%2520and%2520p-Bromophenacyl%2520Bromide%2520O-Methyloxime%26jtitle%3DSynthesis%26date%3D1996%26volume%3D8%26spage%3D927%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. J.</span><span> </span><span class="NLM_article-title">Facile one–pot synthesis of α-chloro sulfoxides from sulfides</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1055%2Fs-1993-25831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3sXitFamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=209-210&author=Y.+H.+Kimauthor=H.+H.+Shinauthor=Y.+J.+Park&title=Facile+one%E2%80%93pot+synthesis+of+%CE%B1-chloro+sulfoxides+from+sulfides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Facile one-pot synthesis of α-chloro sulfoxides from sulfides</span></div><div class="casAuthors">Kim, Yong Hae; Shin, Hyun Ho; Park, Young Jun</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-10</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Sulfides R1SCH2R2 (R1 = Me, (substituted) Ph; R2 = H, Me) reacted with sulfuryl chloride in the presence of metal nitrates in acetonitriles under mild conditions to give the corresponding α-chloro sulfoxides R1SOCHClR2 in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fjcK6uawtbVg90H21EOLACvtfcHk0lj8rtTBzyiMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitFamtbs%253D&md5=f42af41b802580efebc4e40ba753a879</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25831%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DShin%26aufirst%3DH.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26atitle%3DFacile%2520one%25E2%2580%2593pot%2520synthesis%2520of%2520%25CE%25B1-chloro%2520sulfoxides%2520from%2520sulfides%26jtitle%3DSynthesis%26date%3D1993%26spage%3D209%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kallmayer, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span> </span><span class="NLM_article-title">Zur Farbe der N-(4′-Nitrophenacyl)-arylamine</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1002%2Fardp.19803130407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFCgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=1980&pages=315-323&author=H.-J.+Kallmayerauthor=E.+Wagner&title=Zur+Farbe+der+N-%284%E2%80%B2-Nitrophenacyl%29-arylamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Color of N-(4'-nitrophenacyl)arylamines</span></div><div class="casAuthors">Kallmayer, Hans Joerg; Wagner, Eugen</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-23</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">4-O2NC6H4COCH2NHR [I; R = (un)substituted Ph, 2-naphthyl] were prepd. and their UV absorption max. detd.  Their color is explained by intramol. interaction of the electron-accepting nitrobenzoyl group and the electron-donating arylamine part of the mol.  The color is lost on acetylation of the amino group.  There is no indication of an equil. between I and 4-O2NC6H4C(OH):CHNHR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZUUY11RT1wbVg90H21EOLACvtfcHk0lj8rtTBzyiMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFCgtbw%253D&md5=7b01d57f916f8a40485df4825fde9aa3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fardp.19803130407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19803130407%26sid%3Dliteratum%253Aachs%26aulast%3DKallmayer%26aufirst%3DH.-J.%26aulast%3DWagner%26aufirst%3DE.%26atitle%3DZur%2520Farbe%2520der%2520N-%25284%25E2%2580%25B2-Nitrophenacyl%2529-arylamine%26jtitle%3DArch.%2520Pharm.%26date%3D1980%26volume%3D313%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kyongtae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeeock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheol, Y. S.</span><span> </span><span class="NLM_article-title">Reactions of tetrasulfur tetranitride with aryl dibromomethyl ketones: one-pot synthesis of 3-aroylformamido-4-aryl-1,2,5-thiadiazoles and their reactions</span> <span class="citation_source-journal">J. Chem. Soc. Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=253-260&author=K.+Kyongtaeauthor=C.+Jaeeockauthor=Y.+S.+Cheol&title=Reactions+of+tetrasulfur+tetranitride+with+aryl+dibromomethyl+ketones%3A+one-pot+synthesis+of+3-aroylformamido-4-aryl-1%2C2%2C5-thiadiazoles+and+their+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKyongtae%26aufirst%3DK.%26aulast%3DJaeeock%26aufirst%3DC.%26aulast%3DCheol%26aufirst%3DY.%2BS.%26atitle%3DReactions%2520of%2520tetrasulfur%2520tetranitride%2520with%2520aryl%2520dibromomethyl%2520ketones%253A%2520one-pot%2520synthesis%2520of%25203-aroylformamido-4-aryl-1%252C2%252C5-thiadiazoles%2520and%2520their%2520reactions%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D1995%26spage%3D253%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschesche, H.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3231</span><span class="NLM_x">–</span> <span class="NLM_lpage">3243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010887p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3231-3243&author=J.+Schr%C3%B6derauthor=A.+Henkeauthor=H.+Wenzelauthor=H.+Brandstetterauthor=H.+G.+Stammlerauthor=A.+Stammlerauthor=W.+D.+Pfeifferauthor=H.+Tschesche&title=Structure-based+design+and+synthesis+of+potent+matrix+metalloproteinase+inhibitors+derived+from+a+6H-1%2C3%2C4-thiadiazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm010887p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010887p%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DHenke%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DH.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DStammler%26aufirst%3DH.%2BG.%26aulast%3DStammler%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DW.%2BD.%26aulast%3DTschesche%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520potent%2520matrix%2520metalloproteinase%2520inhibitors%2520derived%2520from%2520a%25206H-1%252C3%252C4-thiadiazine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3231%26epage%3D3243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Conde, S.; Martinez, A.; Perez, D. I.; Perez, C.; Moreno, F. J.; Wandosell, F.</span><span> </span><span class="NLM_article-title">Compounds and their therapeutic use</span>. US2003/199508 A1.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conde%2C+S.%3B+Martinez%2C+A.%3B+Perez%2C+D.+I.%3B+Perez%2C+C.%3B+Moreno%2C+F.+J.%3B+Wandosell%2C+F.+Compounds+and+their+therapeutic+use.+US2003%2F199508+A1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConde%26aufirst%3DS.%26atitle%3DCompounds%2520and%2520their%2520therapeutic%2520use" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Diwu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beachdel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaubert, D. H.</span><span> </span><span class="NLM_article-title">A facile protocol for the convenient preparation of amino-substituted [alpha]-bromo- and [alpha],[alpha]-dibromo arylmethylketones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=4987-4990&author=Z.+Diwuauthor=C.+Beachdelauthor=D.+H.+Klaubert&title=A+facile+protocol+for+the+convenient+preparation+of+amino-substituted+%5Balpha%5D-bromo-+and+%5Balpha%5D%2C%5Balpha%5D-dibromo+arylmethylketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiwu%26aufirst%3DZ.%26aulast%3DBeachdel%26aufirst%3DC.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26atitle%3DA%2520facile%2520protocol%2520for%2520the%2520convenient%2520preparation%2520of%2520amino-substituted%2520%255Balpha%255D-bromo-%2520and%2520%255Balpha%255D%252C%255Balpha%255D-dibromo%2520arylmethylketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D4987%26epage%3D4990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Mathivanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayner, D. D. M.</span><span> </span><span class="NLM_article-title">Photochemical generation of radical anions of photolabile aryl ketones</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">8190</span><span class="NLM_x">–</span> <span class="NLM_lpage">8195</span></span><div class="citationLinks">[<a href="/doi/10.1021/j100020a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1995&pages=8190-8195&author=N.+Mathivananauthor=L.+J.+Johnstonauthor=D.+D.+M.+Wayner&title=Photochemical+generation+of+radical+anions+of+photolabile+aryl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fj100020a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100020a048%26sid%3Dliteratum%253Aachs%26aulast%3DMathivanan%26aufirst%3DN.%26aulast%3DJohnston%26aufirst%3DL.%2BJ.%26aulast%3DWayner%26aufirst%3DD.%2BD.%2BM.%26atitle%3DPhotochemical%2520generation%2520of%2520radical%2520anions%2520of%2520photolabile%2520aryl%2520ketones%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1995%26volume%3D99%26spage%3D8190%26epage%3D8195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Watson, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whish, W. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threadgill, M. D.</span><span> </span><span class="NLM_article-title">Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=721-734&author=C.+Y.+Watsonauthor=W.+J.+D.+Whishauthor=M.+D.+Threadgill&title=Synthesis+of+3-substituted+benzamides+and+5-substituted+isoquinolin-1%282H%29-ones+and+preliminary+evaluation+as+inhibitors+of+poly%28ADP-ribose%29polymerase+%28PARP%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%2BY.%26aulast%3DWhish%26aufirst%3DW.%2BJ.%2BD.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520of%25203-substituted%2520benzamides%2520and%25205-substituted%2520isoquinolin-1%25282H%2529-ones%2520and%2520preliminary%2520evaluation%2520as%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529polymerase%2520%2528PARP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D721%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Nobuta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, A.</span><span> </span><span class="NLM_article-title">Facile aerobic photo-oxidative syntheses of [alpha],[alpha]-dibromoacetophenones from aromatic alkynes with 48% aq HBr</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4576</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=4576-4578&author=T.+Nobutaauthor=S.-i.+Hirashimaauthor=N.+Tadaauthor=T.+Miuraauthor=A.+Itoh&title=Facile+aerobic+photo-oxidative+syntheses+of+%5Balpha%5D%2C%5Balpha%5D-dibromoacetophenones+from+aromatic+alkynes+with+48%25+aq+HBr"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNobuta%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.-i.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DA.%26atitle%3DFacile%2520aerobic%2520photo-oxidative%2520syntheses%2520of%2520%255Balpha%255D%252C%255Balpha%255D-dibromoacetophenones%2520from%2520aromatic%2520alkynes%2520with%252048%2525%2520aq%2520HBr%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D4576%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kartinos, N.; Normington, J. B.</span><span> </span><span class="NLM_article-title">Coloration of textile fibers with nitro keto arylamines</span>. US 2708149 19550510.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kartinos%2C+N.%3B+Normington%2C+J.+B.+Coloration+of+textile+fibers+with+nitro+keto+arylamines.+US+2708149+19550510."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKartinos%26aufirst%3DN.%26atitle%3DColoration%2520of%2520textile%2520fibers%2520with%2520nitro%2520keto%2520arylamines" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Baki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szendrei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=75-83&author=A.+Bakiauthor=A.+Bielikauthor=L.+Molnarauthor=G.+Szendreiauthor=G.+M.+Keseru&title=A+high+throughput+luminescent+assay+for+glycogen+synthase+kinase-3beta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DBielik%26aufirst%3DA.%26aulast%3DMolnar%26aufirst%3DL.%26aulast%3DSzendrei%26aufirst%3DG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520high%2520throughput%2520luminescent%2520assay%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Parker, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenoch, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, R. E.</span><span> </span><span class="NLM_article-title">Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1177%2F108705710000500204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=10803607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtF2ls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=77-88&author=G.+J.+Parkerauthor=T.+L.+Lawauthor=F.+J.+Lenochauthor=R.+E.+Bolger&title=Development+of+high+throughput+screening+assays+using+fluorescence+polarization%3A+nuclear+receptor-ligand-binding+and+kinase%2Fphosphatase+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays</span></div><div class="casAuthors">Parker, Gregory J.; Law, Tong Lin; Lenoch, Francis J.; Bolger, Randall E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-88</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Fluorescence polarization (FP) was used to develop high throughput screening (HTS) assays for nuclear receptor-ligand displacement and kinase inhibition.  FP is a soln.-based, homogeneous technique requiring no immobilization or sepn. of reaction components.  The FP-based estrogen receptor (ER) assay is based on the competition of fluorescein-labeled estradiol and estrogen-like compds. for binding to ER.  These studies detd. the Kd for this interaction to be 3 nM for ERα and 2 nM for ERβ; IC50 values for 17β-estradiol, tamoxifen, 4-OH-tamoxifen, and diethylstilbestrol were detd. to be 5.6, 189, 26, and 3.5 nM, resp.  In a screen of 50 lead compds. from a transcriptional activation screen, 21 compds. had IC50 values below 10 μM, with 1 having an almost 100-fold higher affinity for ERβ over ERα.  These data show that an FP-based competitive binding assay can be used to screen diverse compds. with a broad range of binding affinities for ERs.  The FP-based protein-tyrosine kinase (PTK) assay uses fluorescein-labeled phosphopeptides bound to anti-phosphotyrosine antibodies.  Phosphopeptides generated by a kinase compete for this binding.  In c-Src kinase reactions, polarization decreased with time as reaction products displaced the fluorescein-labeled phosphopeptide from the anti-phosphotyrosine antibodies.  The exptl. detd. IC50 of AG 1478 was 400 pM, while genistein did not inhibit the epidermal growth factor receptor at similar concns.  Like the FP-based PTK assay, the protein kinase C (PKC) assay utilizes competition.  PKC isoforms had different turnover rates for the peptide substrate.  The IC50 for staurosporine was < 10 nM for all PKC isoforms.  Tyr phosphatase assays use direct binding rather than competition.  Increasing concns. of T-cell protein-Tyr phosphatase (TC PTP) increased the rate of dephosphorylation.  This change in polarization was dependent on TC PTP and was inhibited by 50 μM Na3VO4.  The IC50 of Na3VO4 was 4 nM for TC PTP.  These data demonstrate that a FP-based assay can detect kinase and phosphatase activity.  Homogeneous, fluorescent techniques such as FP are now methods of choice for screening many types of drug targets.  New HTS instrumentation and assay methods like these make FP a technol. easily incorporated into HTS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrff2kgYgHixLVg90H21EOLACvtfcHk0ljA_4OPcsWW2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtF2ls74%253D&md5=2e6ac4aa8d4d1ef192e6acc70aaef86e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1177%2F108705710000500204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710000500204%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DG.%2BJ.%26aulast%3DLaw%26aufirst%3DT.%2BL.%26aulast%3DLenoch%26aufirst%3DF.%2BJ.%26aulast%3DBolger%26aufirst%3DR.%2BE.%26atitle%3DDevelopment%2520of%2520high%2520throughput%2520screening%2520assays%2520using%2520fluorescence%2520polarization%253A%2520nuclear%2520receptor-ligand-binding%2520and%2520kinase%252Fphosphatase%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2000%26volume%3D5%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Lengyel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostas, J.</span><span> </span><span class="NLM_article-title">Auto-inhibition of Ca(2+)/calmodulin-dependent protein kinase II by its ATP-binding domain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1046%2Fj.1471-4159.2001.00139.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=11181826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhs12gurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2001&pages=1066-1072&author=I.+Lengyelauthor=A.+Nairnauthor=A.+McCluskeyauthor=G.+Tothauthor=B.+Penkeauthor=J.+Rostas&title=Auto-inhibition+of+Ca%282%2B%29%2Fcalmodulin-dependent+protein+kinase+II+by+its+ATP-binding+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Auto-inhibition of Ca2+/calmodulin-dependent protein kinase II by its ATP-binding domain</span></div><div class="casAuthors">Lengyel, I.; Nairn, A. C.; McCluskey, A.; Toth, G.; Penke, B.; Rostas, J. A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Ca2+/calmodulin dependent protein kinase (CaMPK) II is a key enzyme in many physiol. processes.  The enzyme is inactive unless Ca2+/CaM binds to it.  In this inactive form CaMPK-II does not bind ATP suggesting that the ATP-binding domain is involved in an intramol. interaction.  We show here that F12, a 12 amino acid long peptide fragment of the ATP-binding domain (CaMPK-II23-34, GAFSVVRRCVKV) can inhibit the Ca2+/CaM-dependent activity (IC50 of 3 μM) but has no effect on the Ca2+/CaM-independent activity of CaMPK-II.  Kinetic anal. exhibited mixed inhibition with respect to autocamtide-2 and ATP.  The inhibition by F12 showed specificity towards CaMPK-II, but also inhibited CaMPK-I (IC50 = 12.5 μM), while CaMPK-IV (IC50 = 85 μM) was inhibited poorly and cAMP-dependent protein kinase (PKA) was not inhibited.  Substitution of phenylalanine at position 25 to alanine (A12), had little effect on the inhibition of different Ca2+/CaM-dependent protein kinases, suggesting that phenylalanine 25 does not play a crucial role in the interactions involving F12.  Thus the mol. interactions involving the ATP-binding domain appears to play a role in the regulation of nonphosphorylated CaMPK-II activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT35MiHcrSUrVg90H21EOLACvtfcHk0li3X02GoDoB0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhs12gurc%253D&md5=7ad7518c0f9a155e3f37de201f4bc9a7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00139.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00139.x%26sid%3Dliteratum%253Aachs%26aulast%3DLengyel%26aufirst%3DI.%26aulast%3DNairn%26aufirst%3DA.%26aulast%3DMcCluskey%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DPenke%26aufirst%3DB.%26aulast%3DRostas%26aufirst%3DJ.%26atitle%3DAuto-inhibition%2520of%2520Ca%25282%252B%2529%252Fcalmodulin-dependent%2520protein%2520kinase%2520II%2520by%2520its%2520ATP-binding%2520domain%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D76%26spage%3D1066%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Carpenter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">4884</span><span class="NLM_x">–</span> <span class="NLM_lpage">4891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1979&pages=4884-4891&author=G.+Carpenterauthor=L.+Kingauthor=S.+Cohen&title=Rapid+enhancement+of+protein+phosphorylation+in+A-431+cell+membrane+preparations+by+epidermal+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DG.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DRapid%2520enhancement%2520of%2520protein%2520phosphorylation%2520in%2520A-431%2520cell%2520membrane%2520preparations%2520by%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1979%26volume%3D254%26spage%3D4884%26epage%3D4891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Al-Hasani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passlack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. W.</span><span> </span><span class="NLM_article-title">Phosphoryl exchange is involved in the mechanism of the insulin receptor kinase</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1994&pages=17-22&author=H.+Al-Hasaniauthor=W.+Passlackauthor=H.+W.+Klein&title=Phosphoryl+exchange+is+involved+in+the+mechanism+of+the+insulin+receptor+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Hasani%26aufirst%3DH.%26aulast%3DPasslack%26aufirst%3DW.%26aulast%3DKlein%26aufirst%3DH.%2BW.%26atitle%3DPhosphoryl%2520exchange%2520is%2520involved%2520in%2520the%2520mechanism%2520of%2520the%2520insulin%2520receptor%2520kinase%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D349%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderbilt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppert, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5097</span><span class="NLM_x">–</span> <span class="NLM_lpage">5106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=8444886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVKlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=5097-5106&author=D.+J.+Robbinsauthor=E.+Zhenauthor=H.+Owakiauthor=C.+A.+Vanderbiltauthor=D.+Ebertauthor=T.+D.+Geppertauthor=M.+H.+Cobb&title=Regulation+and+properties+of+extracellular+signal-regulated+protein+kinases+1+and+2+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro</span></div><div class="casAuthors">Robbins, David J.; Zhen, Erzhen; Owaki, Hajime; Vanderbilt, Colleen A.; Ebert, Douglas; Geppert, Thomas D.; Cobb, Melanie H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5097-106</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Extracellular signal-regulated protein kinases (ERK) 1 and 2 and mutants of each were expressed in bacteria with a hexahistidine tag and purified using Ni-chelate chromatog.  Basal activity of wild-type ERK2 was ∼2 nmol/min/mg.  Self-catalyzed phosphorylation occurred in vitro on the major physiol. site of tyrosine phosphorylation in an intramol. reaction.  Rabbit muscle ERK activator activated ERK2 500-1000-fold up to a specific activity (∼2 μmol/min/mg) approximating that of ERK1 purified from stimulated cells (Boulton, T.G. et al., 1991).  ERK1 could also be activated by the ERK activator to the same extent.  Mutants lacking the major site of tyrosine phosphorylation were autophosphorylated at a greatly reduced rate and were no longer highly activated by the ERK kinase.  Mutants lacking the major site of threonine phosphorylation were autophosphorylated at the same or an enhanced rate, but the kinase activity of these mutants depended on the residue used to replace the threonine.  Replacement by glutamate rendered the kinase capable of being activated by ERK activator, whereas replacement by alanine did not.  Thus, the carboxyl group of glutamate can provide at least some of the features introduced by phosphothreonine in activated ERKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mgX0PJZ_iLVg90H21EOLACvtfcHk0li3X02GoDoB0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVKlsbk%253D&md5=b2a966b47a7da7c369c1337af9829dc0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DZhen%26aufirst%3DE.%26aulast%3DOwaki%26aufirst%3DH.%26aulast%3DVanderbilt%26aufirst%3DC.%2BA.%26aulast%3DEbert%26aufirst%3DD.%26aulast%3DGeppert%26aufirst%3DT.%2BD.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DRegulation%2520and%2520properties%2520of%2520extracellular%2520signal-regulated%2520protein%2520kinases%25201%2520and%25202%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D5097%26epage%3D5106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flotow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span> </span><span class="NLM_article-title">Ro 09–2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">9579</span><span class="NLM_x">–</span> <span class="NLM_lpage">9585</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi972914c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=9579-9585&author=D.+H.+Williamsauthor=S.+E.+Wilkinsonauthor=T.+Purtonauthor=A.+Lamontauthor=H.+Flotowauthor=E.+J.+Murray&title=Ro+09%E2%80%932210+exhibits+potent+anti-proliferative+effects+on+activated+T+cells+by+selectively+blocking+MKK+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi972914c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi972914c%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DWilkinson%26aufirst%3DS.%2BE.%26aulast%3DPurton%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DA.%26aulast%3DFlotow%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26atitle%3DRo%252009%25E2%2580%25932210%2520exhibits%2520potent%2520anti-proliferative%2520effects%2520on%2520activated%2520T%2520cells%2520by%2520selectively%2520blocking%2520MKK%2520activity%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D9579%26epage%3D9585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Cheng, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatase, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span> </span><span class="NLM_article-title">A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">9248</span><span class="NLM_x">–</span> <span class="NLM_lpage">9256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=9248-9256&author=H.+C.+Chengauthor=H.+Nishioauthor=O.+Hataseauthor=S.+Ralphauthor=J.+H.+Wang&title=A+synthetic+peptide+derived+from+p34cdc2+is+a+specific+and+efficient+substrate+of+src-family+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BC.%26aulast%3DNishio%26aufirst%3DH.%26aulast%3DHatase%26aufirst%3DO.%26aulast%3DRalph%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26atitle%3DA%2520synthetic%2520peptide%2520derived%2520from%2520p34cdc2%2520is%2520a%2520specific%2520and%2520efficient%2520substrate%2520of%2520src-family%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D9248%26epage%3D9256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Uhlen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, J. E.</span><span> </span><span class="NLM_article-title">Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding</span> <span class="citation_source-journal">Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1600-0773.1991.tb01308.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1687079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK38Xlt1Sqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1991&pages=341-350&author=S.+Uhlenauthor=J.+E.+Wikberg&title=Rat+spinal+cord+alpha+2-adrenoceptors+are+of+the+alpha+2A-subtype%3A+comparison+with+alpha+2A-+and+alpha+2B-adrenoceptors+in+rat+spleen%2C+cerebral+cortex+and+kidney+using+3H-RX821002+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Rat spinal cord α2-adrenoceptors are of the α2A-subtype:  comparison with α2A- and α2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding</span></div><div class="casAuthors">Uhlen, Staffan; Wikberg, Jarl E. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-50</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">Binding of the α2-adrenoceptor antagonist radioligand 3H-labeled RX821002 (I) was investigated in membranes from rat spinal cord, spleen, cerebral cortex, and kidney.  The ligand was bound to saturable binding sites with apparent uniform affinities within each tissue.  Seven compds., some of which have previously been reported to be selective for either α2A- or α2B-adrenoceptors, were used in competition with [3H]RX811002.  By using computer modeling, competition curves generated for 3 of these compds. (ARC 239, prazosin, and oxymetazoline) could be resolved into 2-site fits in the kidney; Kd's of the drugs were compatible with the notion that these sites corresponded to α2A- and α2B-adrenoceptors. Moreover, rauwolscine and yohimbine were about 14- and 9-fold selective for α2B-adrenoceptors in the kidney.  In all other tissues studied, drug competition curves were uniphasic and computer modelled into 1-site fits; drug Kd2 were well correlated to those for the α2A-adrenoceptor.  In rat spinal cord, 26 further drugs, which showed wide variation in structure, were evaluated in competition with [3H]RX821002.  Of these compds., competition curves of the agonists UK-14,304, (-) and (+)adrenaline were modelled into 2-site fits whereas those of the remaining compds. could be modelled only into 1-site fits.  Since the high affinity site for UK-14,304 and (-) and (+) adrenaline was eliminated when EDTA, Gpp(NH)p, and 140 mM NaCll was present in the assay, the heterogeneity obsd. in the spinal cord was considered to be due to the formation of high and low affinity conformations of the α2-adrenoceptor for agonists.  Thus, [3H]RX821002 is useful to label both α2A- and α2B-adrenoceptors in the rat.  Moreover, the binding sites labeled by [3H]RX821002 in the spinal cord appear to consist of a single population of α2-adrenoceptors of the α2A-type.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtig83D_yaLrVg90H21EOLACvtfcHk0lh8iW9Fi7_53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xlt1Sqsg%253D%253D&md5=49dada36f50ee7bdc9d14561613159a6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1991.tb01308.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1991.tb01308.x%26sid%3Dliteratum%253Aachs%26aulast%3DUhlen%26aufirst%3DS.%26aulast%3DWikberg%26aufirst%3DJ.%2BE.%26atitle%3DRat%2520spinal%2520cord%2520alpha%25202-adrenoceptors%2520are%2520of%2520the%2520alpha%25202A-subtype%253A%2520comparison%2520with%2520alpha%25202A-%2520and%2520alpha%25202B-adrenoceptors%2520in%2520rat%2520spleen%252C%2520cerebral%2520cortex%2520and%2520kidney%2520using%25203H-RX821002%2520ligand%2520binding%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1991%26volume%3D69%26spage%3D341%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">–</span> <span class="NLM_lpage">9766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">MacKenzie, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanLeeuwen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugsley, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demattos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span> </span><span class="NLM_article-title">Characterization of the human dopamine D3 receptor expressed in transfected cell lines</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2F0922-4106%2894%2990212-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=7907989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK2cXps1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=79-85&author=R.+G.+MacKenzieauthor=D.+VanLeeuwenauthor=T.+A.+Pugsleyauthor=Y.+H.+Shihauthor=S.+Demattosauthor=L.+Tangauthor=R.+D.+Toddauthor=K.+L.+O%E2%80%99Malley&title=Characterization+of+the+human+dopamine+D3+receptor+expressed+in+transfected+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human dopamine D3 receptor expressed in transfected cell lines</span></div><div class="casAuthors">MacKenzie, Robert G.; VanLeeuwen, Donald; Pugsley, Thomas A.; Shih, Yu Hsin; Demattos, Steve; Tang, Lei; Todd, Richard D.; O'Malley, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">A full-length cDNA clone of the human dopamine D3 receptor was obtained by the polymerase chain reaction using reverse-transcribed RNA from human brain as the template.  The cDNA was inserted into an expression vector which was then stably transfected into either Chinese hamster ovary (CHO), SK-N-MC human epithelioma or mouse CCL1.3 fibroblast cell lines.  Post-transfection, the Bmax for D3 receptor expression was 1.9, 1.1 and 0.4 pmol/mg protein in the CHO-K1, SK-N-MC and CCL1.3 cell lines, resp.  The D3 receptor expressed in CHO-K1 and CCL1.3 cells exhibited similar radioligand binding profiles, esp. for the D3-selective compd., 7-hydroxy-2-(di-n-propylamino)tetralin (7-OH-DPAT).  Radioligand-binding competition curves of presumed D3 agonists were shifted to the right by the addn. of guanine nucleotides and Na+ to the assay buffer.  Presumed D3-receptor agonists had no effect on cAMP accumulation in any of the D3-transfected cell lines although cAMP accumulation was inhibited by dopamine D2 receptor activation in D2-transfected CHO and CCL1.3 cells and by activation of the exogenously expressed neuropeptide Y receptor in SK-N-MC cells.  Also, D3 receptor activation neither potentiated ATP-stimulated arachidonic acid release from CHO cells nor stimulated inositol phosphate prodn. in CCL1.3-cells although both of these responses were elicited by D2 agonists in D2-transfected cells.  The authors conclude that the signalling properties of the D3 receptor differ from those of its closest homolog, the D2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Y89qF3KkyLVg90H21EOLACvtfcHk0lghkUZuzoZqdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXps1OjtA%253D%253D&md5=d63ed27e6550f53e765d5ebb35f8b323</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990212-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990212-7%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26aulast%3DVanLeeuwen%26aufirst%3DD.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DShih%26aufirst%3DY.%2BH.%26aulast%3DDemattos%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520expressed%2520in%2520transfected%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D266%26spage%3D79%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Murphy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snowhill, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1007%2FBF00971514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=2890112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFSlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=775-781&author=D.+E.+Murphyauthor=E.+W.+Snowhillauthor=M.+Williams&title=Characterization+of+quisqualate+recognition+sites+in+rat+brain+tissue+using+DL-%5B3H%5Dalpha-amino-3-hydroxy-5-methylisoxazole-4-propionic+acid+%28AMPA%29+and+a+filtration+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay</span></div><div class="casAuthors">Murphy, Deborah E.; Snowhill, Elaine W.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">775-82</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The binding of [3H]AMPA (DL-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid), a ligand for the putative quisqualate excitatory amino acid receptor subtype, was evaluated by using centrifugation and filtration receptor binding techniques in rat brain crude synaptosomal membrane prepns.  Maximal specific binding of [3H]AMPA occurred in Triton X-100 treated membranes in the presence of the chaotropic agent KSCN.  The effects of KSCN on binding were reversible and optimal at 100 mM.  Supernatant obtained from detergent-treated membranes inhibited specific [3H]AMPA and [3H]kainic acid binding, suggesting the presence of an inhibitory agent which was tentatively identified as glutamate.  By using centrifugation, satn. anal. revealed 2 distinct binding sites in both the absence and presence of KSCN.  The chaotrope was most effective in increasing binding at the low-affinity binding site, enhancing the affinity (Kd) without a concomitant change in the total no. of binding sites.  By using filtration, a single binding site was detected in Triton-treated membranes.  Like the data obtained by centrifugation, KSCN enhanced the affinity of the receptor (Kd value = 10 nM) without altering the no. of binding sites (Bmax = 1.2 pmol/mg protein).  The rank order of potency of various glutamate analogs in the [3H]AMPA binding assay was quisqualate > AMPA > L-glutamate > kainate > D-glutamate, consistent with the labeling of a quisqualate-type excitatory amino acid receptor subtype.  L-Glutamic acid di-Et ester and 2-amino-7-phosphonoheptanoic acid were inactive.  The present technique provides a rapid, reliable assay for the evaluation of quisqualate-type excitatory amino acid agonists and(or) antagonists that may be used to discover more potent and selective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67fm2hn_iG7Vg90H21EOLACvtfcHk0lghkUZuzoZqdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFSlsLo%253D&md5=0601f24a2117628ae6b8d19ce788f64a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2FBF00971514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00971514%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BE.%26aulast%3DSnowhill%26aufirst%3DE.%2BW.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520quisqualate%2520recognition%2520sites%2520in%2520rat%2520brain%2520tissue%2520using%2520DL-%255B3H%255Dalpha-amino-3-hydroxy-5-methylisoxazole-4-propionic%2520acid%2520%2528AMPA%2529%2520and%2520a%2520filtration%2520assay%26jtitle%3DNeurochem.%2520Res.%26date%3D1987%26volume%3D12%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Sills, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brundish, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilusz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">[3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1016%2F0014-2999%2891%2990063-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1674916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFGmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=1991&pages=19-24&author=M.+A.+Sillsauthor=G.+Faggauthor=M.+Pozzaauthor=C.+Angstauthor=D.+E.+Brundishauthor=S.+D.+Hurtauthor=E.+J.+Wiluszauthor=M.+Williams&title=%5B3H%5DCGP+39653%3A+a+new+N-methyl-D-aspartate+antagonist+radioligand+with+low+nanomolar+affinity+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]CGP 39653:  a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain</span></div><div class="casAuthors">Sills, Matthew A.; Fagg, Graham; Pozza, Mario; Angst, Christof; Brundish, Derek E.; Hurt, Stephen D.; Wilusz, E. Jay; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">CGP 39653 (D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) was initially discovered to inhibit the binding of [3H]L-glutamate and [3H]3-((±)2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid ([3H]CPP) with Ki values of 230 and 5 nM, resp.  The radiolabeled compd. [3H]CGP 39653 binds to rat frontal cortical membranes in a saturable and reversible manner.  Anal. of satn. expts. revealed that the ligand labels one binding site with a Kd value of 6 nM.  Competition expts. indicated that the order of potency of a no. of competitive excitatory amino acid agonist and antagonist compds. was similar to that found previously for other N-methyl-D-aspartate (NMDA) receptor ligands.  In contrast to these competitive inhibitors, which produced steep inhibition curves, glycine inhibited binding in a complex manner.  When the functional activity of the unlabeled compd. was explored, CGP 39653 blocked NMDA-evoked depolarizations in the rat cortical wedge in vitro and inhibited L-glutamate-stimulated [3H]N(1-[2-thienyl]cyclohexyl)3,4-piperidine ([3H]TCP) binding in cortical membranes.  These results suggest that [3H]CGP 39653 selectively binds to the NMDA receptor as an antagonist with high affinity and is currently the ligand of choice for labeling the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHj03Ynmvs4LVg90H21EOLACvtfcHk0liRby6OX3VG3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFGmtLw%253D&md5=6e8faa38104681b1e5b8c35b0eb54c60</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2891%2990063-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252891%252990063-V%26sid%3Dliteratum%253Aachs%26aulast%3DSills%26aufirst%3DM.%2BA.%26aulast%3DFagg%26aufirst%3DG.%26aulast%3DPozza%26aufirst%3DM.%26aulast%3DAngst%26aufirst%3DC.%26aulast%3DBrundish%26aufirst%3DD.%2BE.%26aulast%3DHurt%26aufirst%3DS.%2BD.%26aulast%3DWilusz%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3D%255B3H%255DCGP%252039653%253A%2520a%2520new%2520N-methyl-D-aspartate%2520antagonist%2520radioligand%2520with%2520low%2520nanomolar%2520affinity%2520in%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D192%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Richards, M. H.</span><span> </span><span class="NLM_article-title">Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1111%2Fj.1476-5381.1990.tb13002.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=1694463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1990&pages=753-761&author=M.+H.+Richards&title=Rat+hippocampal+muscarinic+autoreceptors+are+similar+to+the+M2+%28cardiac%29+subtype%3A+comparison+with+hippocampal+M1%2C+atrial+M2+and+ileal+M3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype:  comparison with hippocampal M1, atrial M2 and ileal M3 receptors</span></div><div class="casAuthors">Richards, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-61</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Affinity consts. for 15 non-selective or putatively selective muscarinic antagonists were detd. at muscarinic autoreceptors and postsynaptic receptors (linked to phosphatidylinositol (PI) hydrolysis) in rat hippocampal slices, at muscarinic receptors mediating contractility in guinea pig atria or ileal smooth muscle, and at binding sites in rat cerebral cortical membranes labeled with [3H]-1-quinuclidinyl benzilate or [3H]pirenzepine.  Comparison of the affinities of these antagonists at central M1 receptors (inositol-monophosphate formation in rat hippocampal slices) with their affinities at peripheral M1 receptors (inhibition by McN-A-343 of elec. stimulated twitches in rabbit vas deferens) provides support for the suggestion that these receptors may differ pharmacol.  Comparison of affinity consts. obtained by displacement of specifically bound [3H]pirenzepine from rat cerebral cortical membranes with those obtained in functional tests showed poor correlations between affinities for binding sites and for functional atrial receptors or for hippocampal autoreceptors.  A correlation was found between affinities for [3H]pirenzepine binding and those detd. at muscarinic receptors linked to PI turnover in rat hippocampus.  A correlation was also obtained between the affinities for specific [3H]pirenzepine binding sites in cortical membranes and the affinities at ileal receptors.  Comparison of the affinity values for muscarinic autoreceptors in rat hippocampus with affinity values obtained from in vitro models of muscarinic receptor subtypes showed no correlations between those autoreceptors and either M1 or M3 receptors.  A correlation was found between antagonist affinities for hippocampal autoreceptors and muscarinic receptors in the heart.  Therefore, muscarinic autoreceptors in rat hippocampus are pharmacol. similar to the M2 (cardiac) muscarinic receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbrJ_5EoHibrVg90H21EOLACvtfcHk0liRby6OX3VG3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFansb8%253D&md5=fdec2ce6085afb564726f91294916192</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1990.tb13002.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1990.tb13002.x%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BH.%26atitle%3DRat%2520hippocampal%2520muscarinic%2520autoreceptors%2520are%2520similar%2520to%2520the%2520M2%2520%2528cardiac%2529%2520subtype%253A%2520comparison%2520with%2520hippocampal%2520M1%252C%2520atrial%2520M2%2520and%2520ileal%2520M3%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D99%26spage%3D753%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Pabreza, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">[3H]cytisine binding to nicotinic cholinergic receptors in brain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=9-12&author=L.+A.+Pabrezaauthor=S.+Dhawanauthor=K.+J.+Kellar&title=%5B3H%5Dcytisine+binding+to+nicotinic+cholinergic+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPabreza%26aufirst%3DL.%2BA.%26aulast%3DDhawan%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3D%255B3H%255Dcytisine%2520binding%2520to%2520nicotinic%2520cholinergic%2520receptors%2520in%2520brain%26jtitle%3DMol.%2520Pharmacol.%26date%3D1991%26volume%3D39%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Sharples, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliakov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span> </span><span class="NLM_article-title">UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=10751429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVert7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=2783-2791&author=C.+G.+Sharplesauthor=S.+Kaiserauthor=L.+Soliakovauthor=M.+J.+Marksauthor=A.+C.+Collinsauthor=M.+Washburnauthor=E.+Wrightauthor=J.+A.+Spencerauthor=T.+Gallagherauthor=P.+Whiteakerauthor=S.+Wonnacott&title=UB-165%3A+a+novel+nicotinic+agonist+with+subtype+selectivity+implicates+the+alpha4beta2*+subtype+in+the+modulation+of+dopamine+release+from+rat+striatal+synaptosomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes</span></div><div class="casAuthors">Sharples, Christopher G. V.; Kaiser, Sergio; Soliakov, Lev; Marks, Michael J.; Collins, Allan C.; Washburn, Mark; Wright, Emma; Spencer, James A.; Gallagher, Timothy; Whiteaker, Paul; Wonnacott, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2783-2791</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Presynaptic nicotinic acetylcholine receptors (nAChRs) on striatal synaptosomes stimulate dopamine release.  Partial inhibition by the α3β2-selective α-conotoxin-MII indicates heterogeneity of presynaptic nAChRs on dopamine terminals.  We have used this α-conotoxin and UB-165, a novel hybrid of epibatidine and anatoxin-1, to address the hypothesis that the α-conotoxin-MII-insensitive subtype is composed of α4 and β2 subunits.  UB-165 shows intermediate potency, compared with the parent mols., at α4β2* and α3-contg. binding sites, and resembles epibatidine in its high discrimination of these sites over α7-type and muscle binding sites.  (±)-Epibatidine, (±)-anatoxin-a, and (±)-UB-165 stimulated [3H]-dopamine release from striatal synaptosomes with EC50 values of 2.4, 134, and 88 nM, and relative efficacies of 1:0.4:0.2, resp.  α-Conotoxin-MII inhibited release evoked by these agonists by 48, 56, and 88%, resp., suggesting that (±)-UB-165 is a very poor agonist at the α-conotoxin-MII-insensitive nAChR subtype.  In assays of 86Rb+ efflux from thalamic synaptosomes, a model of an α4β2* nAChR response, (±)-UB-165 was a very weak partial agonist; the low efficacy of (±)-UB-165 at α4β2 nAChR was confirmed in Xenopus oocytes expressing various combinations of human nAChR subunits.  In contrast, (±)-UB-165 and (±)-anatoxin-a were similarly efficacious and similarly sensitive to α-conotoxin-MII in increasing intracellular Ca2+ in SH-SY5Y cells, a functional assay for native α3-contg. nAChR.  These data support the involvement of α4β2* nAChR in the presynaptic modulation of striatal dopamine release and illustrate the utility of exploiting a novel partial agonist, together with a selective antagonist, to dissect the functional roles of nAChR subtypes in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2MBUMY6viQ7Vg90H21EOLACvtfcHk0ljj1rTH_Bd3CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVert7s%253D&md5=f93c15d79098ecf79b07bd526dfcfc97</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharples%26aufirst%3DC.%2BG.%26aulast%3DKaiser%26aufirst%3DS.%26aulast%3DSoliakov%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DJ.%2BA.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DUB-165%253A%2520a%2520novel%2520nicotinic%2520agonist%2520with%2520subtype%2520selectivity%2520implicates%2520the%2520alpha4beta2%252A%2520subtype%2520in%2520the%2520modulation%2520of%2520dopamine%2520release%2520from%2520rat%2520striatal%2520synaptosomes%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D2783%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=687-699&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Multiple+serotonin+receptors%3A+differential+binding+of+%5B3H%5D5-hydroxytryptamine%2C+%5B3H%5Dlysergic+acid+diethylamide+and+%5B3H%5Dspiroperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520differential%2520binding%2520of%2520%255B3H%255D5-hydroxytryptamine%252C%2520%255B3H%255Dlysergic%2520acid%2520diethylamide%2520and%2520%255B3H%255Dspiroperidol%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Morley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshar, M.</span><span> </span><span class="NLM_article-title">Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock</span> <span class="citation_source-journal">J. Comput. Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm1016279&amp;key=10.1023%2FB%3AJCAM.0000035199.48747.1e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=15368919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsl2qtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=189-208&author=S.+D.+Morleyauthor=M.+Afshar&title=Validation+of+an+empirical+RNA-ligand+scoring+function+for+fast+flexible+docking+using+Ribodock"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock</span></div><div class="casAuthors">Morley, S. David; Afshar, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-208</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We report the design and validation of a fast empirical function for scoring RNA-ligand interactions, and describe its implementation within RiboDock, a virtual screening system for automated flexible docking.  Building on well-known protein-ligand scoring function foundations, features were added to describe the interactions of common RNA-binding functional groups that were not handled adequately by conventional terms, to disfavor non-complementary polar contacts, and to control non-specific charged interactions.  The results of validation expts. against known structures of RNA-ligand complexes compare favorably with previously reported methods.  Binding modes were well predicted in most cases and good discrimination was achieved between native and non-native ligands for each binding site, and between native and non-native binding sites for each ligand.  Further evidence of the ability of the method to identify true RNA binders is provided by compd. selection ('enrichment factor') expts. based around a series of HIV-1 TAR RNA-binding ligands.  Significant enrichment in true binders was achieved amongst high scoring docking hits, even when selection was from a library of structurally related, pos. charged mols.  Coupled with a semi-automated cavity detection algorithm for identification of putative ligand binding sites, also described here, the method is suitable for the screening of very large databases of mols. against RNA and RNA-protein interfaces, such as those presented by the bacterial ribosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1tsnKXC_oVbVg90H21EOLACvtfcHk0ljj1rTH_Bd3CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsl2qtrk%253D&md5=c8e8c73d0e65330f44d1d97a50b62a0d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1023%2FB%3AJCAM.0000035199.48747.1e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AJCAM.0000035199.48747.1e%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DS.%2BD.%26aulast%3DAfshar%26aufirst%3DM.%26atitle%3DValidation%2520of%2520an%2520empirical%2520RNA-ligand%2520scoring%2520function%2520for%2520fast%2520flexible%2520docking%2520using%2520Ribodock%26jtitle%3DJ.%2520Comput.%2520Aided%2520Mol.%2520Des.%26date%3D2004%26volume%3D18%26spage%3D189%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">Virtual screening in structure-based drug discovery</span> <span class="citation_source-journal">Mini Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm1016279&amp;key=15379645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=779-791&author=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=Virtual+screening+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening in structure-based drug discovery</span></div><div class="casAuthors">Barril, X.; Hubbard, R. E.; Morley, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in structure detn. and computational methods have encouraged the development of structure-based virtual screening.  Here we survey progress in the field and review the most recent methods, validation expts. and real applications, including an inhouse example of hit identification for the oncol. target Hsp90.  These results provide a basis for discussing the current state of structure-based virtual screening and to outline the developments that are expected to have a major impact in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy7o9-h9rF3bVg90H21EOLACvtfcHk0ljj1rTH_Bd3CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D&md5=2625c1aec0337bcc67d6b62dd9b8a737</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DVirtual%2520screening%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D779%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Dewar, M. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoebisch, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. J. P.</span><span> </span><span class="NLM_article-title">Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3902</span><span class="NLM_x">–</span> <span class="NLM_lpage">3909</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00299a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm1016279&amp;key=1%3ACAS%3A528%3ADyaL2MXktFWlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1985&pages=3902-3909&author=M.+J.+S.+Dewarauthor=E.+G.+Zoebischauthor=E.+F.+Healyauthor=J.+J.+P.+Stewart&title=Development+and+use+of+quantum+mechanical+molecular+models.+76.+AM1%3A+a+new+general+purpose+quantum+mechanical+molecular+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development and use of quantum mechanical molecular models.  76.  AM1:  a new general purpose quantum mechanical molecular model</span></div><div class="casAuthors">Dewar, Michael J. S.; Zoebisch, Eve G.; Healy, Eamonn F.; Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3902-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new parametric quantum mech. mol. model, AM1 (Austin Model 1), based on the NDDO approxn., is described.  In it the major weaknesses of MNDO, in particular failure to reproduce H bonds, are overcome without any increase in computing time.  Results for 167 mols. are reported.  Parameters are currently available for C, H, O, and N.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB-oi6B_HZY7Vg90H21EOLACvtfcHk0lh2l_4o_YPUVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktFWlsLk%253D&md5=5733ca359609184eb3d58fc52c73d2de</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00299a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00299a024%26sid%3Dliteratum%253Aachs%26aulast%3DDewar%26aufirst%3DM.%2BJ.%2BS.%26aulast%3DZoebisch%26aufirst%3DE.%2BG.%26aulast%3DHealy%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DDevelopment%2520and%2520use%2520of%2520quantum%2520mechanical%2520molecular%2520models.%252076.%2520AM1%253A%2520a%2520new%2520general%2520purpose%2520quantum%2520mechanical%2520molecular%2520model%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1985%26volume%3D107%26spage%3D3902%26epage%3D3909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.,  Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.</span>Gaussian 03, rev B.04; <span class="NLM_publisher-name">Gaussian, Inc.</span>, <span class="NLM_publisher-loc">Pittsburgh PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=J.+A.+Montgomery&author=T.+Vreven&author=K.+N.+Kudin&author=J.+C.+Burant&author=J.+M.+Millam&author=S.+S.+Iyengar&author=J.+Tomasi&author=V.+Barone&author=B.+Mennucci&author=M.+Cossi&author=G.+Scalmani&author=N.+Rega&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=M.+Klene&author=X.+Li&author=J.+E.+Knox&author=H.+P.+Hratchian&author=J.+B.+Cross&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=P.+Y.+Ayala&author=K.+Morokuma&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=V.+G.+Zakrzewski&author=S.+Dapprich&author=A.+D.+Daniels&author=M.+C.+Strain&author=O.+Farkas&author=D.+K.+Malick&author=A.+D.+Rabuck&author=K.+Raghavachari&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=Q.+Cui&author=A.+G.+Baboul&author=S.+Clifford&author=J.+Cioslowski&author=B.+B.+Stefanov&author=G.+Liu&author=A.+Liashenko&author=P.+Piskorz&author=I.+Komaromi&author=R.+L.+Martin&author=D.+J.+Fox&author=T.+Keith&author=M.+A.+Al-Laham&author=C.+Y.+Peng&author=A.+Nanayakkara&author=M.+Challacombe&author=P.+M.+W.+Gill&author=B.+Johnson&author=W.+Chen&author=M.+W.+Wong&author=C.+Gonzalez&author=J.+A.+Pople&title=Gaussian+03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252003%26pub%3DGaussian%252C%2520Inc%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B','PDB','1J1B'); return false;">PDB: 1J1B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3F88','PDB','3F88'); return false;">PDB: 3F88</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0E','PDB','1R0E'); return false;">PDB: 1R0E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q5K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q5K','PDB','1Q5K'); return false;">PDB: 1Q5K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UV5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UV5','PDB','1UV5'); return false;">PDB: 1UV5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O5K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2O5K','PDB','2O5K'); return false;">PDB: 2O5K</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a href="/doi/suppl/10.1021/jm1016279">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34181"></div></div></div></div></div><hr /></hr><p class="last">Poses for selected GSK-3 inhibitors upon docking to their targets; docked poses for derivatives of adenine (<b>32</b>) and maleimide (<b>40</b>) containing the halomethyketone moiety; elemental analyses of compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1016279/suppl_file/jm1016279_si_001.pdf">jm1016279_si_001.pdf (310.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1016279&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-12%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm1016279%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1016279" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ac9420cdb3dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
